Breast diseases

Guidelines, reviews, epidemiology

Benign breast diseases

• Brazil
  • Clinics
    • Management of benign and suspicious breast lesions during the coronavirus disease pandemic: recommendations for triage and treatment [2020]
• Canada
  • Canadian Journal of Surgery
    • A survey of Canadian breast health professionals’ recommendations for high-risk benign breast disease [2019]
• China
  • Chinese Medical Journal
    • Clinical practice guidelines for intraductal papilloma: Chinese Society of breast surgery (CSBrS) practice guidelines 2021 [2021]
    • Clinical practice guideline for diagnosis and treatment of hyperplasia of the mammary glands: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021 [2021]
    • Clinical practice guideline for breast fibroadenoma: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021 [2021]
• France
  • Archive ouverte HAL
    • Clinical practice guidelines from the French College of Gynecologists and Obstetricians (CNGOF): benign breast tumors [2016]
• Germany
  • Breast Care
    • Benign Breast Tumours - Diagnosis and Management [2018]
• Spain
  • Breast
    • Differences in breast cancer risk after benign breast disease by type of screening diagnosis [2020]
  • International Journal of Environmental Research and Public Health
    • Long-Term Risk of Breast Cancer after Diagnosis of Benign Breast Disease by Screening Mammography [2022]
• United Kingdom
  • Association of Breast Surgery
    • Guidance and pathways for the assessment of children with breast symptoms [2021]
    • Management of Fibroadenomas [2019]
    • Guidelines for the investigation and management of spontaneous nipple discharge in the absence of a breast lump [2019]
  • National Institute for Health and Care Excellence
    • High-intensity focused ultrasound for symptomatic breast fibroadenoma [2017]
• United States
  • Breast Cancer Research and Treatment
    • Pathologic Discordance to Clinical Management Decisions Suggests Overtreatment in Pediatric Benign Breast Disease [2019]
• {Related topics}
  • Topic
    • Mastitis
    • Gynecomastia
    • Breast plastic surgery
    • Breast imaging
    • Breast cancer
    • Breast biopsy, breast pathology

Breast biopsy, breast pathology

• Australasia
  • Royal College of Pathologists of Australasia
    • Breast
• Australia
  • Cancer Australia
    • Position Statement on the use of fine needle aspiration (FNA) and core biopsy of the breast in the BreastScreen Australia program [2020]
    • High level review of evidence and guidelines to inform the Position Statement on the use of fine needle aspiration (FNA) and core biopsy of the breast in the BreastScreen Australia program [2020]
• Brazil
  • Value in Health Regional Issues
    • The Negative Impact of the New Coronavirus Pandemic on the Trend of Breast Biopsies and Their Direct Costs: Interrupted Time Series Analysis [2023]
• Canada
  • Current Oncology
    • Testing for her2 in breast cancer: current pathology challenges faced in Canada [2012]
• Central and Eastern Europe
  • Pathology & Oncology Research
    • Pathological Diagnosis, Work-Up and Reporting of Breast Cancer 1st Central-Eastern European Professional Consensus Statement on Breast Cancer [2022]
• China
  • Breast
    • Clinicopathological characteristics and prognosis of breast cancer with special histological types: A surveillance, epidemiology, and end results database analysis [2020]
  • Chinese Medical Journal
    • Clinical practice guidelines for visualized percutaneous breast tissue clips: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021 [2021]
    • Clinical practice guidelines for ultrasound-guided vacuum-assisted breast biopsy: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021 [2021]
• Egypt
  • JCO Global Oncology
    • Clinicopathologic Features of Breast Cancer in Egypt-Contemporary Profile and Future Needs: A Systematic Review and Meta-Analysis [2023]
• Europe
  • European Society of Breast Imaging
    • Image-guided breast biopsy and localisation: recommendations for information to women and referring physicians by the European Society of Breast Imaging [2020]
• India
  • Indian Journal of Medical Research
    • Stereotactic breast biopsy: A review & applicability in the Indian context [2021]
• International
  • Acta Cytologica
    • Systematic Review and Meta-Analysis of the Diagnostic Accuracy of the International Academy of Cytology Yokohama System for Reporting Breast Fine-Needle Aspiration Biopsy in Diagnosing Breast Cancer [2023]
  • Annals of Oncology
    • Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration [2015]
  • Breast Cancer Research and Treatment
    • First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions) [2016]
  • Breast Health Global Initiative
    • Can pathology diagnostic services for cancer be stratified and serve global health? [2020]
  • Histopathology
    • Phyllodes tumours of the breast: a consensus review [2016]
    • Breast lesions of uncertain malignant nature and limited metastatic potential: Proposals to improve their recognition and clinical management [2016]
  • International Academy of Cytology
    • IAC Standardized Reporting of Breast Fine-Needle Aspiration Biopsy Cytology [2017]
  • International Collaboration on Cancer Reporting
    • Invasive Carcinoma of the Breast [2022]
    • Ductal Carcinoma In Situ, Variants of Lobular Carcinoma In Situ and Low Grade Lesions [2021]
  • Modern Pathology
    • Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group [2015]
• Iran
  • World Journal of Surgical Oncology
    • Chronological changes and trend of breast cancer clinics and pathology among Iranian women during 22 years from the largest breast cancer registry in Iran [2019]
• Italy
  • Pathologica
    • Pathological examination of breast cancer samples before and after neoadjuvant therapy: recommendations from the Italian Group for the Study of Breast Pathology - Italian Society of Pathology (GIPaM-SIAPeC) [2022]
• Netherlands
  • Breast
    • The impact of standardized structured reporting of pathology reports for breast cancer care [2022]
• New Zealand
  • Ministry of Health New Zealand
    • Report of the National Panel to review Breast Biopsy Errors [2012]
• Sub-Saharan Africa
  • BMC Health Services Research
    • Breast cancer pathology services in sub-Saharan Africa: a survey within population-based cancer registries [2020]
• Switzerland
  • Acta Radiologica
    • Lesions with unclear malignant potential (B3) after minimally invasive breast biopsy: evaluation of vacuum biopsies performed in Switzerland and recommended further management [2015]
• United Kingdom
  • Association of Breast Surgery
    • Best Practise Guidelines for Surgeons in Breast Cancer Screening [2018]
  • British Journal of Cancer
    • The presentation, management and outcome of patients with ductal carcinoma in situ (DCIS) with microinvasion (invasion <=1 mm in size)-results from the UK Sloane Project [2022]
  • Journal of Clinical Pathology
    • Updated UK Recommendations for HER2 assessment in breast cancer [2015]
  • National Institute for Health and Care Excellence
    • MammaTyper in vitro diagnostic test for determining breast cancer subtypes [2018]
    • Image-guided radiofrequency excision biopsy of breast lesions [2009]
  • NHS England
    • NHS Breast Screening Programme Guidance: Biopsy testing guidance
  • Public Health England
    • Breast screening: how to record vacuum-assisted excisions
  • Royal College of Pathologists
    • Guidelines for non-operative diagnostic procedures and reporting in breast cancer screening [2021]
    • Pathology reporting of breast disease in surgical excision specimens incorporating the dataset for histological reporting of breast cancer (low-res) [2016]
    • Pathology reporting of breast disease in surgical excision specimens incorporating the dataset for histological reporting of breast cancer (high-res) [2016]
• United States
  • Agency for Healthcare Research and Quality
    • Core-Needle Biopsy for Breast Abnormalities [2016]
  • American College of Radiology
    • ACR Practice Parameter for the Performance of Ultrasound-Guided Percutaneous Breast Interventional Procedures
    • ACR Practice Parameter for the Performance of Stereotactic- Guided Breast Interventional Procedure
    • ACR Practice Parameter for the Performance of Magnetic Resonance Imaging-Guided Breast Interventional Procedures
  • Annals of Surgical Oncology
    • The 21-Gene Recurrence Score in Clinically High-Risk Lobular and Ductal Breast Cancer: A National Cancer Database Study [2022]
    • Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer [2018]
  • BMC Women's Health
    • Development of a diagnostic test set to assess agreement in breast pathology: practical application of the Guidelines for Reporting Reliability and Agreement Studies (GRRAS) [2013]
  • Breast
    • Surgical Margin Reporting in Breast Conserving Surgery: Does compliance with guidelines affect re-excision and mastectomy rates? [2015]
  • Breast Cancer Surveillance Consortium
    • Breast biopsy patterns and findings among older women undergoing screening mammography: The role of age and comorbidity [2022]
    • Breast Biopsy Recommendations and Breast Cancers Diagnosed during the COVID-19 Pandemic [2022]
    • Breast Biopsy Intensity and Findings Following Breast Cancer Screening in Women With and Without a Personal History of Breast Cancer [2018]
    • Trends in Breast Tissue Sampling and Pathology Diagnoses among Women Undergoing Mammography in the U.S.: A Report from the Breast Cancer Surveillance Consortium [2015]
  • CA: A Cancer Journal for Clinicians
    • Breast Cancer—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual [2017]
  • JAMA Oncology
    • Clinicopathologic Characteristics and Prognosis of ERBB2-Low Breast Cancer Among Patients in the National Cancer Database [2023]
• {Related topics}
  • Topic
    • Sentinel lymph node biopsy
    • Breast cancer diagnosis
    • Breast cancer
    • Benign breast diseases

Breast cancer

• Africa
  • Breast Care
    • A Review on Breast Cancer Care in Africa [2015]
  • Infectious Agents and Cancer
    • An update on the management of breast cancer in Africa [2017]
• Americas
  • Pan American Health Organization
    • Breast cancer
• Argentina
  • Journal of Cancer Education
    • Argentina's National Program for Control of Breast Cancer: Time 1, Patient Navigation, and Patient Cancer Education Experience [2022]
• Asia
  • Asia-Pacific Journal of Oncology Nursing
    • The Effectiveness of Support Groups in Asian Breast Cancer Patients: An Integrative Review [2016]
  • BMC Health Services Research
    • Health system barriers influencing timely breast cancer diagnosis and treatment among women in low and middle-income Asian countries: evidence from a mixed-methods systematic review [2022]
  • European Society for Medical Oncology
    • Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, staging and treatment of patients with metastatic breast cancer [2023]
    • Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with early breast cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS [2020]
• Australia
  • Australian Institute of Health and Welfare
    • Breast cancer in young women: key facts about breast cancer in women in their 20s and 30s [2015]
  • Cancer Australia
    • Breast Cancer: a handbook for Aboriginal and Torres Strait Islander Health Workers [2022]
    • Shared follow-up care for early breast cancer: summary of evidence [2019]
    • Influencing best practice in breast cancer [2016]
    • Clinical guidance for the management of lobular carcinoma in situ [2016]
    • Learner’s Guide: Providing information and support to Aboriginal and Torres Strait Islander women with breast cancer [2012]
    • Facilitator’s Guide: Providing information and support to Aboriginal and Torres Strait Islander women with breast cancer [2012]
  • International Journal for Equity in Health
    • Does breast cancer policy meet the needs of Aboriginal and Torres Strait Islander women in Australia? a review [2023]
• Bosnia and Herzegovina
  • Biomolecules and Biomedicine
    • Guidelines for breast cancer management in Bosnia and Herzegovina [2023]
  • Bosnian Journal of Basic Medical Sciences
    • 2020 consensus guideline for optimal approach to the diagnosis and treatment of HER2-positive breast cancer in Bosnia and Herzegovina [2020]
• Brazil
  • BMC Health Services Research
    • The trend and direct costs of screening and chemotherapy treatment of breast cancer in the new coronavirus pandemic: total and interrupted time series study [2022]
  • Ciência & Saúde Coletiva
    • Temporal trends in social security benefits for female breast cancer in Brazil [2022]
  • JCO Global Oncology
    • Impact of COVID-19 Disease in Early Breast Cancer Management: A Summary of the Current Evidence [2022]
• Canada
  • BC Cancer Agency
    • Breast Cancer
  • BCGuidelines
    • Breast Disease and Cancer: Diagnosis [2013]
    • Breast Cancer: Management and Follow-Up [2013]
  • Canadian Cancer Society
    • Breast cancer
  • Canadian Family Physician
    • Primary care physician use across the breast cancer care continuum. CanIMPACT study using Canadian administrative data [2016]
  • Journal of the National Cancer Institute
    • Out-of-Pocket Costs in the Year After Early Breast Cancer Among Canadian Women and Spouses [2013]
  • Public Health Agency of Canada
    • Breast Cancer
• China
  • Annals of Translational Medicine
    • National consensus in China on diagnosis and treatment of patients with advanced breast cancer [2015]
  • Cancer
    • Chinese expert consensus on the clinical diagnosis and treatment of advanced breast cancer (2018) [2020]
  • Chinese Journal of Cancer Research
    • Chinese guidelines for diagnosis and treatment of breast cancer 2018 (English version) [2019]
  • Chinese Medical Journal
    • Clinical practice guidelines for ductal carcinoma in situ: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021 [2021]
    • Clinical practice guidelines for diagnosis and treatment of invasive breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021 [2021]
• Costa Rica, Mexico
  • PLoS ONE
    • Cost-Effectiveness of Breast Cancer Control Strategies in Central America: The Cases of Costa Rica and Mexico [2014]
• Cuba
  • International Journal of Clinical and Experimental Medicine
    • Application of hazard models for patients with breast cancer in Cuba [2011]
• Denmark
  • Clinical Epidemiology
    • Danish Breast Cancer Cooperative Group [2016]
• Developing countries
  • World Journal of Clinical Oncology
    • Challenges to the early diagnosis and treatment of breast cancer in developing countries [2014]
• Eastern Europe
  • SAGE Open Medicine
    • Comparative analysis of the access to health-care services and breast cancer therapy in 10 Eastern European countries [2020]
• Egypt
  • Eastern Mediterranean Health Journal
    • Presentation and management of female breast cancer in Egypt [2022]
• Europe
  • Breast
    • Why is appropriate healthcare inaccessible for many European breast cancer patients? – The EBCC 12 manifesto [2021]
    • The requirements of a specialist breast centre [2020]
    • Addressing disparities and challenges in underserved patient populations with metastatic breast cancer in Europe [2020]
    • New approaches for improving outcomes in breast cancer in Europe [2015]
  • Breast Cancer Research and Treatment
    • Healthcare providers’ adherence to breast cancer guidelines in Europe: a systematic literature review [2020]
  • European Society for Medical Oncology
    • ESO-ESMO fifth international consensus guidelines for breast cancer in young women (BCY5) [2022]
    • ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer [2021]
    • ESO–ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4) [2020]
    • ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer [2020]
    • Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [2019]
    • ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3) [2017]
    • Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [2015]
    • ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2) [2014]
    • Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [2012]
  • European Society of Breast Cancer Specialists
    • The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer [2012]
  • Journal of Obstetrics and Gynaecology of India
    • Guidance and Standards for Breast Cancer Care in Europe [2020]
• France
  • Clinical Breast Cancer
    • Ductal Carcinoma in Situ: A French National Survey. Analysis of 2125 Patients [2020]
  • European Journal of Breast Health
    • Breast Cancer Management during the COVID 19 Pandemic: French Guidelines [2020]
  • PLoS ONE
    • Compliance with clinical guidelines for breast cancer management: A population-based study of quality-of-care indicators in France [2019]
• Gambia
  • BMC Health Services Research
    • Geospatial analysis and impact of targeted development of breast cancer care in The Gambia: a cross-sectional study [2021]
• Germany
  • Archives of Gynecology and Obstetrics
    • Multidisciplinary breast centres in Germany: a review and update of quality assurance through benchmarking and certification [2012]
  • Breast Care
    • AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2021 [2021]
    • AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2021 [2021]
    • AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2020 [2020]
    • AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2019 [2019]
    • AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2019 [2019]
    • AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2016 [2016]
    • AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2016 [2016]
  • Deutsches Ärzteblatt International
    • The Screening, Diagnosis, Treatment, and Follow-Up of Breast Cancer [2018]
  • Geburtshilfe und Frauenheilkunde
    • Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer [2018]
  • Institute for Quality and Efficiency in Health Care
    • Systematic Guideline Search and Appraisal, as Well as Extraction of Relevant Recommendations, for the DMP "Breast Cancer" [2014]
• High-income countries
  • International Journal of Environmental Research and Public Health
    • What Is the Evidence Globally for Culturally Safe Strategies to Improve Breast Cancer Outcomes for Indigenous Women in High Income Countries? A Systematic Review [2021]
• India
  • South Asian Journal of Cancer
    • Breast cancer: An overview of published Indian data [2016]
• International
  • Annals of Translational Medicine
    • A quality evaluation of the clinical practice guidelines on breast cancer using the RIGHT checklist [2021]
  • Breast Health Global Initiative
    • The role of dissemination and implementation science in global breast cancer control programs: Frameworks, methods, and examples [2020]
    • The Breast Health Global Initiative 2018 Global Summit on Improving Breast Healthcare Through Resource-Stratified Phased Implementation: Methods and overview [2020]
    • Situational analysis of breast health care systems: Why context matters [2020]
  • Current Oncology
    • Clinical practice guidelines in breast cancer [2018]
  • Senologic International Society
    • Breast Cancer Management During the COVID-19 Pandemic: The Senologic International Society Survey [2021]
• Iran
  • Iranian Journal of Public Health
    • Psychological Consequences of Breast Cancer in Iran: A Meta-Analysis [2019]
    • The Economic Burden of Breast Cancer in Iran [2015]
• Ireland
  • Department of Health
    • Diagnosis, Staging and Treatment of Patients with Breast Cancer [2015]
• Japan
  • BMC Research Notes
    • Cost of illness of breast cancer in Japan: trends and future projections [2015]
  • Breast Cancer
    • Characteristics of female breast cancer in Japan: annual report of the National Clinical Database in 2018 [2023]
    • Recommendations for the management of breast cancer patients during the COVID-19 pandemic from the Japan Breast Cancer Society [2021]
• Latin America
  • Cancer Reports
    • Recommendations for streamlining precision medicine in breast cancer care in Latin America [2021]
  • ecancermedicalscience
    • Management of non-invasive tumours, benign tumours and breast cancer during the COVID-19 pandemic: recommendations based on a Latin American survey [2020]
  • Globalization and Health
    • Breast cancer policy in Latin America: account of achievements and challenges in five countries [2016]
• Lithuania
  • Medicina
    • The cost of newly diagnosed breast cancer in Lithuania, 2011 [2015]
• Low and middle income countries
  • Oncologist
    • Economic Evaluations of Breast Cancer Care in Low- and Middle-Income Countries: A Scoping Review [2021]
  • Systematic Reviews
    • Economic analyses of breast cancer control in low- and middle-income countries: a systematic review [2013]
• Malaysia
  • Ministry of Health Malaysia
    • Management of Breast Cancer (3rd Edition) [2019]
• Mexico
  • ecancermedicalscience
    • Costs of breast cancer care in Mexico: analysis of two insurance coverage scenarios [2015]
• Middle East, North Africa
  • ecancermedicalscience
    • Do we need regional guidelines for breast cancer management in the MENA region? MENA Breast Cancer Guidelines project [2017]
• Netherlands
  • Breast
    • Patterns of care over 10 years in young breast cancer patients in the Netherlands, a nationwide population-based study [2022]
    • Trends in incidence, treatment, survival and subsequent breast cancer in lobular carcinoma in situ in the Netherlands: A population-based analysis [2021]
  • Journal of Hematology & Oncology
    • Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study [2021]
• New Zealand
  • Ministry of Health New Zealand
    • Management of Early Breast Cancer: Evidence-based Best Practice Guideline [2009]
  • PLoS ONE
    • Differences in Breast Cancer Survival between Public and Private Care in New Zealand: Which Factors Contribute? [2016]
• Republic of Korea
  • Cancer Research and Treatment
    • The Economic Burden of Breast Cancer in Korea from 2007-2010 [2015]
• South Africa
  • Journal of Oncology
    • Improving Breast Cancer Control via the Use of Community Health Workers in South Africa: A Critical Review [2011]
  • National Department of Health
    • Breast Cancer Control Policy [2017]
• Spain
  • International Journal of Environmental Research and Public Health
    • Breast Cancer Care Quality Indicators in Spain: A Systematic Review [2021]
• Sub-Saharan Africa
  • International Agency for Research on Cancer
    • Breast Cancer Outcomes in Sub-Saharan Africa [2021]
  • JCO Global Oncology
    • Assessment of Breast Cancer Management in Sub-Saharan Africa [2021]
• Uganda
  • African Health Sciences
    • Breast cancer guidelines for Uganda (2nd Edition 2008) [2008]
• United Arab Emirates
  • JCO Global Oncology
    • Breast Cancer in the United Arab Emirates [2023]
• United Kingdom
  • British Journal of Cancer
    • Inflammatory breast cancer: time to standardise diagnosis assessment and management, and for the joining of forces to facilitate effective research [2015]
  • International Journal of Breast Cancer
    • A Nationwide Cross-Sectional Survey of UK Breast Surgeons' Views on the Management of Ductal Carcinoma In Situ [2015]
  • National Institute for Health and Care Excellence
    • Early and locally advanced breast cancer: diagnosis and management [2024]
    • Advanced breast cancer: diagnosis and treatment [2017]
    • Breast cancer [2016]
    • Breast cancer
  • Scottish Government
    • Breast cancer clinical quality performance indicators [2016]
• United States
  • American Cancer Society
    • Breast Cancer Facts & Figures 2019-2020 [2019]
    • Breast Cancer
  • American Society of Clinical Oncology
    • Breast Cancer
  • Centers for Disease Control and Prevention
    • Breast Cancer
  • JNCI Cancer Spectrum
    • Epidemiology, Biology, Treatment, and Prevention of Ductal Carcinoma In Situ (DCIS) [2018]
  • M.D. Anderson Cancer Center
    • Inflammatory Breast Cancer
    • Breast Cancer
  • National Comprehensive Cancer Network
    • NCCN Guidelines Updates: Breast Cancer [2019]
    • Breast Cancer
  • Obstetrics & Gynecology
    • Executive Summary of the Early-Onset Breast Cancer Evidence Review Conference [2020]
  • OncoLink
    • Breast Cancer
• WHO
  • International Agency for Research on Cancer
    • Breast cancer
  • World Health Organization
    • Global breast cancer initiative implementation framework: assessing, strengthening and scaling up of services for the early detection and management of breast cancer [2023]
    • The Global Breast Cancer Initiative
    • Breast cancer: Fact sheet
• WHO Eastern Mediterranean Region
  • WHO Eastern Mediterranean Region
    • Guidelines for management of breast cancer [2006]
• {Related topics}
  • Topic
    • Triple negative breast cancer
    • Sentinel lymph node biopsy
    • Menopause, hormone replacement therapy, breast cancer
    • Gynecologic oncology
    • Familial breast cancer
    • Breast plastic surgery
    • Breast imaging
    • Breast cancer treatment
    • Breast cancer stem cells
    • Breast cancer screening, mammography
    • Breast cancer risk
    • Breast cancer prevention
    • Breast cancer markers
    • Breast cancer epidemiology
    • Breast cancer diagnosis
    • Breast cancer and pregnancy
    • Breast biopsy, breast pathology
    • Benign breast diseases

Breast cancer and pregnancy

• Australia, New Zealand
  • Birth
    • Perinatal outcomes of women with gestational breast cancer in Australia and New Zealand: A prospective population-based study [2022]
• Canada
  • Current Oncology
    • Outcome of patients with pregnancy during or after breast cancer: a review of the recent literature [2015]
• China
  • Breast Cancer Research and Treatment
    • Physicians’ attitudes towards reproduction in young patients with early breast cancer in China [2020]
  • Chinese Medical Journal
    • Clinical practice guidelines for pregnancy-associated breast cancer: Chinese society of breast surgery (CSBrS) practice guidelines 2021 [2021]
• France
  • Breast
    • Prognosis of triple-negative breast cancer associated with pregnancy: A propensity score-matched analysis from the French CALG (Cancer Associé à la Grossesse) network [2022]
• International
  • BMC Cancer
    • Prognosis of pregnancy-associated breast cancer: a meta-analysis [2020]
  • Journal of Advanced Nursing
    • Women's experiences of gestational breast cancer and their interactions with the healthcare system: A scoping review [2023]
• Republic of Korea
  • Breast
    • Prognosis of pregnancy after breast cancer diagnosis according to the type of treatment: A population-based study in Korea by the SMARTSHIP group [2022]
  • Cancer Research and Treatment
    • Outcomes of Pregnancy after Breast Cancer in Korean Women: A Large Cohort Study [2020]
  • Frontiers in Oncology
    • The Risk Factors, Incidence and Prognosis of Postpartum Breast Cancer: A Nationwide Study by the SMARTSHIP Group [2022]
  • Journal of Breast Cancer
    • Neoadjuvant Chemotherapy and Prognosis of Pregnancy-Associated Breast Cancer: A Time-Trends Study of the Korean Breast Cancer Registry Database [2018]
  • Oncologist
    • Prognostic Impact of Pregnancy in Korean Patients with Breast Cancer [2019]
  • PLoS ONE
    • Pregnancy-Associated Risk Factors of Postpartum Breast Cancer in Korea: A Nationwide Health Insurance Database Study [2016]
• Taiwan
  • Oncologist
    • Mortality of Pregnancy Following Breast Cancer Diagnoses in Taiwanese Women [2020]
• Turkey
  • Turkish Journal of Surgery
    • Fertility and breast cancer: Recommendations of the 2019 Izmir Consensus Conference [2020]
• United Kingdom
  • European Journal of Cancer
    • Survival after breast cancer in women with a subsequent live birth: Influence of age at diagnosis and interval to subsequent pregnancy [2022]
• United States
  • Academy of Breastfeeding Medicine
    • ABM Clinical Protocol #34: Breast Cancer and Breastfeeding [2020]
  • Breast
    • Obstetric complications at time of delivery amongst breast cancer survivors: A population-based cohort study [2022]
  • Breast Cancer Research
    • Outcomes of children exposed in utero to chemotherapy for breast cancer [2014]
  • National Cancer Institute
    • Breast Cancer Treatment During Pregnancy (PDQ®)
• {Related topics}
  • Topic
    • Obstetrics, perinatology
    • Breast cancer

Breast cancer diagnosis

• Africa
  • JCO Global Oncology
    • Prevalence of Themes Linked to Delayed Presentation of Breast Cancer in Africa: A Meta-Analysis of Patient-Reported Studies [2020]
• Australia
  • Cancer Australia
    • Investigation of a new breast symptom - a guide for general practitioners [2021]
    • Summary of the development process and methodology for the investigation of a new breast symptom GP card [2017]
• China
  • Cancer Medicine
    • Disparities in stage at diagnosis among breast cancer molecular subtypes in China [2023]
• Low and middle income countries
  • Psycho-Oncology
    • Duration of the patient interval in breast cancer and factors associated with longer delays in low-and middle-income countries: A systematic review with meta-analysis [2023]
• Sub-Saharan Africa
  • Lancet Global Health
    • Stage at diagnosis of breast cancer in sub-Saharan Africa: a systematic review and meta-analysis [2016]
• United Kingdom
  • Association of Breast Surgery
    • Best practice diagnostic guidelines for patients presenting with breast symptoms [2010]
  • British Journal of Cancer
    • The impact of the first 2 years of the COVID-19 pandemic on breast cancer diagnoses: a population-based study in England [2023]
• United States
  • American College of Radiology
    • Stage I Breast Cancer: Initial Work up and Surveillance for Local Recurrence and Distant Metastases in Asymptomatic Women
• {Related topics}
  • Topic
    • Breast imaging
    • Breast cancer screening, mammography
    • Breast cancer
    • Breast biopsy, breast pathology

Breast cancer epidemiology

• Africa
  • African Health Sciences
    • Clustering time trends of breast cancer incidence in Africa: a 27-year longitudinal study in 53 countries [2021]
  • Journal of Global Health
    • Estimating the incidence of breast cancer in Africa: a systematic review and meta-analysis [2018]
• Algeria
  • Cancer Treatment and Research Communications
    • Epidemiology of breast cancer in women based on diagnosis data from oncologists and senologists in Algeria [2020]
• Arab countries
  • International Journal of Surgery
    • Age at diagnosis of breast cancer in Arab nations [2010]
• Arctic countries
  • International Journal of Circumpolar Health
    • Breast cancer in the Arctic – changes over the past decades [2012]
• Asia
  • Breast Care
    • Current Status and Future Projections of Breast Cancer in Asia [2015]
  • Cancer
    • The Prevalence and Assessment of ErbB2-Positive Breast Cancer in Asia [2010]
  • Cancer Management and Research
    • Recent insights into breast cancer incidence trends among four Asian countries using age-period-cohort model [2019]
  • Journal of the National Cancer Institute
    • Female Breast Cancer Incidence Among Asian and Western Populations: More Similar Than Expected [2015]
  • Scientific Reports
    • Trends and Projections in Breast Cancer Mortality among four Asian countries (1990–2017): Evidence from five Stochastic Mortality Models [2020]
• Australia
  • BMC Cancer
    • A population-based study of breast cancer prevalence in Australia: predicting the future health care needs of women living with breast cancer [2014]
  • Cancer Australia
    • Report to the Nation - breast cancer 2012 [2012]
• Australia, Japan
  • Asian Pacific Journal of Cancer Prevention
    • Comparative Analysis of Breast Cancer Incidence Rates between Australia and Japan: Screening Target Implications [2020]
• Austria
  • Scientific Reports
    • Trends in female breast cancer incidence, mortality, and survival in Austria, with focus on age, stage, and birth cohorts (1983-2017) [2022]
• Bahamas
  • Breast Cancer : Basic and Clinical Research
    • Breast Cancer in the Bahamas in 2009–2011 [2016]
• Bahrain
  • Sultan Qaboos University Medical Journal
    • Epidemiology of Breast Cancer among Bahraini Women: Data from the Bahrain Cancer Registry [2014]
• Brazil
  • BMC Public Health
    • Temporal trends in female breast cancer mortality in Brazil and correlations with social inequalities: ecological time-series study [2015]
  • BMC Women's Health
    • The role of health policy in the burden of breast cancer in Brazil [2017]
  • Frontiers in Oncology
    • Breast Cancer Mortality in Young Women in Brazil [2021]
  • JCO Global Oncology
    • Epidemiological Analyses Reveal a High Incidence of Breast Cancer in Young Women in Brazil [2021]
  • Lancet Global Health
    • Ethnoracial and social trends in breast cancer staging at diagnosis in Brazil, 2001–14: a case only analysis [2019]
  • Revista da Associação Médica Brasileira
    • Female breast cancer mortality in Brazil and its regions [2014]
  • Scientific Reports
    • Effects of the high-inequality of income on the breast cancer mortality in Brazil [2019]
• Canada
  • Canadian Cancer Society
    • Breast cancer statistics
  • Canadian Journal of Public Health
    • The incidence of breast cancer in Canada 1971–2015: trends in screening-eligible and young-onset age groups [2020]
• Central African Republic
  • BMC Public Health
    • Epidemiology of breast cancer: retrospective study in the Central African Republic [2016]
• Central and Eastern Europe
  • Journal of Medical Economics
    • Breast cancer-related mortality in Central and Eastern Europe: years of life lost and productivity costs [2023]
• Central and South America
  • Cancer Epidemiology
    • Female breast cancer in Central and South America [2016]
• China
  • BMC Public Health
    • Historical trends in breast Cancer among women in China from age-period-cohort modeling of the 1990–2015 breast Cancer mortality data [2020]
  • Cancer Biology & Medicine
    • Breast cancer incidence and mortality in women in China: temporal trends and projections to 2030 [2021]
  • Chinese Medical Journal
    • Global and regional trends in incidence and mortality of female breast cancer and associated factors at national level in 2000 to 2019 [2022]
  • International Journal of Environmental Research and Public Health
    • Analysis on Incidence and Mortality Trends and Age-Period-Cohort of Breast Cancer in Chinese Women from 1990 to 2019 [2023]
  • Medicine
    • Epidemiological and Clinicopathological Trends of Breast Cancer in Chinese Patients During 1993 to 2013 [2015]
• China, Japan, Republic of Korea
  • BMC Cancer
    • Burden, trends, and risk factors for breast cancer in China from 1990 to 2019 and its predictions until 2034: an up-to-date overview and comparison with those in Japan and South Korea [2022]
• Croatia
  • Oncologist
    • COVID-19 Pandemic Effects on Breast Cancer Diagnosis in Croatia: A Population- and Registry-Based Study [2021]
• Cyprus
  • Data in Brief
    • Epidemiology of breast cancer in Cyprus: Data on newly diagnosed cases and survival rates [2018]
• Denmark
  • International Journal of Cancer
    • Divergent estrogen receptor-positive and -negative breast cancer trends and etiologic heterogeneity in Denmark [2013]
  • International Journal of Epidemiology
    • Incidence of metachronous contralateral breast cancer in Denmark 1978–2009 [2014]
• Developing countries
  • Frontiers in Public Health
    • Trend of disease burden and risk factors of breast cancer in developing countries and territories, from 1990 to 2019: Results from the Global Burden of Disease Study 2019 [2023]
• East and South Asia
  • Frontiers in Nutrition
    • Breast Cancer Mortality Trends and Predictions to 2030 and Its Attributable Risk Factors in East and South Asian Countries [2022]
• East Asia, United States
  • International Journal of Environmental Research and Public Health
    • Secular Trends of Breast Cancer in China, South Korea, Japan and the United States: Application of the Age-Period-Cohort Analysis [2015]
• Egypt
  • Journal of Thoracic Disease
    • Breast cancer in Egypt, China and Chinese: statistics and beyond [2014]
• Eritrea
  • International Journal of Breast Cancer
    • Incidence of Breast Cancer in Eritrea: A Retrospective Study from 2011 to 2017 [2019]
• Europe
  • Archives of Medical Science : AMS
    • Breast cancer mortality trends in Europe among women in perimenopausal and postmenopausal age (45+) [2020]
  • BMJ
    • Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database [2010]
  • Breast Care
    • Breast Cancer Statistics in the European Union: Incidence and Survival across European Countries [2019]
  • European Journal of Cancer
    • European trends in breast cancer mortality, 1980–2017 and predictions to 2025 [2021]
  • European Journal of Public Health
    • Socioeconomic inequalities in breast cancer incidence and mortality in Europe—a systematic review and meta-analysis [2016]
  • JCO Global Oncology
    • Trends in Breast Cancer Mortality Between 2001 and 2017: An Observational Study in the European Union and the United Kingdom [2021]
• France
  • Breast Cancer Research
    • Evolution of breast cancer incidence in young women in a French registry from 1990 to 2018: Towards a change in screening strategy? [2022]
• Germany
  • Breast Cancer Research and Treatment
    • Changes in the incidence of early-onset breast cancer in Germany between 2010 and 2022 [2023]
  • Deutsches Ärzteblatt International
    • Trends Over Time in Breast-Cancer-Specific Mortality in Germany [2021]
  • Geburtshilfe und Frauenheilkunde
    • Long-term Incidence and Mortality Trends for Breast Cancer in Germany [2020]
  • PLoS ONE
    • Incidence and Mortality Trends in German Women with Breast Cancer Using Age, Period and Cohort 1999 to 2008 [2016]
• Germany, United States
  • Cancers
    • Divergent Patterns and Trends in Breast Cancer Incidence, Mortality and Survival Among Older Women in Germany and the United States [2020]
• Ghana
  • International Journal of Breast Cancer
    • Pattern of Breast Cancer Distribution in Ghana: A Survey to Enhance Early Detection, Diagnosis, and Treatment [2016]
• Greece, Sweden
  • BMC Cancer
    • Paradoxes of breast cancer incidence and mortality in two corners of Europe [2022]
• Gulf Cooperation Council
  • Eastern Mediterranean Health Journal
    • Ecological study of breast cancer incidence among nationals and nonnationals in the Gulf Cooperation Council countries [2023]
• Hong Kong
  • British Journal of Cancer
    • Breast cancer incidence and mortality in a transitioning Chinese population: current and future trends [2014]
• Iceland
  • Scientific Reports
    • In situ breast cancer incidence patterns in Iceland and differences in ductal carcinoma in situ treatment compared to Sweden [2020]
• India
  • Cancer Causes and Control
    • Symposium report: breast cancer in India—trends, environmental exposures and clinical implications [2021]
  • Indian Journal of Surgical Oncology
    • Time Trends in Breast Cancer Among Indian Women Population: An Analysis of Population Based Cancer Registry Data [2015]
• International
  • Aging
    • Global incidence and mortality of breast cancer: a trend analysis [2021]
  • BioMed Research International
    • Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures [2022]
  • Breast
    • Current and future burden of breast cancer: Global statistics for 2020 and 2040 [2022]
  • Cancer Communications
    • Global patterns of breast cancer incidence and mortality: A population-based cancer registry data analysis from 2000 to 2020 [2021]
  • Cancer Epidemiology Biomarkers & Prevention
    • International Variation in Female Breast Cancer Incidence and Mortality Rates [2015]
  • EClinicalMedicine
    • Global breast cancer incidence and mortality trends by region, age-groups, and fertility patterns [2021]
  • Frontiers in Oncology
    • The Global, Regional, and National Burden and Trends of Breast Cancer From 1990 to 2019: Results From the Global Burden of Disease Study 2019 [2021]
    • The Burden and Trends of Breast Cancer From 1990 to 2017 at the Global, Regional, and National Levels: Results From the Global Burden of Disease Study 2017 [2020]
  • Journal of Advanced Research
    • Epidemiological and sociodemographic transitions of female breast cancer incidence, death, case fatality and DALYs in 21 world regions and globally, from 1990 to 2017: An Age-Period-Cohort Analysis [2021]
  • Journal of Research in Medical Sciences
    • Worldwide trends in breast cancer incidence from 1993 to 2012: Age-period-cohort analysis and joinpoint regression [2020]
  • Lancet Global Health
    • Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study [2020]
  • Scientific Data
    • Global trends and forecasts of breast cancer incidence and deaths [2023]
  • Scientific Reports
    • Worldwide Age at Onset of Female Breast Cancer: A 25-Year Population-Based Cancer Registry Study [2019]
• Iran
  • Breast Cancer Research
    • National and subnational burden of female and male breast cancer and risk factors in Iran from 1990 to 2019: results from the Global Burden of Disease study 2019 [2023]
  • Eastern Mediterranean Health Journal
    • Incidence pattern and spatial analysis of breast cancer in Iranian women: Geographical Information System applications [2018]
  • Frontiers in Oncology
    • National and Subnational Incidence, Mortality, and Years of Life Lost Due to Breast Cancer in Iran: Trends and Age-Period-Cohort Analysis Since 1990 [2021]
  • Iranian Journal of Public Health
    • Age at Diagnosis of Breast Cancer in Iran: A Systematic Review and Meta-Analysis [2021]
  • PLoS ONE
    • Geographical and socioeconomic inequalities in female breast cancer incidence and mortality in Iran: A Bayesian spatial analysis of registry data [2021]
• Iraq
  • Asian Pacific Journal of Cancer Prevention
    • Trends in Breast Cancer Incidence in Iraq During the Period 2000-2019 [2021]
• Jamaica
  • JCO Global Oncology
    • Breast Cancer in Jamaica: Trends From 2010 to 2014—Is Mortality Increasing? [2020]
• Kazakhstan
  • Asian Pacific Journal of Cancer Prevention
    • Study on Breast Cancer in Kazakhstan Using the Functional Time Series [2023]
    • Impact of Screening on Breast Cancer Incidence in Kazakhstan: Results of Component Analysis [2021]
  • Frontiers in Public Health
    • Prevalence, incidence, and mortality rates of breast cancer in Kazakhstan: data from the Unified National Electronic Health System, 2014-2019 [2023]
  • Iranian Journal of Public Health
    • Breast Cancer in Megapolises of Kazakhstan: Epidemiological Assessment of Incidence and Mortality [2019]
• Kyrgyzstan
  • Asian Pacific Journal of Cancer Prevention
    • Breast Cancer Incidence in Kyrgyzstan: Report of 15 Years of Cancer Registry [2022]
• Latin America
  • BMC Public Health
    • Disparities in breast cancer mortality among Latin American women: trends and predictions for 2030 [2023]
  • ecancermedicalscience
    • Locally advanced breast cancer in young women in Latin America [2019]
• Lebanon
  • Medicina
    • Breast Cancer Epidemiology among Lebanese Women: An 11-Year Analysis [2019]
• Lithuania
  • BMC Public Health
    • An analysis of time trends in breast and prostate cancer mortality rates in Lithuania, 1986-2020 [2022]
• Mongolia
  • Cancer Causes and Control
    • Breast cancer incidence in Mongolia [2012]
• Montenegro
  • European Review for Medical and Pharmacological Sciences
    • Trend of breast cancer mortality in Montenegro, 1990-2018 - Joinpoint regression [2022]
• Netherlands
  • BMC Cancer
    • Burden of early, advanced and metastatic breast cancer in The Netherlands [2018]
  • European Journal of Public Health
    • Breast cancer diagnosis and death in the Netherlands: a changing burden [2014]
  • International Journal of Cancer
    • Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands between 1989 and 2017 [2021]
• Norway
  • BMC Cancer
    • Long term trends of breast cancer incidence according to proliferation status [2022]
  • Breast Cancer Research
    • Incidence of breast cancer subtypes in immigrant and non-immigrant women in Norway [2022]
• Peru
  • BMC Cancer
    • Breast cancer mortality trends in Peruvian women [2020]
• Poland
  • BMC Public Health
    • Trends of mortality due to breast cancer in Poland, 2000–2016 [2020]
  • Breast Cancer Research and Treatment
    • Changes in the survival of patients with breast cancer: Poland, 2000-2019 [2023]
  • Przeglad Menopauzalny = Menopause Review
    • Incidence of and mortality from breast cancer among women in Poland in the years 2001-2010 [2014]
• Republic of Korea
  • Cancer Research and Treatment
    • Age-Period-Cohort Analysis of Female Breast Cancer Mortality in Korea [2015]
  • International Journal for Equity in Health
    • Increased breast cancer mortality only in the lower education group: age-period-cohort effect in breast cancer mortality by educational level in South Korea, 1983-2012 [2017]
  • Journal of Breast Cancer
    • Breast Cancer Statistics in Korea, 2018 [2021]
    • Breast Cancer Statistics in Korea in 2017: Data from a Breast Cancer Registry [2020]
    • Breast Cancer Epidemiology of the Working-Age Female Population Reveals Significant Implications for the South Korean Economy [2018]
    • Basic Findings Regarding Breast Cancer in Korea in 2015: Data from a Breast Cancer Registry [2018]
    • The Basic Facts of Korean Breast Cancer in 2013: Results of a Nationwide Survey and Breast Cancer Registry Database [2016]
    • The Basic Facts of Korean Breast Cancer in 2012: Results from a Nationwide Survey and Breast Cancer Registry Database [2015]
    • The Basic Facts of Korean Breast Cancer in 2011: Results of a Nationwide Survey and Breast Cancer Registry Database [2014]
• Saudi Arabia
  • Medicina
    • Breast Cancer Incidence Patterns in the Saudi Female Population: A 17-Year Retrospective Analysis [2022]
  • Saudi Medical Journal
    • Recent incidence and descriptive epidemiological survey of breast cancer in Saudi Arabia [2015]
• Sweden
  • British Journal of Cancer
    • Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study [2022]
• Switzerland
  • Swiss Medical Weekly
    • Net survival of women diagnosed with breast tumours: a population-based study in Switzerland [2023]
• Taiwan
  • Oncotarget
    • Epidemiology and survival outcome of breast cancer in a nationwide study [2017]
  • Scientific Reports
    • Forecast of a future leveling of the incidence trends of female breast cancer in Taiwan: an age-period-cohort analysis [2022]
• Taiwan, United States
  • Cancer Medicine
    • Comparison of annual percentage change in breast cancer incidence rate between Taiwan and the United States—A smoothed Lexis diagram approach [2017]
• United Kingdom
  • Breast Cancer Research and Treatment
    • Breast cancer incidence and survival in Scotland by socio-economic deprivation and tumour subtype [2022]
  • British Journal of Cancer
    • Impact of the SARS-CoV-2 pandemic on female breast, colorectal and non-small cell lung cancer incidence, stage and healthcare pathway to diagnosis during 2020 in Wales, UK, using a national cancer clinical record system [2022]
  • Cancer Research UK
    • Breast cancer statistics
  • JAMA Network Open
    • Estimated Prevalence of Metastatic Breast Cancer in England, 2016-2021 [2022]
• United States
  • American Cancer Society
    • Breast cancer statistics, 2019 [2019]
    • Breast cancer statistics, 2017, racial disparity in mortality by state [2017]
    • Cancer statistics: Breast cancer in situ [2015]
    • Breast cancer statistics, 2015: Convergence of incidence rates between black and white women [2015]
    • Breast cancer statistics, 2013 [2013]
    • Breast Cancer Statistics
  • American Journal of Cancer Research
    • Changing trends and disparities in 5-year overall survival of women with invasive breast cancer in the United States, 1975-2015 [2021]
  • Breast Cancer Research
    • Risk of contralateral breast cancer according to first breast cancer characteristics among women in the USA, 1992–2016 [2021]
  • Breast Cancer Research and Treatment
    • Breast cancer diagnosis and treatment during the COVID-19 pandemic in a nationwide, insured population [2022]
  • Cancer
    • Trends in breast cancer incidence rates by race/ethnicity: Patterns by stage, socioeconomic position, and geography in the United States, 1999-2017 [2022]
    • United States Breast Cancer Mortality Trends in Young Women According to Race [2014]
  • Cancer Epidemiology
    • Breast cancer incidence trends in Asian women aged 20 or older as compared to other ethnic women in the United States from 2000 to 2018 by time period, age and tumor stage [2022]
  • Cancer Epidemiology Biomarkers & Prevention
    • Estimation of the Number of Women Living with Metastatic Breast Cancer in the United States [2017]
  • Centers for Disease Control and Prevention
    • Trends in Breast Cancer Incidence, by Race, Ethnicity, and Age Among Women Aged >=20 Years — United States, 1999–2018 [2022]
    • Patterns and Trends in Age-Specific Black-White Differences in Breast Cancer Incidence and Mortality – United States, 1999–2014 [2016]
    • Vital Signs: Racial Disparities in Breast Cancer Severity — United States, 2005–2009 [2012]
  • International Journal of Environmental Research and Public Health
    • Modeling Geospatial Patterns of Late-Stage Diagnosis of Breast Cancer in the US [2017]
    • Geospatial Analysis of Inflammatory Breast Cancer and Associated Community Characteristics in the United States [2017]
    • Assessing the Racial and Ethnic Disparities in Breast Cancer Mortality in the United States [2017]
  • International Journal of Health Geographics
    • Geographic disparities in late stage breast cancer incidence: results from eight states in the United States [2015]
  • JAMA Network Open
    • Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015 [2020]
  • JNCI Cancer Spectrum
    • Breast Cancer Incidence Trends by Estrogen Receptor Status Among Asian American Ethnic Groups, 1990–2014 [2020]
    • Incidence and Survival Among Young Women With Stage I–III Breast Cancer: SEER 2000–2015 [2019]
  • Journal of the National Cancer Institute
    • Decreasing Incidence of Estrogen Receptor-Negative Breast Cancer in the United States: Trends by Race and Region [2022]
    • Annual Report to the Nation on the Status of Cancer, 1975–2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State [2015]
  • National Cancer Institute
    • Female Breast Cancer
  • World Journal of Oncology
    • Breast Cancer Incidence and Behavior in Younger Patients: A Study From the Surveillance, Epidemiology and End Results Database [2020]
• Vietnam
  • Cancer Biology & Medicine
    • Female breast cancer in Vietnam: a comparison across Asian specific regions [2015]
• WHO
  • International Agency for Research on Cancer
    • Breast fact sheet
  • World Health Organization
    • Breast cancer
• WHO Eastern Mediterranean Region
  • BMC Women's Health
    • Incidence trend of breast Cancer in women of eastern Mediterranean region countries from 1998 to 2019: A systematic review and meta-analysis [2020]
• {Related topics}
  • Topic
    • Breast cancer

Breast cancer markers

• Africa
  • PLoS Medicine
    • Receptor-Defined Subtypes of Breast Cancer in Indigenous Populations in Africa: A Systematic Review and Meta-Analysis [2014]
• Australia
  • Medical Services Advisory Committee
    • A 50 gene signature assay for predicting breast cancer recurrence [2021]
    • Gene expression profiling of 21 genes in breast cancer to quantify the risk of disease recurrence and predict adjuvant chemotherapy benefit [2013]
• Canada
  • Canadian Agency for Drugs and Technologies in Health
    • Oncotype DX in Women and Men with ER-Positive, HER2-Negative Early Stage Breast Cancer who are Lymph Node Negative: A Review of Clinical Effectiveness and Guidelines [2014]
    • Oncotype DX in Women and Men with ER-Positive HER2-Negative Early Stage Breast Cancer Who are Lymph Node-Positive: A Review of Clinical Effectiveness and Guidelines [2014]
  • Canadian Association of Pathologists
    • Ki67 in Breast Cancer Assay: An Ad Hoc Testing Recommendation from the Canadian Association of Pathologists Task Force [2023]
  • Ontario Health
    • Clinical Utility of Multigene Profiling Assays in Early-Stage Invasive Breast Cancer: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline [2022]
    • Gene Expression Profiling Tests for Early-Stage Invasive Breast Cancer: A Health Technology Assessment [2020]
• China
  • Cancer Epidemiology Biomarkers & Prevention
    • Cytochrome P450 1B1 and Catechol-O-Methyltransferase Genetic Polymorphisms and Breast Cancer Risk in Chinese Women: Results from the Shanghai Breast Cancer Study and a Meta-analysis [2005]
  • Chinese Medical Journal
    • Clinical practice guidelines for multigene assays in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021 [2021]
  • Scientific Reports
    • Current evidence on circRNAs as potential theranostic markers for detecting chemoresistance in breast cancer: a systematic review and meta-analysis [2022]
    • Impact of the 2018 ASCO/CAP guidelines on HER2 fluorescence in situ hybridization interpretation in invasive breast cancers with immunohistochemically equivocal results [2019]
• Europe
  • European Commission
    • Recommendations from the European Commission Initiative on Breast Cancer for multigene testing to guide the use of adjuvant chemotherapy in patients with early breast cancer, hormone receptor positive, HER-2 negative [2021]
  • European Journal of Cancer
    • Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM) [2017]
• France
  • PLoS ONE
    • Prospective, multicenter French study evaluating the clinical impact of the Breast Cancer Intrinsic Subtype-Prosigna® Test in the management of early-stage breast cancers [2017]
• Germany
  • Institute for Quality and Efficiency in Health Care
    • Biomarker-based tests for the decision for or against adjuvant systemic chemotherapy in primary breast cancer [2016]
• India
  • Indian Journal of Medical Research
    • Improving accuracy of breast cancer biomarker testing in India [2017]
  • South Asian Journal of Cancer
    • Practical consensus recommendations on management of HR + ve early breast cancer with specific reference to genomic profiling [2018]
• International
  • Cancer
    • Use of standard markers and incorporation of molecular markers into breast cancer therapy [2011]
  • Cancer Treatment and Research Communications
    • Circulating tumor DNA for breast cancer: Review of active clinical trials [2022]
  • Critical Reviews in Oncology/Hematology
    • Gene expression signatures in older patients with breast cancer: A systematic review [2023]
  • International Journal of Molecular Sciences
    • Assessing the Role of MicroRNAs in Predicting Breast Cancer Recurrence-A Systematic Review [2023]
  • International Ki67 in Breast Cancer Working Group
    • Ki67 as a Companion Diagnostic: Good or Bad News? [2022]
    • Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group [2021]
  • Seminars in Cancer Biology
    • Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer - ScienceDirect [2017]
• Ireland
  • Health Information and Quality Authority
    • A rapid HTA of gene expression profiling tests for guiding the use of adjuvant chemotherapy in early-stage invasive breast cancer [2023]
• Italy
  • Cancers
    • Definition of High-Risk Early Hormone-Positive HER2-Negative Breast Cancer: A Consensus Review [2022]
  • Oncotarget
    • Multigene tests for breast cancer: the physician’s perspective [2021]
• Latin America
  • JCO Global Oncology
    • Practice-Changing Use of the 21-Gene Test for the Management of Patients With Early-Stage Breast Cancer in Latin America [2021]
• Norway
  • Norwegian Institute of Public Health
    • Molecular tests for detection of PIK3CA mutations in men and postmenopausal women with HR+/HER2–, locally advanced or metastatic breast cancer [2022]
    • Prosigna Gene Signature to Assess Expected Benefit from Chemotherapy in Breast Cancer [2019]
• Republic of Korea
  • Breast Cancer Research
    • Clinical significance of HER2-low expression in early breast cancer: a nationwide study from the Korean Breast Cancer Society [2022]
  • Journal of Breast Cancer
    • Impact of the Updated Guidelines on Human Epidermal Growth Factor Receptor 2 (HER2) Testing in Breast Cancer [2020]
• Rwanda
  • Bulletin of the World Health Organization
    • Breast cancer molecular diagnostics in Rwanda: a cost-minimization study of immunohistochemistry versus a novel GeneXpert® mRNA expression assay [2023]
• Singapore
  • Singapore Medical Journal
    • Concordance between core needle biopsy and surgical specimen for ER, PgR and Her2neu receptor status in breast cancer and study of difference in reliability between the two groups with the change in ASCO/CAP guidelines [2016]
• Spain
  • Sociedad Española de Oncología Médica
    • Consensus of the Spanish society of laboratory medicine and the Spanish society of medical oncology on the methodology and criteria for evaluation of circulating tumour markers in breast cancer [2021]
    • Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology [2018]
• Sweden
  • Cancers
    • Variability in Breast Cancer Biomarker Assessment and the Effect on Oncological Treatment Decisions: A Nationwide 5-Year Population-Based Study [2021]
• Switzerland
  • PLoS ONE
    • Impact of Modified 2013 ASCO/CAP Guidelines on HER2 Testing in Breast Cancer. One Year Experience [2015]
• United Kingdom
  • Breast Cancer Research and Treatment
    • The impact of Oncotype DX breast cancer assay results on clinical practice: a UK experience [2020]
  • British Journal of Cancer
    • Distinct temporal trends in breast cancer incidence from 1997 to 2016 by molecular subtypes: a population-based study of Scottish cancer registry data [2020]
  • Health Technology Assessment
    • Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis [2019]
  • National Institute for Health and Care Excellence
    • Magseed for locating impalpable breast cancer lesions [2020]
    • Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer [2018]
• United States
  • American Society of Clinical Oncology
    • Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update [2020]
    • Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update—Integration of Results From TAILORx [2019]
    • Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update [2018]
    • Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update [2017]
    • Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline [2016]
    • Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline [2015]
    • Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update [2014]
    • Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer
    • Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer
    • Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer
    • Estrogen and Progesterone Receptor Testing in Breast Cancer
  • Breast Cancer Research and Treatment
    • Utilization and impact of 21-gene recurrence score assay for breast cancer in clinical practice across the United States: lessons learned from the 2010 to 2012 National Cancer Data Base analysis [2016]
  • Cancer
    • Adjuvant chemotherapy in patients with invasive lobular carcinoma and use of the 21-gene recurrence score: A National Cancer Database analysis [2022]
  • Cancer Medicine
    • Surgeon and medical oncologist peer network effects on the uptake of the 21-gene breast cancer recurrence score assay [2021]
  • College of American Pathologists
    • Quantitative Image Analysis of Human Epidermal Growth Factor Receptor 2 Immunohistochemistry for Breast Cancer: Guideline From the College of American Pathologists [2019]
  • Genetics in Medicine
    • Recommendations from the EGAPP Working Group: does the use of Oncotype DX tumor gene expression profiling to guide treatment decisions improve outcomes in patients with breast cancer? [2016]
  • JAMA Network Open
    • Incidence Trends of Breast Cancer Molecular Subtypes by Age and Race/Ethnicity in the US From 2010 to 2016 [2020]
  • NPJ Breast Cancer
    • The incidence of discordant clinical and genomic risk in patients with invasive lobular or ductal carcinoma of the breast: a National Cancer Database Study [2021]
• {Related topics}
  • Topic
    • Breast cancer

Breast cancer prevention

• Australia
  • Preventing Chronic Disease: Public Health Research, Practice and Policy
    • Strategies for Piloting a Breast Health Promotion Program in the Chinese-Australian Population [2012]
• Europe
  • Nature Reviews Clinical Oncology
    • Personalized early detection and prevention of breast cancer: ENVISION consensus statement [2020]
• Hong Kong
  • Centre for Health Protection
    • Recommendations on Prevention and Screening for Breast Cancer For Health Professionals [2021]
  • Hong Kong Medical Journal
    • Recommendations on prevention and screening for breast cancer in Hong Kong [2018]
• Spain
  • Sociedad Española de Oncología Médica
    • SEOM guide to primary and secondary prevention of cancer: 2014 [2014]
• United Kingdom
  • British Journal of General Practice
    • Prescribing tamoxifen in primary care for the prevention of breast cancer: a national online survey of GPs’ attitudes [2017]
  • Public Health Genomics
    • Clinician-Reported Barriers to Implementing Breast Cancer Chemoprevention in the UK: A Qualitative Investigation [2016]
• United States
  • Agency for Healthcare Research and Quality
    • Medication Use for the Risk Reduction of Primary Breast Cancer in Women: A Systematic Review for the U.S. Preventive Services Task Force  [2019]
  • American Society of Clinical Oncology
    • Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update [2019]
    • Use of Endocrine Therapy for Breast Cancer Risk Reduction
  • Breast Cancer Research and Treatment
    • The impact of cancer prevention guideline adherence on overall mortality in a high-risk cohort of women from the New York site of the Breast Cancer Family Registry [2015]
  • Journal of the National Cancer Institute
    • Practical Problems With Clinical Guidelines for Breast Cancer Prevention Based on Remaining Lifetime Risk [2015]
  • National Cancer Institute
    • Breast Cancer Prevention (PDQ®)
  • Preventing Chronic Disease: Public Health Research, Practice and Policy
    • Inclusion of Evidence-Based Breast Cancer Control Recommendations and Guidelines in State Comprehensive Cancer Control Plans [2020]
  • U.S. Preventive Services Task Force
    • Breast Cancer: Medication Use to Reduce Risk [2019]
• {Related topics}
  • Topic
    • Breast cancer

Breast cancer risk

• Asia
  • Asian Pacific Association for the Study of the Liver
    • A Review of the Epidemiology of Breast Cancer in Asia: Focus on Risk Factors [2020]
  • Heliyon
    • Assessment of the risk of developing breast cancer using the Gail model in Asian females: A systematic review [2020]
  • Journal of Preventive Medicine and Public Health
    • Breast Density and Risk of Breast Cancer in Asian Women: A Meta-analysis of Observational Studies [2016]
• Australia
  • Cancer Australia
    • Risk factors for breast cancer: A review of the evidence 2018 [2018]
    • Breast Cancer Risk Factors At a Glance [2018]
• Australia, Canada, United States
  • International Journal of Environmental Research and Public Health
    • Oral Contraceptive Use and Assessment of Breast Cancer Risk among Premenopausal Women via Molecular Characteristics: Systematic Review with Meta-Analysis [2022]
• Belarus
  • International Journal of Epidemiology
    • Breast cancer risk in residents of Belarus exposed to Chernobyl fallout while pregnant or lactating: standardized incidence ratio analysis, 1997 to 2016 [2022]
• Canada
  • Environment International
    • Associations between incident breast cancer and ambient concentrations of nitrogen dioxide from a national land use regression model in the Canadian National Breast Screening Study [2019]
  • International Journal of Breast Cancer
    • Adherence to cancer prevention guidelines and risk of breast cancer [2014]
• Caribbean
  • International Journal for Equity in Health
    • Social determinants of breast cancer in the Caribbean: a systematic review [2017]
• China
  • Chinese Journal of Cancer
    • Active and passive smoking with breast cancer risk for Chinese females: a systematic review and meta-analysis [2014]
  • Chinese Medical Journal
    • Clinical practice guidelines for risk assessment to identify women at high risk of breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021 [2021]
  • International Journal of Clinical and Experimental Medicine
    • GSTT1 polymorphism and breast cancer risk in the Chinese population: an updated meta-analysis and review [2015]
  • Journal of Breast Cancer
    • The Catechol-O-Methyltransferase Val158Met Polymorphism Contributes to the Risk of Breast Cancer in the Chinese Population: An Updated Meta-Analysis [2014]
  • Journal of Cancer Research and Therapeutics
    • Association between fibroblast growth factor receptor-2 gene polymorphism and risk of breast cancer in Chinese populations: A HuGE review and meta-analysis [2016]
  • Tumor Biology
    • Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk in Chinese population: a meta-analysis of 22 case–control studies [2013]
• Denmark
  • Breast Cancer Research
    • Hypothyroidism and the risk of breast cancer recurrence and all-cause mortality - a Danish population-based study [2019]
  • International Journal of Cancer
    • Antiplatelet drugs and breast cancer risk in a large nationwide Danish case-control study [2023]
• Europe
  • BMC Medicine
    • Dietary intake of trans fatty acids and breast cancer risk in 9 European countries [2021]
  • Cancer Epidemiology
    • European Code against Cancer 4th Edition: Breastfeeding and cancer [2015]
  • Environmental Health Perspectives
    • Long-Term Exposure to Ambient Air Pollution and Incidence of Postmenopausal Breast Cancer in 15 European Cohorts within the ESCAPE Project [2017]
• Finland
  • European Journal of Epidemiology
    • The association between night shift work and breast cancer risk in the Finnish twins cohort [2023]
• France
  • Environment International
    • Risk of breast cancer associated with long-term exposure to benzo[a]pyrene (BaP) air pollution: Evidence from the French E3N cohort study [2021]
  • JAMA Network Open
    • Contraceptive Use in Premenopausal Women With Early Breast Cancer [2022]
• Germany
  • Breast Cancer Research and Treatment
    • Association between gout and subsequent breast cancer: a retrospective cohort study including 67,598 primary care patients in Germany [2023]
    • Positive association between body height and breast cancer prevalence: a retrospective study with 135,741 women in Germany [2022]
• Gulf Cooperation Council
  • World Journal of Clinical Oncology
    • Correlation between breast cancer and lifestyle within the Gulf Cooperation Council countries: A systematic review [2020]
• International
  • Advances in Nutrition
    • Racial and Ethnic Disparities in the Impact of Obesity on Breast Cancer Risk and Survival: A Global Perspective [2015]
  • Annals of Medicine
    • The association between breast cancer and consumption of dairy products: a systematic review [2023]
  • Asian Pacific Journal of Cancer Prevention
    • Use and Applicability of the Gail Model to Calculate Breast Cancer Risk: A Scoping Review [2022]
  • BMC Cancer
    • Global, regional, and national mortality trends of female breast cancer by risk factor, 1990–2017 [2021]
  • BMC Women's Health
    • The relation between obesity and breast cancer risk in women by considering menstruation status and geographical variations: a systematic review and meta-analysis [2023]
  • Breast Cancer : Targets and Therapy
    • Epidemiological characteristics of and risk factors for breast cancer in the world [2019]
  • Cancer
    • Fiber consumption and breast cancer incidence: A systematic review and meta-analysis of prospective studies [2020]
  • Cancers
    • Oral Contraceptive Use and Breast Cancer Risk According to Molecular Subtypes Status: A Systematic Review and Meta-Analysis of Case-Control Studies [2022]
    • Oral Contraceptive Use and Breast Cancer Risk Assessment: A Systematic Review and Meta-Analysis of Case-Control Studies, 2009–2020 [2021]
  • Environmental Research
    • Environmental exposures and breast cancer risk in the context of underlying susceptibility: A systematic review of the epidemiological literature [2020]
  • Epidemiology and Psychiatric Sciences
    • Association of antipsychotic use with breast cancer: a systematic review and meta-analysis of observational studies with over 2 million individuals [2022]
  • Frontiers in Endocrinology
    • Benign thyroid disease and the risk of breast cancer: An updated systematic review and meta-analysis [2022]
  • Frontiers in Oncology
    • Global Trends in Death, Years of Life Lost, and Years Lived With Disability Caused by Breast Cancer Attributable to Secondhand Smoke From 1990 to 2019 [2022]
  • International Journal of Behavioral Nutrition and Physical Activity
    • The global, regional, and national disease burden of breast cancer attributable to low physical activity from 1990 to 2019: an analysis of the Global Burden of Disease Study 2019 [2022]
  • International Journal of Environmental Research and Public Health
    • Use of Oral Contraceptives as a Potential Risk Factor for Breast Cancer: A Systematic Review and Meta-Analysis of Case-Control Studies Up to 2010 [2021]
    • Maternal Pregnancy Hormone Concentrations in Countries with Very Low and High Breast Cancer Risk [2020]
  • Journal of Clinical Oncology
    • Updated Breast Cancer Surveillance Recommendations for Female Survivors of Childhood, Adolescent, and Young Adult Cancer From the International Guideline Harmonization Group [2020]
  • Lancet Oncology
    • Recommendations for Breast Cancer Surveillance for Female Childhood, Adolescent and Young Adult Cancer Survivors Treated with Chest Radiation: A Report from the International Late Effects of Childhood Cancer Guideline Harmonization Group [2013]
  • Nutrients
    • Isoflavone Consumption and Risk of Breast Cancer: An Updated Systematic Review with Meta-Analysis of Observational Studies [2023]
• Iran
  • European Journal of Medical Research
    • Breast cancer risk factors in Iranian women: a systematic review and meta-analysis of matched case-control studies [2022]
  • International Journal of Preventive Medicine
    • Menstrual and Reproductive Factors and Risk of Breast Cancer in Iranian Female Population: A Systematic Review and Meta-Analysis [2022]
  • Iranian Journal of Basic Medical Sciences
    • Human papillomavirus and breast cancer in Iran: a meta- analysis [2016]
  • Journal of Cancer Prevention
    • The Role of Oral Contraceptive Pills on Increased Risk of Breast Cancer in Iranian Populations: A Meta-analysis [2016]
    • The Evaluation of p53 Polymorphism at Codon 72 and Association With Breast Cancer in Iran: A Systematic Review and Meta-analysis [2016]
• Ireland
  • BMC Public Health
    • Factors associated with public awareness of the relationship between alcohol use and breast cancer risk [2023]
• Italy
  • International Journal of Environmental Research and Public Health
    • Geographic Inequalities in Breast Cancer in Italy: Trend Analysis of Mortality and Risk Factors [2020]
• Japan
  • BMC Public Health
    • Association of job category and occupational activity with breast cancer incidence in Japanese female workers: the JACC study [2020]
  • Breast Cancer
    • Alcohol consumption and breast cancer prognosis after breast cancer diagnosis: a systematic review and meta-analysis of the Japanese Breast Cancer Society Clinical Practice Guideline, 2022 edition [2023]
  • Breast Cancer Research and Treatment
    • Cholesterol and breast cancer risk: a cohort study using health insurance claims and health checkup databases [2023]
  • Cancer Medicine
    • Impact of reproductive factors on breast cancer incidence: Pooled analysis of nine cohort studies in Japan [2021]
  • Japanese Journal of Clinical Oncology
    • Soy Intake and Breast Cancer Risk: An Evaluation Based on a Systematic Review of Epidemiologic Evidence Among the Japanese Population [2014]
    • Breastfeeding and Breast Cancer Risk: An Evaluation Based on a Systematic Review of Epidemiologic Evidence Among the Japanese Population [2012]
• Latin America
  • Genes
    • Genetic Epidemiology of Breast Cancer in Latin America [2019]
• Mongolia
  • PLoS ONE
    • The Role of Hormones in the Differences in the Incidence of Breast Cancer between Mongolia and the United Kingdom [2014]
• Netherlands
  • Breast Cancer Research and Treatment
    • The proportion of postmenopausal breast cancer cases in the Netherlands attributable to lifestyle-related risk factors [2015]
  • Cancer Medicine
    • Risk of breast cancer in women after a salivary gland carcinoma or pleomorphic adenoma in the Netherlands [2020]
  • European Journal of Epidemiology
    • The association of a combined healthy lifestyle with the risk of postmenopausal breast cancer subtypes in the Netherlands Cohort Study [2023]
  • Oncologist
    • Evaluating the Age-Based Recommendations for Long-Term Follow-Up in Breast Cancer [2020]
• New Zealand
  • Breast Cancer Research and Treatment
    • Post-diagnostic statin use and breast cancer-specific mortality: a population-based cohort study [2023]
• Norway
  • British Journal of Cancer
    • The fraction of breast cancer attributable to smoking: The Norwegian women and cancer study 1991–2012 [2016]
  • European Journal of Endocrinology
    • Low-dose aspirin and risk of breast cancer: a Norwegian population-based cohort study of one million women [2023]
• Palestine
  • JCO Global Oncology
    • Awareness of Palestinian Women About Breast Cancer Risk Factors: A National Cross-Sectional Study [2022]
• Qatar
  • Journal of Primary Care & Community Health
    • Assessing Breast Cancer Risk Estimates Based on the Gail Model and Its Predictors in Qatari Women [2017]
• Republic of Korea
  • Scientific Reports
    • Impact of air pollution on breast cancer incidence and mortality: a nationwide analysis in South Korea [2020]
• Singapore
  • Scientific Reports
    • Incidence of breast cancer attributable to breast density, modifiable and non-modifiable breast cancer risk factors in Singapore [2020]
• Spain
  • BMC Cancer
    • An assessment of existing models for individualized breast cancer risk estimation in a screening program in Spain [2013]
  • Scientific Reports
    • Validating a breast cancer score in Spanish women. The MCC-Spain study [2018]
• Sweden
  • Breast Cancer Research and Treatment
    • Drug use disorder and risk of incident and fatal breast cancer: a nationwide epidemiological study [2021]
  • Fertility and Sterility
    • Ovarian stimulation and risk of breast cancer in Swedish women [2017]
• Switzerland
  • Frontiers in Public Health
    • Estimating 10-year risk of lung and breast cancer by occupation in Switzerland [2023]
    • Breast cancer and occupation: Non-parametric and parametric net survival analyses among Swiss women (1990-2014) [2023]
  • Gland Surgery
    • The impact of overweight and obesity on breast cancer: data from Switzerland, so far a country little affected by the current global obesity epidemic [2014]
• Taiwan
  • BMC Cancer
    • Female breast cancer incidence predisposing risk factors identification using nationwide big data: a matched nested case-control study in Taiwan [2022]
  • BMJ Open
    • Thyroid disorders and breast cancer risk in Asian population: a nationwide population-based case–control study in Taiwan [2018]
  • International Journal of Environmental Research and Public Health
    • Breast Cancer Incidence among Female Workers by Different Occupations and Industries: A Longitudinal Population-Based Matched Case-Control Study in Taiwan [2022]
  • International Journal of Obesity
    • Body mass index and breast cancer: analysis of a nation-wide population-based prospective cohort study on 1 393 985 Taiwanese women [2015]
  • Scientific Reports
    • Reproductive and environmental exposures and the breast cancer risk in Taiwanese women [2021]
• Ukraine
  • European Journal of Epidemiology
    • Breast cancer risk in Ukrainian women exposed to Chornobyl fallout while pregnant or lactating: standardized incidence ratio analysis, 1998 to 2016 [2022]
• United Kingdom
  • BMJ
    • Age and sex can predict cancer risk in people referred with breast symptoms [2023]
  • Breast Cancer Research and Treatment
    • Reproductive history differs by molecular subtypes of breast cancer among women aged = 50 years in Scotland diagnosed 2009-2016: a cross-sectional study [2022]
  • British Journal of Cancer
    • Proactive breast cancer risk assessment in primary care: a review based on the principles of screening [2023]
    • Ethnic differences in breast cancer incidence in England are due to differences in known risk factors for the disease: prospective study [2013]
  • Cancer Medicine
    • Breastfeeding reduces the risk of breast cancer: A call for action in high-income countries with low rates of breastfeeding [2023]
    • Thyroid dysfunction and breast cancer risk among women in the UK Biobank cohort [2021]
  • Faculty of Sexual & Reproductive Healthcare
    • Response to Study Contemporary Hormonal Contraception and the Risk of Breast Cancer [2017]
  • JAMA Network Open
    • Association of Nongenetic Factors With Breast Cancer Risk in Genetically Predisposed Groups of Women in the UK Biobank Cohort [2020]
  • PLoS Medicine
    • Combined and progestagen-only hormonal contraceptives and breast cancer risk: A UK nested case-control study and meta-analysis [2023]
• United States
  • American Cancer Society
    • Challenges in DCIS Risk Communication and Decision-Making: Report from an American Cancer Society and National Cancer Institute Workshop [2012]
  • American Journal of Epidemiology
    • Maximum and Time-Dependent Body Mass Index and Breast Cancer Incidence Among Postmenopausal Women in the Black Women's Health Study [2022]
  • Applied Geography
    • Identifying county-level factors for female breast cancer incidence rate through a large-scale population study [2020]
  • Breast Cancer Research and Treatment
    • Validation of a breast cancer risk prediction model based on the key risk factors: family history, mammographic density and polygenic risk [2023]
  • Breast Cancer Surveillance Consortium
    • Association of Breast Density With Breast Cancer Risk Among Women Aged 65 Years or Older by Age Group and Body Mass Index [2021]
    • Breast Cancer Population Attributable Risk Proportions Associated with Body Mass Index and Breast Density by Race/Ethnicity and Menopausal Status [2020]
    • Population-Attributable Risk Proportion of Clinical Risk Factors for Breast Cancer [2017]
    • Association between air pollution and mammographic breast density in the Breast Cancer Surveilance Consortium [2017]
    • Risk Factors That Increase Risk of Estrogen Receptor-Positive and -Negative Breast Cancer [2016]
    • Identifying women with dense breasts at high risk for interval cancer: a cohort study [2015]
    • Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk [2007]
  • Cancer
    • Accelerometer-measured physical activity and postmenopausal breast cancer incidence in the Women's Health Accelerometry Collaboration [2023]
    • Insulin resistance and breast cancer incidence and mortality in postmenopausal women in the Women’s Health Initiative [2020]
    • A review of body size and breast cancer risk in Hispanic and African American women [2011]
  • Frontiers in Public Health
    • Race, Age, and Obesity Disparities in Adult Physical Activity Levels in Breast Cancer Patients And Controls [2014]
  • JAMA Network Open
    • Trends in Parity and Breast Cancer Incidence in US Women Younger Than 40 Years From 1935 to 2015 [2020]
  • JAMA Oncology
    • Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States [2016]
  • Journal of the National Cancer Institute
    • Ethylene oxide emissions and incident breast cancer and non-Hodgkin lymphoma in a US cohort [2023]
  • Molecular and Cellular Endocrinology
    • US EPA's regulatory pesticide evaluations need clearer guidelines for considering mammary gland tumors and other mammary gland effects [2020]
  • National Cancer Institute
    • Postpartum Remodeling, Lactation, and Breast Cancer Risk: Summary of a National Cancer Institute–Sponsored Workshop [2013]
    • Breast Cancer Risk Assessment Tool
  • National Comprehensive Cancer Network
    • Breast Cancer Risk Reduction, Version 2.2015 [2015]
  • PLoS ONE
    • A complex systems model of breast cancer etiology: The Paradigm II Model [2023]
• {Related topics}
  • Topic
    • Familial breast cancer
    • Breast cancer

Breast cancer screening, mammography

• Albania
  • Institute of Public Health
    • Breast Cancer Screening in Albania During 2007-2008 [2013]
• Asia
  • Cancer Medicine
    • At what age should screening mammography be recommended for Asian women? [2015]
  • Hong Kong Medical Journal
    • Understanding breast cancer screening—past, present, and future [2018]
• Australia
  • Australian and New Zealand Journal of Public Health
    • BreastScreen Australia national data by factors of interest for risk-based screening: routinely reported data and opportunities for enhancement [2022]
  • Australian Institute of Health and Welfare
    • BreastScreen Australia monitoring report 2020 [2020]
    • BreastScreen Australia data dictionary: version 1.2 [2019]
    • Analysis of breast cancer outcomes and screening behaviour for BreastScreen Australia [2018]
  • Cancer Australia
    • Early detection of breast cancer [2015]
    • Overdiagnosis from mammographic screening [2014]
  • Clinical Oncology Society of Australia
    • Mammographic / Breast Density - Facts and Issues paper [2021]
  • Journal of Clinical Medicine
    • Breast Density Notification: An Australian Perspective [2020]
  • Public Health Research and Practice
    • Public health advocacy in action: the case of unproven breast cancer screening in Australia [2016]
• Brazil
  • Cadernos de Saúde Pública
    • Guidelines for early detection of breast cancer in Brazil. III - Challenges for implementation [2018]
    • Guidelines for early detection of breast cancer in Brazil. II - New national recommendations, main evidence, and controversies [2018]
    • Guidelines for early detection of breast cancer in Brazil. I - Development methods [2018]
  • Epidemiologia e Serviços de Saúde
    • Evaluation of breast cancer screening indicators in the female population using the National Health System, Brazil, 2018-2019: a descriptive study [2023]
    • Assessment of actions for breast cancer early detection in Brazil using process indicators: a descriptive study with Sismama data, 2010-2011 [2017]
  • Frontiers in Public Health
    • Breast cancer screening and diagnosis in older adults women in Brazil: why it is time to reconsider the recommendations [2023]
  • International Journal of Public Health
    • COVID-19 and Breast Cancer in Brazil [2023]
  • Journal of Global Health
    • 10-year opportunistic mammographic screening scenario in Brazil and its impact on breast cancer early detection: a nationwide population-based study [2022]
  • Radiologia Brasileira
    • Contribution of the Unified Health Care System to mammography screening in Brazil, 2013 [2016]
  • Revista Brasileira de Ginecologia e Obstetrícia
    • Recommendations for the Screening of Breast Cancer of the Brazilian College of Radiology and Diagnostic Imaging, Brazilian Society of Mastology and Brazilian Federation of Gynecology and Obstetrics Association [2023]
    • Breast Cancer Screening: Updated Recommendations of the Brazilian College of Radiology and Diagnostic Imaging, Brazilian Breast Disease Society, and Brazilian Federation of Gynecological and Obstetrical Associations [2017]
  • Revista da Associação Médica Brasileira
    • Breast cancer screening in Brazil. Barriers related to the health system [2017]
• Canada
  • BMJ
    • Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial [2014]
  • Canadian Agency for Drugs and Technologies in Health
    • Digital Breast Tomosynthesis for the Screening and Diagnosis of Breast Cancer: A Review of the Diagnostic Accuracy, Cost-Effectiveness and Guidelines [2019]
  • Canadian Association of Radiologists Journal
    • Addressing Misinformation About the Canadian Breast Screening Guidelines [2023]
  • Canadian Family Physician
    • Breast density notification [2023]
    • Examining screening mammography participation among women aged 40 to 74 [2017]
  • Canadian Journal of Surgery
    • CJS debate: Is mammography useful in average-risk screening for breast cancer? [2016]
  • Canadian Task Force on Preventive Health Care
    • Breast Cancer Update (2018) [2018]
  • CMAJ
    • Applying the 2011 Canadian guidelines for breast cancer screening in practice [2012]
  • CMAJ Open
    • The cost-effectiveness of adding tomosynthesis to mammography-based breast cancer screening: an economic analysis [2021]
  • Current Oncology
    • How Did CNBSS Influence Guidelines for So Long and What Can That Teach Us? [2022]
    • Screening for breast cancer in 2018—what should we be doing today? [2018]
    • Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies [2016]
  • Journal of Breast Imaging
    • The Fundamental Flaws of the CNBSS Trials: A Scientific Review [2022]
  • Journal of Medical Screening
    • The randomized trial of mammography screening that was not-A cautionary tale [2022]
  • Ontario Health
    • Breast Screening for Survivors of Breast Cancer [2017]
    • Women's Experiences of Inaccurate Breast Cancer Screening Results: A Systematic Review and Qualitative Meta-synthesis [2016]
    • Ultrasound as an Adjunct to Mammography for Breast Cancer Screening: A Health Technology Assessment [2016]
    • Magnetic Resonance Imaging as an Adjunct to Mammography for Breast Cancer Screening in Women at Less Than High Risk for Breast Cancer: A Health Technology Assessment [2016]
  • PLOS Computational Biology
    • Is mammography screening beneficial: An individual-based stochastic model for breast cancer incidence and mortality [2020]
• Chile
  • Breast
    • Mammogram screening in Chile: Using mixed methods to implement health policy planning at the primary care level [2011]
  • Revista de Saúde Pública
    • Effectiveness of breast cancer screening policies in countries with medium-low incidence rates [2018]
• China
  • Cancer Biology & Medicine
    • Interpretation of breast cancer screening guideline for Chinese women [2019]
  • China CDC Weekly
    • Breast Cancer Screening Rates Among Women Aged 20 Years and Above — China, 2015 [2021]
  • International Journal of Environmental Research and Public Health
    • Recommending Breast Cancer Screening to My Mum: Examining the Interplay of Threat, Efficacy, and Virality on Recommendation Intention in the Chinese Context [2023]
  • Oncologist
    • Breast Cancer Challenges and Screening in China: Lessons From Current Registry Data and Population Screening Studies [2015]
  • Population Health Metrics
    • Estimating disability-adjusted life years for breast cancer and the impact of screening in female populations in China, 2015-2030: an exploratory prevalence-based analysis applying local weights [2022]
  • Preventing Chronic Disease: Public Health Research, Practice and Policy
    • Breast Cancer Screening Among Adult Women in China, 2010 [2013]
• Croatia
  • Croatian Medical Journal
    • Results of the National Breast Cancer Screening Program in Croatia (2006-2016) [2022]
• Czech Republic
  • BMC Public Health
    • Breast cancer screening in the Czech Republic: time trends in performance indicators during the first seven years of the organised programme [2011]
• Democratic Republic of Congo
  • BMC Public Health
    • From the set-up of a screening program of breast cancer patients to the identification of the first BRCA mutation in the DR Congo [2014]
• Denmark
  • Clinical Epidemiology
    • Morbidity as a Predictor for Participation in the Danish National Mammography Screening Program: A Cross-Sectional Study [2020]
    • Danish Quality Database for Mammography Screening [2016]
  • eLife
    • Nationwide mammography screening participation in Denmark during the COVID-19 pandemic: An observational study [2023]
  • International Journal of Cancer
    • Benefit-to-harm ratio of the Danish breast cancer screening programme [2017]
• Developing countries
  • Clinics
    • Breast cancer screening in developing countries [2017]
• Ethiopia
  • PLoS ONE
    • Breast self-examination practice and its determinants among women in Ethiopia: A systematic review and meta-analysis [2021]
• Europe
  • BMC Cancer
    • The impact of mammography screening programmes on incidence of advanced breast cancer in Europe: a literature review [2018]
  • BMC Public Health
    • Development of breast cancer mortality considering the implementation of mammography screening programs – a comparison of western European countries [2019]
  • Cancer Epidemiology Biomarkers & Prevention
    • European Breast Cancer Service Screening Outcomes: A First Balance Sheet of the Benefits and Harms [2014]
  • Cancers
    • Extending Age Ranges in Breast Cancer Screening in Four European Countries: Model Estimations of Harm-to-Benefit Ratios [2021]
  • European Commission
    • Benefits and harms of annual, biennial, or triennial breast cancer mammography screening for women at average risk of breast cancer: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC) [2022]
    • Digital breast tomosynthesis compared to diagnostic mammographic projections (including magnification) among women recalled at screening mammography: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC) [2021]
    • Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators [2020]
    • Breast Cancer Screening and Diagnosis: A Synopsis of the European Breast Guidelines [2020]
    • European guidelines on breast cancer screening and diagnosis
  • European Menopause and Andropause Society
    • EMAS position statement: Individualized breast cancer screening versus population-based mammography screening programmes [2014]
  • European Society of Breast Imaging
    • Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies [2017]
    • Mammography: an update of the EUSOBI recommendations on information for women [2017]
    • Mammography: EUSOBI recommendations for women's information [2012]
  • International Journal of Cancer
    • The potential of breast cancer screening in Europe [2021]
  • International Journal of Oncology
    • Breast cancer in European Union: An update of screening programmes as of March 2014 (Review) [2014]
  • Preventive Medicine
    • Presence, characteristics and equity of access to breast cancer screening programmes in 27 European countries in 2010 and 2014. Results from an international survey [2016]
• Finland
  • International Journal of Cancer
    • Cancer incidence and mortality patterns in women with breast symptoms in the mammography screening programme: A matched cohort analysis [2019]
• France
  • BMC Medical Ethics
    • Women's participation in breast cancer screening in France - an ethical approach [2014]
• Germany
  • Breast Care
    • Relevance of Health Economics in the Early Detection of Breast Cancer in Germany – the View of the Professional Association of Practicing Gynecologic Oncologists e.V. (BNGO) [2013]
  • Cancer Prevention Research
    • Estimating the Breast Cancer Burden in Germany and Implications for Risk-based Screening [2021]
  • Frontiers in Oncology
    • Assessing and Explaining Geographic Variations in Mammography Screening Participation and Breast Cancer Incidence [2019]
  • Institute for Quality and Efficiency in Health Care
    • Review of age limits in the mammography screening programme [2022]
  • International Journal of Cancer
    • Breast cancer incidence and mortality before and after implementation of the German mammography screening program [2020]
  • RöFo
    • Guideline for determining the mean glandular dose according to DIN 6868-162 and threshold contrast visibility according to the quality assurance guideline for digital mammography systems [2014]
• Ghana
  • BMC Health Services Research
    • Mapping evidence on knowledge of breast cancer screening and its uptake among women in Ghana: a scoping review [2022]
  • Heliyon
    • The prevalence and predictive factors of breast cancer screening among older Ghanaian women [2020]
• Hong Kong
  • Hong Kong Medical Journal
    • Update on the Recommendations on Breast Cancer Screening by the Cancer Expert Working Group on Cancer Prevention and Screening [2022]
• Hungary
  • BMC Public Health
    • Breast cancer screening and its associating factors among hungarian women aged 45-65: a cross-sectional study based on the European health interview surveys from 2009 to 2019 [2023]
• Iceland
  • Breast Cancer : Targets and Therapy
    • Population-based service mammography screening: the Icelandic experience [2013]
• India
  • Journal of Cancer Research and Therapeutics
    • Knowledge, attitude, and practice towards breast cancer and its screening among women in India: A systematic review [2021]
• International
  • Asian Pacific Journal of Cancer Prevention
    • Cultural, Religious and Socio-Ethical Misconceptions among Muslim Women towards Breast Cancer Screening: A Systematic Review [2022]
  • Breast
    • A systematic review of the impact of the COVID-19 pandemic on breast cancer screening and diagnosis [2023]
    • Global guidelines for breast cancer screening: A systematic review [2022]
  • Breast Cancer Research
    • Studies of parenchymal texture added to mammographic breast density and risk of breast cancer: a systematic review of the methods used in the literature [2022]
  • Breast Health Global Initiative
    • Breast cancer early detection: A phased approach to implementation [2020]
  • Cancer Medicine
    • Systematic reviews as a “lens of evidence”: Determinants of cost-effectiveness of breast cancer screening [2019]
  • Cancers
    • Worldwide Review and Meta-Analysis of Cohort Studies Measuring the Effect of Mammography Screening Programmes on Incidence-Based Breast Cancer Mortality [2020]
  • Global Health Action
    • The global role, impact, and limitations of Community Health Workers (CHWs) in breast cancer screening: a scoping review and recommendations to promote health equity for all [2021]
  • Journal of Medical Screening
    • Assessing the impact of the COVID-19 pandemic on breast cancer screening and diagnosis rates: A rapid review and meta-analysis [2022]
  • Journal of the American Board of Family Medicine
    • Breast Cancer Screening in Older Women: the importance of shared decision making [2020]
• Iran
  • Iranian Journal of Cancer Prevention
    • Cost-Effectiveness of Three Rounds of Mammography Breast Cancer Screening in Iranian Women [2016]
  • Journal of Research in Medical Sciences
    • Status of breast cancer screening strategies and indicators in Iran: A scoping review [2022]
• Ireland
  • Health Information and Quality Authority
    • Review of information management practices at BreastCheck [2018]
  • Journal of Medical Screening
    • Interval cancer audit and disclosure in breast screening programmes: An international survey [2023]
• Israel
  • International Journal of Cancer
    • Correlation between cumulative mammographic density and age-specific incidence of breast cancer: A biethnic study in Israel [2022]
• Italy
  • BMC Health Services Research
    • Integrating mammography screening programmes into specialist breast centres in Italy: insights from a national survey of Senonetwork breast centres [2022]
  • Epidemiologia e Prevenzione
    • Problems, solutions, and perspectives in the evaluation of interval cancers in Italian mammography screening programmes: a position paper from the Italian group for mammography screening (GISMa) [2015]
  • La radiologia medica
    • Structured reporting of x-ray mammography in the first diagnosis of breast cancer: a Delphi consensus proposal [2022]
    • Digital breast tomosynthesis (DBT): recommendations from the Italian College of Breast Radiologists (ICBR) by the Italian Society of Medical Radiology (SIRM) and the Italian Group for Mammography Screening (GISMa) [2017]
• Japan
  • Asian Pacific Journal of Cancer Prevention
    • Analysis of Predictors of Breast Cancer Screening among Japanese Women Using Nationally Representative Survey Data, 2001–2013 [2021]
  • Breast Cancer
    • The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer Screening and Diagnosis, 2018 Edition [2020]
  • Cancer Epidemiology
    • Japanese cancer screening programs during the COVID-19 pandemic: Changes in participation between 2017-2020 [2023]
  • Japanese Journal of Clinical Oncology
    • The Japanese Guidelines for Breast Cancer Screening [2016]
• Kuwait
  • Annals of Saudi Medicine
    • Kuwait National Mammography Screening Program: outcomes of 5 years of screening in Kuwaiti women [2021]
• Latin America and the Caribbean
  • Pan American Health Organization
    • Mammography Services Quality Assurance: Baseline Standards for Latin America and the Caribbean [2016]
• Lesotho
  • BMC Cancer
    • Factors associated with the uptake of clinical breast examination among women of reproductive age in Lesotho: analysis of a national survey [2023]
• Lithuania
  • Acta Medica Lituanica
    • Breast Cancer Screening Program in Lithuania: Trends in Breast Cancer Mortality Before and During the Introduction of the Mammography Screening Program [2020]
  • Cancer Control
    • Trends in Breast Cancer Incidence and Stage Distribution Before and During the Introduction of the Mammography Screening Program in Lithuania [2019]
  • International Journal of Environmental Research and Public Health
    • Predictors and Trend in Attendance for Breast Cancer Screening in Lithuania, 2006–2014 [2019]
• Low and middle income countries
  • Indian Journal of Medical Research
    • Screening for breast cancer: Cost-effective solutions for low- & middle-income countries [2021]
  • Journal of Global Health
    • Economic evaluations of mammography to screen for breast cancer in low- and middle-income countries: A systematic review [2022]
• Malaysia
  • Asian Pacific Journal of Cancer Prevention
    • Breast Cancer Screening in Malaysia: A Policy Review [2021]
  • BMC Public Health
    • Breast cancer and breast cancer screening use-beliefs and behaviours in a nationwide study in Malaysia [2023]
• Mexico
  • Revista de Investigación Clínica
    • Estimation of the Cost-Effectiveness of Breast Cancer Screening Using Mammography in Mexico Through a Simulation [2016]
• Namibia
  • BMC Public Health
    • Prevalence and determinants of breast self-examination practices among women in their reproductive age in Namibia: an analysis of the 2013 Namibia demographic and Health Survey [2023]
• Netherlands
  • BMJ
    • Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study [2017]
• New Zealand
  • Ministry of Health New Zealand
    • Cohort and case control analyses of breast cancer mortality: BreastScreen Aotearoa 1999-2011 [2015]
    • BreastScreen Aotearoa National Policy and Quality Standards [2013]
  • National Screening Unit
    • BreastScreen Aotearoa
• Nordic countries
  • Radiography
    • Factors affecting women's participation in mammography screening in Nordic countries: A systematic review [2023]
• Norway
  • European Journal of Public Health
    • Trends in breast cancer stage distribution before, during and after introduction of a screening programme in Norway [2014]
  • International Journal of Cancer
    • Cost-effectiveness of the Norwegian breast cancer screening program [2017]
• Palestine
  • BMC Public Health
    • Women's awareness of breast cancer symptoms: a national cross-sectional study from Palestine [2022]
• Peru
  • PLoS ONE
    • Cost-Effectiveness Analysis of Breast Cancer Control Interventions in Peru [2013]
• Portugal
  • European Journal of Public Health
    • Mammography use for breast cancer screening in Portugal: results from the 2005/2006 National Health Survey [2013]
  • Preventing Chronic Disease: Public Health Research, Practice and Policy
    • Mammography Use in Portugal: National Health Survey 2014 [2017]
• Qatar
  • BMJ Open
    • Do socioeconomic factors influence breast cancer screening practices among Arab women in Qatar? [2015]
  • International Journal of Environmental Research and Public Health
    • Breast Cancer Knowledge, Attitudes and Practices amongst Women in Qatar [2022]
• Republic of Korea
  • BMC Women's Health
    • Retrospective observation on contribution and limitations of screening for breast cancer with mammography in Korea: detection rate of breast cancer and incidence rate of interval cancer of the breast [2016]
  • Epidemiology and Health
    • Trends in breast cancer screening rates among Korean women: results from the Korean National Cancer Screening Survey, 2005-2020 [2022]
    • Effect of mammography screening on the long-term survival of breast cancer patients: results from the National Cancer Screening Program in Korea [2022]
  • Korean Journal of Radiology
    • Performance of Screening Mammography: A Report of the Alliance for Breast Cancer Screening in Korea [2016]
    • Clinical Image Evaluation of Film Mammograms in Korea: Comparison with the ACR Standard [2013]
  • Scientific Reports
    • Impact of health disparities on national breast cancer screening participation rates in South Korea [2023]
• Saudi Arabia
  • Women's Health
    • Level and predictors of breast cancer awareness among Saudi women: A nationwide study [2022]
• Singapore
  • Annals Academy of Medicine Singapore
    • Barriers to breast cancer screening in Singapore: A literature review [2022]
  • PLoS ONE
    • Factors associated with false-positive mammography at first screen in an Asian population [2019]
  • Singapore Medical Journal
    • The Case for Breast Cancer Screening in Singapore [2002]
• Slovenia
  • PLoS ONE
    • Prognostic factors and outcomes in women with breast cancer in Slovenia in relation to step-wise implementation of organized screening [2022]
• South Africa
  • SA Journal of Radiology
    • Screening mammography with special reference to guidelines in South Africa [2018]
• Spain
  • PLoS ONE
    • Cost-Effectiveness of Double Reading versus Single Reading of Mammograms in a Breast Cancer Screening Programme [2016]
    • Association between the Adherence to the International Guidelines for Cancer Prevention and Mammographic Density [2015]
• Sub-Saharan Africa
  • BMC Cancer
    • Breast cancer screening in sub-Saharan Africa: a systematic review and ethical appraisal [2022]
  • BMC Public Health
    • Influence of distance to health facilities on clinical breast cancer screening behaviour among women in five sub-Saharan African countries [2023]
  • BMJ Open
    • Prevalence and determinants of breast cancer screening in four sub-Saharan African countries: a population-based study [2020]
• Sweden
  • Journal of the Royal Society of Medicine
    • Statistical analyses in Swedish randomised trials on mammography screening and in other randomised trials on cancer screening: a systematic review [2015]
• Switzerland
  • BMC Health Services Research
    • Breast cancer screening attendance in two Swiss regions dominated by opportunistic or organized screening [2016]
  • New England Journal of Medicine
    • Abolishing Mammography Screening Programs? A View from the Swiss Medical Board [2014]
  • Swiss Medical Weekly
    • Controversies in the mammography screening programme in Switzerland [2014]
• Syria
  • Cancer Treatment and Research Communications
    • Assessing Syrian women's knowledge of breast cancer risk factors, warning signs, and barriers to preventive measures: A cross-sectional study [2023]
• Taiwan
  • International Journal of Environmental Research and Public Health
    • Inequality in the Utilization of Breast Cancer Screening between Women with and without Disabilities in Taiwan: A Propensity-Score-Matched Nationwide Cohort Study [2022]
• Tunisia
  • Health Research Policy and Systems
    • Contextual differences considered in the Tunisian ADOLOPMENT of the European guidelines on breast cancer screening [2021]
• United Kingdom
  • Association of Breast Surgery
    • Duration and frequency of surveillance mammography after primary breast cancer treatment [2015]
  • BMC Cancer
    • Risk stratified breast cancer screening: UK healthcare policy decision-making stakeholders’ views on a low-risk breast screening pathway [2020]
  • BMJ Open
    • Improving screening recall services for women with false-positive mammograms: a comparison of qualitative evidence with UK guidelines [2015]
  • British Journal of Cancer
    • The projected impact of the COVID-19 lockdown on breast cancer deaths in England due to the cessation of population screening: a national estimation [2022]
    • Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study [2016]
    • Estimating breast cancer mortality reduction and overdiagnosis due to screening for different strategies in the United Kingdom [2014]
    • The benefits and harms of breast cancer screening: an independent review [2013]
  • Cancer Medicine
    • A case-control study to evaluate the impact of the breast screening programme on breast cancer incidence in England [2023]
  • Health Technology Assessment
    • Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT [2020]
  • Healthcare Improvement Scotland
    • Digital breast tomosynthesis (DBT) - breast screening recall: Advice Statement [2018]
    • Digital breast tomosynthesis (DBT) - asymptomatic women attending breast screening: Advice Statement [2018]
    • Review of the Scottish Breast Screening Programme: December 2016 [2016]
    • Breast screening standards
  • National Institute for Health and Care Excellence
    • Contrast-enhanced spectral mammography for breast cancer [2022]
    • Artificial intelligence in mammography [2021]
  • Nature Communications
    • Cost-effectiveness requirements for implementing artificial intelligence technology in the Women's UK Breast Cancer Screening service [2023]
  • NHS Digital
    • Breast Screening Programme
  • NHS England
    • Statement on reporting of breast density
    • NHS Breast screening programme screening standards valid for data collected from 1 April 2021
    • NHS Breast screening programme screening standards valid for data collected from 1 April 2017
    • Breast screening: very high risk women surveillance protocols
    • Breast screening: professional guidance
    • Breast screening: information leaflets
    • Breast screening: guidance on implementation of Ionising Radiation (Medical Exposure) Regulations (2017)
    • Breast screening supporting information
    • Breast screening programme: standards
  • Office for Health Improvement and Disparities
    • Breast screening pathway requirements specification
  • Public Health England
    • Opting out of breast screening
    • Breast screening: routine quality control tests for breast tomosynthesis
    • Breast screening: repeat mammograms
    • Breast screening: remote radiographic supervision
    • Breast screening: programme overview
    • Breast screening: organising very high risk (VHR) screening
    • Breast screening: manage mammograms and records
    • Breast screening: mammography equipment technical and practical evaluation reports
    • Breast screening: interval cancers and duty of candour toolkit
    • Breast screening: interval cancers
    • Breast screening: implementing remote image reading
    • Breast screening: guidance on partial or incomplete screening mammography
    • Breast screening: guidance for breast screening mammographers
    • Breast screening: ergonomics in screening mammography
    • Breast screening: digital breast tomosynthesis
    • Breast screening: care pathway
  • Public Health Scotland
    • Scottish breast screening programme statistics
  • Public Health Wales
    • Breast screening
  • UK National Screening Committee
    • UK National Screening Committee's approach to reviewing evidence on artificial intelligence in breast cancer screening [2022]
    • Breast cancer
• United States
  • Agency for Healthcare Research and Quality
    • Supplemental Screening for Breast Cancer in Women With Dense Breasts [2016]
    • Screening for Breast Cancer: A Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation [2016]
    • Screening for Breast Cancer With Digital Breast Tomosynthesis [2016]
  • American Cancer Society
    • Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society [2015]
    • Breast Cancer Screening Guidelines
  • American College of Obstetricians and Gynecologists
    • The U.S. Food and Drug Administration Requires Notification of Breast Density in Mammography Reports [2023]
    • Management of Women With Dense Breasts Diagnosed by Mammography [2015]
  • American College of Physicians
    • Screening for Breast Cancer in Average-Risk Women: A Guidance Statement From the American College of Physicians [2019]
  • American College of Radiology
    • Updated Recommendations by the American College of Radiology for Breast Cancer Screening in Individuals at Higher-Than-Average Risk [2023]
    • Breast Cancer Screening Recommendations Inclusive of All Women at Average Risk: Update from the ACR and Society of Breast Imaging [2021]
    • Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR [2018]
    • ACR Statement on Reporting Breast Density in Mammography Reports and Patient Summaries [2017]
    • ACR Position Statement on Screening Mammography and Health Care Coverage [2016]
    • Breast Cancer Screening
    • ACR–AAPM–SIIM Practice Parameter for Determinants of Image Quality In Mammography
    • ACR Practice Parameter for the Performance of Screening and Diagnostic Mammography
    • ACR Practice Parameter for the Performance of Digital Breast Tomosynthesis (DBT)
  • American Journal of Roentgenology
    • Beyond the Mammography Quality Standards Act: Measuring the Quality of Breast Cancer Screening Programs [2014]
  • Annals of Internal Medicine
    • Aggregate Cost of Mammography Screening in the United States: Comparison of Current Practice and Advocated Guidelines [2014]
  • Association of Women's Health, Obstetric and Neonatal Nurses
    • Breast Cancer Screening [2017]
  • Breast Cancer Research and Treatment
    • Breast Cancer Screening in the Era of Density Notification Legislation: Summary of 2014 Massachusetts Experience and Suggestion of An Evidence-Based Management Algorithm by Multi-disciplinary Expert Panel [2015]
  • Breast Cancer Surveillance Consortium
    • Mammography adherence in relation to function-related indicators in older women [2022]
    • Diagnostic Mammography Performance across Racial and Ethnic Groups in a National Network of Community-Based Breast Imaging Facilities [2022]
    • Trade-Offs Between Harms and Benefits of Different Breast Cancer Screening Intervals Among Low-Risk Women [2021]
    • Function-related Indicators and Outcomes of Screening Mammography in Older Women: Evidence from the Breast Cancer Surveillance Consortium Cohort [2021]
    • Screening Mammography Outcomes: Risk of Breast Cancer and Mortality by Comorbidity Score and Age [2020]
    • Trends in Clinical Breast Density Assessment From the Breast Cancer Surveillance Consortium [2019]
    • Digital Breast Tomosynthesis: Radiologist Learning Curve [2019]
    • Quantifying performance thresholds for recommending screening mammography: a revealed preference analysis of USPSTF guidelines [2018]
    • National Performance Benchmarks for Modern Diagnostic Digital Mammography: Update from the Breast Cancer Surveillance Consortium [2017]
    • Change in Breast Cancer Screening Intervals Since the 2009 USPSTF Guideline [2017]
    • Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes [2016]
    • Performance of digital screening mammography among older women in the United States [2015]
    • One versus Two Breast Density Measures to Predict 5- and 10-Year Breast Cancer Risk [2015]
    • Diagnostic Accuracy of Digital Screening Mammography With and Without Computer-Aided Detection [2015]
    • Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status [2015]
    • Timeliness of abnormal screening and diagnostic mammography follow-up at facilities serving vulnerable women [2013]
    • Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates? [2013]
    • Reported mammographic density: film-screen versus digital acquisition [2013]
    • Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy [2013]
    • Impact of mammography screening interval on breast cancer diagnosis by menopausal status and BMI [2013]
    • Facility characteristics do not explain higher false-positive rates in diagnostic mammography at facilities serving vulnerable women [2012]
    • Timeliness of follow-up after abnormal screening mammogram: variability of facilities [2011]
    • Effectiveness of computer-aided detection in community mammography practice [2011]
    • Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study [2011]
    • Accuracy of diagnostic mammography at facilities serving vulnerable women [2011]
    • Time trends in radiologists' interpretive performance at screening mammography from the community-based Breast Cancer Surveillance Consortium, 1996-2004 [2010]
    • Performance of first mammography examination in women younger than 40 years [2010]
    • Physician workload in mammography [2008]
    • An assessment of the quality of mammography care at facilities treating medically vulnerable populations [2008]
    • Factors associated with imaging and procedural events used to detect breast cancer after screening mammography [2007]
    • Improving the concordance of mammography assessment and management recommendations [2006]
  • Cancer
    • Performance of digital screening mammography among older women in the U.S [2014]
    • Mammographic Screening Interval in Relation to Tumor Characteristics and False-positive Risk by Race/Ethnicity and Age [2013]
  • Cancer Epidemiology Biomarkers & Prevention
    • Do Community Health Worker Interventions Improve Rates of Screening Mammography in the United States? A Systematic Review [2011]
  • Cancer Medicine
    • Factors associated with mammography use: A side-by-side comparison of results from two national surveys [2020]
  • Centers for Disease Control and Prevention
    • Vital Signs: Mammography Use and Association with Social Determinants of Health and Health-Related Social Needs Among Women — United States, 2022 [2024]
    • Mammography
  • Food and Drug Administration
    • Mammography Quality Standards Act and Program
  • International Journal of Environmental Research and Public Health
    • The Impact of IT-Based Healthcare Communication on Mammography Screening Utilization among Women in the United States: National Health Interview Survey (2011-2018) [2022]
  • JAMA Internal Medicine
    • The Divide Between Breast Density Notification Laws and Evidence-Based Guidelines for Breast Cancer Screening [2015]
  • JAMA Network Open
    • Inclusion of the US Preventive Services Task Force Recommendation for Mammography in State Comprehensive Cancer Control Plans in the US [2022]
  • JAMA Oncology
    • Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants: A Comparative Modeling Analysis [2022]
  • Journal of General Internal Medicine
    • Racial Disparities Persist in Cancer Screening: New USPSTF Colorectal Cancer Screening Guidelines Illuminate Inadequate Breast Cancer Screening Guidelines for Black Women [2022]
    • Guideline-Inconsistent Breast Cancer Screening for Women over 50: A Vignette-Based Survey [2014]
  • Journal of the American College of Radiology
    • Impact of the COVID-19 Pandemic on Breast Imaging: An Analysis of the National Mammography Database [2022]
  • Journal of the National Cancer Institute
    • Breast cancer screening during the COVID-19 pandemic: moving from disparities to health equity [2023]
  • Journal of Women's Health
    • Screening Mammography Among Older Women: A Review of United States Guidelines and Potential Harms [2019]
    • Prevalence of Out-Of-Pocket Payments for Mammography Screening Among Recently Screened Women [2019]
  • Milbank Quarterly
    • Why Was the US Preventive Services Task Force's 2009 Breast Cancer Screening Recommendation So Objectionable? A Historical Analysis [2022]
  • National Academies of Sciences, Engineering, and Medicine
    • Assessing and Improving the Interpretation of Breast Images [2015]
  • National Cancer Institute
    • Breast Cancer Screening (PDQ®)
  • PLoS ONE
    • Impact of the 2009 US Preventive Services Task Force Guidelines on Screening Mammography Rates on Women in Their 40s [2014]
  • Radiology
    • Registry-based Study of Trends in Breast Cancer Screening Mammography before and after the 2009 U.S. Preventive Services Task Force Recommendations [2014]
  • U.S. Preventive Services Task Force
    • Breast Cancer: Screening [2016]
• WHO
  • International Agency for Research on Cancer
    • Atlas of breast cancer early detection [2023]
    • Breast Cancer Screening [2016]
    • Breast-Cancer Screening — Viewpoint of the IARC Working Group [2015]
    • Breast self-examination (BSE)
  • World Health Organization
    • WHO position paper on mammography screening [2014]
• WHO Eastern Mediterranean Region
  • WHO Eastern Mediterranean Region
    • Guidelines for the early detection and screening of breast cancer [2006]
• {Related topics}
  • Topic
    • Breast imaging
    • Breast cancer diagnosis
    • Breast cancer
    • Benign breast diseases

Breast cancer stem cells

• International
  • Cells
    • Preclinical and Clinical Trials of New Treatment Strategies Targeting Cancer Stem Cells in Subtypes of Breast Cancer [2023]
• United States
  • Scientific Reports
    • Identification of FDA-approved Drugs Targeting Breast Cancer Stem Cells Along With Biomarkers of Sensitivity [2013]
• {Related topics}
  • Topic
    • Breast cancer

Breast cancer treatment

• Africa
  • JCO Global Oncology
    • Adherence to Oral Anticancer Medications Among Women With Breast Cancer in Africa: A Scoping Review [2023]
• Arab countries
  • Health and Quality of Life Outcomes
    • Quality of life in Arab women with breast cancer: a review of the literature [2016]
• Asia
  • BMJ Open
    • Health-related quality of life in Asian patients with breast cancer: a systematic review [2018]
  • Journal of Breast Cancer
    • Patient Management with Eribulin in Metastatic Breast Cancer: A Clinical Practice Guide [2016]
  • PLoS ONE
    • Predicting Survival of De Novo Metastatic Breast Cancer in Asian Women: Systematic Review and Validation Study [2014]
• Australia
  • Australian Journal of General Practice
    • Update on the management of early-stage breast cancer [2019]
    • Advanced breast cancer [2019]
  • Cancer Australia
    • Guidance for the management of early breast cancer: Recommendations and practice points [2020]
    • Guidance for the management of early breast cancer: Methods [2020]
    • Recommendations for follow-up of women with early breast cancer [2010]
  • Journal of Comorbidity
    • Incidence of Comorbidities in Women with Breast Cancer Treated with Tamoxifen or an Aromatase Inhibitor: An Australian Population-Based Cohort Study [2018]
  • PLoS ONE
    • Women Commencing Anastrozole, Letrozole or Tamoxifen for Early Breast Cancer: The Impact of Comorbidity and Demographics on Initial Choice [2014]
• Austria
  • SpringerPlus
    • Cost effectiveness of personalized treatment in women with early breast cancer: the application of OncotypeDX and Adjuvant! Online to guide adjuvant chemotherapy in Austria [2015]
  • Wiener klinische Wochenschrift
    • Updated Austrian treatment algorithm in HER2+ metastatic breast cancer [2022]
    • Austrian treatment algorithms in HER2-positive metastatic breast cancer: a 2022 update [2022]
• Brazil
  • International Journal of Environmental Research and Public Health
    • Waiting Time between Breast Cancer Diagnosis and Treatment in Brazilian Women: An Analysis of Cases from 1998 to 2012 [2020]
• Bulgaria
  • Frontiers in Public Health
    • Treatment patterns, adherence to international guidelines, and financial mechanisms of the market access of advanced breast cancer therapy in Bulgaria [2023]
• Canada
  • Breast Cancer Research and Treatment
    • A Canadian national guideline on the neoadjuvant treatment of invasive breast cancer, including patient assessment, systemic therapy, and local management principles [2022]
  • Canadian Agency for Drugs and Technologies in Health
    • Regional Chemotherapy for the Treatment of Breast Cancer: A Review of Clinical Effectiveness, Cost-Effectiveness and Guidelines [2018]
  • Canadian Family Physician
    • Breast Cancer Survivorship Tool [2020]
    • Follow-up after treatment for breast cancer: Practical guide to survivorship care for family physicians [2016]
  • Current Oncology
    • Management of Oligometastatic Breast Cancer: An Expert Committee's Opinion [2023]
    • Systemic treatment approaches in her2-negative advanced breast cancer—guidance on the guidelines [2015]
    • Optimal systemic therapy for early breast cancer in women: a clinical practice guideline [2015]
    • Cost-effectiveness of lapatinib plus letrozole in her2-positive, hormone receptor–positive metastatic breast cancer in Canada [2013]
  • Ontario Health
    • Systemic targeted therapy for her2-positive early female breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline [2015]
    • Adjuvant endocrine therapy for early breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline [2015]
    • Adjuvant chemotherapy for early female breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline [2015]
    • Cancer Care Ontario’s Position Statement on Guidelines for Breast Cancer Well Follow-Up Care [2012]
• Canada, United States
  • CA: A Cancer Journal for Clinicians
    • Clinical practice guidelines on the evidence-based use of integrative therapies during and following breast cancer treatment [2017]
• Central and Eastern Europe
  • Pathology & Oncology Research
    • Systemic Treatment of Breast Cancer. 1st Central-Eastern European Professional Consensus Statement on Breast Cancer [2022]
    • Breast Cancer Survivorship Programme: Follow-Up, Rehabilitation, Psychosocial Oncology Care. 1st Central-Eastern European Professional Consensus Statement on Breast Cancer [2022]
• China
  • Annals of Translational Medicine
    • Chemotherapy or endocrine therapy, first-line treatment for patients with hormone receptor-positive HER2-negative metastatic breast cancer in China: a real-world study [2021]
  • Cancer Biology & Medicine
    • Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guidelines in 2022: stratification and classification [2022]
  • Chinese Medical Journal
    • Clinical practice guidelines for breast cancer implantable intravenous infusion ports: Chinese Society of Breast Surgery practice guidelines 2021 [2021]
  • Frontiers in Oncology
    • Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer: A Nation-Wide Multicenter Epidemiological Study in China [2021]
  • Frontiers in Public Health
    • The outcome of neoadjuvant chemotherapy and the current trend of surgical treatment in young women with breast cancer: A multicenter real-world study (CSBrS-012) [2023]
  • Journal of Oncology
    • Comparisons of Treatment for HER2-Positive Breast Cancer between Chinese and International Practice: A Nationwide Multicenter Epidemiological Study from China [2021]
  • Oncotarget
    • A nation-wide multicenter 10-year (1999–2008) retrospective study of chemotherapy in Chinese breast cancer patients [2017]
  • Supportive Care in Cancer
    • Financial toxicity in female patients with breast cancer: a national cross-sectional study in China [2022]
• China, United States
  • JAMA Network Open
    • Trends in Disparities and Transitions of Treatment in Patients With Early Breast Cancer in China and the US, 2011 to 2021 [2023]
• Denmark
  • Journal of the National Cancer Institute
    • The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis [2022]
• Egypt
  • Journal of the Egyptian National Cancer Institute
    • Primary therapy of early breast cancer: Egyptian view of 2021 St. Gallen consensus [2022]
• Europe
  • BMC Cancer
    • Patterns of resource utilization and cost for postmenopausal women with hormone-receptor–positive, human epidermal growth factor receptor-2–negative advanced breast cancer in Europe [2015]
  • BMC Health Services Research
    • Adherence to breast cancer guidelines is associated with better survival outcomes: a systematic review and meta-analysis of observational studies in EU countries [2020]
  • Clinical Breast Cancer
    • A European, Observational Study of Endocrine Therapy Administration in Patients With an Initial Diagnosis of Hormone Receptor-Positive Advanced Breast Cancer [2017]
  • Critical Reviews in Oncology/Hematology
    • Systemic treatment for hormone receptor-positive/HER2-negative advanced/metastatic breast cancer: A review of European real-world evidence studies [2022]
  • European Society for Medical Oncology
    • Application of the ESMO-Magnitude of Clinical Benefit Scale (V.1.1) to the field of early breast cancer therapies [2020]
• Europe, United States
  • Cancer Treatment Reviews
    • Adjuvant and neoadjuvant breast cancer treatments: A systematic review of their effects on mortality [2022]
  • Cancers
    • FDA and EMA Approvals of New Breast Cancer Drugs—A Comparative Regulatory Analysis [2020]
• France
  • JAMA Network Open
    • Comparison of Management and Outcomes in ERBB2-Low vs ERBB2-Zero Metastatic Breast Cancer in France [2022]
• Germany
  • BMC Cancer
    • The adherence paradox: guideline deviations contribute to the increased 5-year survival of breast cancer patients [2015]
  • Breast Cancer
    • Adjuvant chemotherapeutic treatment of 1650 patients with early breast cancer in routine care in Germany: data from the prospective TMK cohort study [2018]
  • Breast Care
    • International Consensus Conference for Advanced Breast Cancer, Lisbon 2019: ABC5 Consensus - Assessment by a German Group of Experts [2020]
    • Treatment of Early Breast Cancer Patients: Evidence, Controversies, Consensus: Focusing on Systemic Therapy – German Experts' Opinions for the 16th International St. Gallen Consensus Conference (Vienna 2019) [2019]
    • ABC4 Consensus: Assessment by a German Group of Experts [2018]
    • ABC3 Consensus: Assessment by a German Group of Experts [2016]
    • 14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus – Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts [2015]
    • Guideline Conformity Treatment in Young Women with Early-Onset Breast Cancer in Germany [2014]
    • 13th St. Gallen International Breast Cancer Conference 2013: Primary Therapy of Early Breast Cancer Evidence, Controversies, Consensus – Opinion of a German Team of Experts (Zurich 2013) [2013]
  • Deutsche Gesellschaft für Radioonkologie
    • Post-neoadjuvant treatment with capecitabine and trastuzumab emtansine in breast cancer patients-sequentially, or better simultaneously? [2021]
  • Geburtshilfe und Frauenheilkunde
    • Treatment of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: German Expert Opinions on the 17th International St. Gallen Consensus Conference [2021]
    • AGO Algorithms for the Treatment of Breast Cancer: Update 2021 [2021]
    • ABC5 International Consensus Conference on Advanced Breast Cancer, Lisbon, 16 November 2019: Commentary by the German panel of experts on the ABC5 voting results [2020]
    • Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer [2018]
    • 4th International Consensus Conference on Advanced Breast Cancer (ABC4), Lisbon, November 4, 2017 : ABC4 Consensus: Assessment by a Panel of German Experts [2018]
    • Initial Treatment of Patients with Primary Breast Cancer: Evidence, Controversies, Consensus [2017]
    • ABC3 Consensus Commented from the Perspective of the German Guidelines [2016]
    • Primary Therapy of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: Opinions of German Specialists to the 14th St. Gallen International Breast Cancer Conference 2015 (Vienna 2015) [2015]
  • Institute for Quality and Efficiency in Health Care
    • Palbociclib (breast cancer) - Benefit assessment according to §35a Social Code Book V [2017]
  • International Journal of Cancer
    • Time trends of neoadjuvant chemotherapy for early breast cancer [2020]
• Ghana
  • PLoS ONE
    • Geospatial availability of breast cancer treatment modalities and hypothetical access improvement in Ghana: A nationwide survey [2023]
• Greece
  • BMC Health Services Research
    • Everolimus plus exemestane versus bevacizumab-based chemotherapy for second-line treatment of hormone receptor-positive metastatic breast cancer in Greece: An economic evaluation study [2015]
• Hong Kong
  • Hong Kong Medical Journal
    • Preoperative considerations and benefits of neoadjuvant chemotherapy: insights from a 12-year review of the Hong Kong Breast Cancer Registry [2023]
• India
  • Indian Journal of Medical Research
    • Consensus on contentious issues relevant for breast cancer management for the Indian scenario: Statements following a multicentre expert group meeting [2021]
    • Breast cancer survivorship in India [2021]
  • Indian Journal of Surgery
    • Indian Solutions for Indian Problems—Association of Breast Surgeons of India (ABSI) Practical Consensus Statement, Recommendations, and Guidelines for the Treatment of Breast Cancer in India [2017]
  • Journal of Cancer Research and Therapeutics
    • Patient-reported quality of life outcomes in Indian breast cancer patients: Importance, review of the researches, determinants and future directions [2013]
  • South Asian Journal of Cancer
    • Practical Consensus Recommendations for Optimizing Risk versus Benefit of Chemotherapy in Patients with HR Positive Her2 Negative Early Breast Cancer in India [2021]
• International
  • Annals of Oncology
    • Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021 [2021]
    • Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 [2015]
  • BMJ Open
    • Evidence-based recommendations on care for breast cancer survivors for primary care providers: a review of evidence-based breast cancer guidelines [2017]
  • Breast
    • The impact of medication side effects on adherence and persistence to hormone therapy in breast cancer survivors: A quantitative systematic review [2022]
    • Factors influencing five-year adherence to adjuvant endocrine therapy in breast cancer patients: A systematic review [2022]
    • Customizing early breast cancer therapies - The 2021 St. Gallen International Breast Cancer Consensus Conference [2022]
    • Quality and reporting of clinical guidelines for breast cancer treatment: A systematic review [2020]
  • Breast Care
    • St. Gallen/Vienna 2021: A Brief Summary of the Consensus Discussion on Customizing Therapies for Women with Early Breast Cancer [2021]
    • St. Gallen/Vienna 2019: A Brief Summary of the Consensus Discussion on the Optimal Primary Breast Cancer Treatment [2019]
  • Breast Health Global Initiative
    • Breast cancer treatment: A phased approach to implementation [2020]
  • Cancer Treatment Reviews
    • Risk-based decision-making in the treatment of HER2-positive early breast cancer: Recommendations based on the current state of knowledge [2021]
  • European Society for Medical Oncology
    • 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5) [2020]
    • 4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4) [2018]
    • 3rd ESO–ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3) [2017]
  • Geburtshilfe und Frauenheilkunde
    • Update Breast Cancer 2021 Part 3 – Current Developments in the Treatment of Early Breast Cancer: Review and Assessment of Specialised Treatment Scenarios by an International Expert Panel [2021]
  • Health Expectations
    • Shared decision making in breast cancer treatment guidelines: Development of a quality assessment tool and a systematic review [2020]
  • JAMA Network Open
    • Financial Toxicity Among Patients With Breast Cancer Worldwide: A Systematic Review and Meta-analysis [2023]
  • JCO Global Oncology
    • Are NCCN Resource-Stratified Guidelines for Breast Cancer Systemic Therapy Achievable? A Population-Based Study of Global Need and Economic Impact [2021]
  • Journal of Cancer Survivorship
    • Strategies to self-manage side-effects of adjuvant endocrine therapy among breast cancer survivors: an umbrella review of empirical evidence and clinical guidelines [2022]
  • Journal of the National Cancer Institute
    • International Guidelines for Management of Metastatic Breast Cancer: Can Metastatic Breast Cancer Be Cured? [2010]
    • International Guidelines for Management of Metastatic Breast Cancer: Combination vs Sequential Single-Agent Chemotherapy [2009]
  • NPJ Breast Cancer
    • Evidence-based guidelines for managing patients with primary ER+ HER2- breast cancer deferred from surgery due to the COVID-19 pandemic [2020]
  • Oncologist
    • Ovarian Function Suppression: A Deeper Consideration of the Role in Early Breast Cancer and its Potential Impact on Patient Outcomes: A Consensus Statement from an International Expert Panel [2022]
  • Oncotarget
    • Role of cooperative groups and funding source in clinical trials supporting guidelines for systemic therapy of breast cancer [2018]
  • PLoS ONE
    • Global treatment costs of breast cancer by stage: A systematic review [2018]
• Ireland, Netherlands
  • PLoS ONE
    • Treatment Strategies and Survival of Older Breast Cancer Patients – An International Comparison between the Netherlands and Ireland [2015]
• Italy
  • BMC Cancer
    • An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: the ERA project [2018]
  • Breast
    • Influence of adherence with guideline-driven recommendations on survival in women operated for breast cancer: Real-life evidence from Italy [2020]
• Japan
  • Breast Cancer
    • The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition [2020]
    • Evidence produced in Japan: tegafur-based preparations for postoperative chemotherapy in breast cancer [2013]
  • Japanese Journal of Clinical Oncology
    • The Transition of Breast Cancer Treatment and Japan Clinical Oncology Group Research Over Two Decades [2012]
• Latin America and the Caribbean
  • Oncologist
    • Health-Related Quality of Life in Patients with Breast Cancer in Latin America and the Caribbean: A Systematic Review and Meta-Analysis [2021]
• Low and middle income countries
  • BMC Cancer
    • Essential medicines for breast cancer in low and middle income countries [2015]
  • Breast Health Global Initiative
    • Supportive care during treatment for breast cancer: Resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement [2013]
    • Supportive care after curative treatment for breast cancer (survivorship care): Resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement [2013]
• Morocco
  • Breast Journal
    • Management of breast cancer during COVID-19 pandemic in Morocco [2020]
• Netherlands
  • BMC Cancer
    • Cost-effectiveness and resource use of implementing MRI-guided NACT in ER-positive/HER2-negative breast cancers in The Netherlands [2016]
  • Breast Cancer Research and Treatment
    • The increasing importance of histologic grading in tailoring adjuvant systemic therapy in 30,843 breast cancer patients [2021]
    • The association of socioeconomic status on treatment strategy in patients with stage I and II breast cancer in the Netherlands [2021]
• Netherlands, United Kingdom
  • European Journal of Cancer
    • Differences in treatment and survival of older patients with operable breast cancer between the United Kingdom and the Netherlands - A comparison of two national prospective longitudinal multi-centre cohort studies [2022]
• New Zealand
  • Breast
    • New Zealand experience with implementation of the ESO-ESMO consensus guidelines for advanced breast cancer-report of achievements and lessons learned [2022]
  • International Journal of Environmental Research and Public Health
    • Use of Non-Cancer Medications in New Zealand Women at the Diagnosis of Primary Invasive Breast Cancer: Prevalence, Associated Factors and Effects on Survival [2020]
• Nigeria
  • ecancermedicalscience
    • Assessment of guideline adherence in breast cancer management among oncologists in Nigeria [2021]
• Norway
  • Breast Cancer Research and Treatment
    • Stage-specific survival has improved for young breast cancer patients since 2000: but not equally [2020]
• Republic of Korea
  • Annals of Surgical Treatment and Research
    • The reality in the follow-up of breast cancer survivors: survey of Korean Breast Cancer Society [2015]
  • Cancer Research and Treatment
    • Quality Assessment and Trend for Breast Cancer Treatment Practice across South Korea Based on Nationwide Analysis of Korean Health Insurance Data during 2013-2017 [2023]
  • ClinicoEconomics and Outcomes Research
    • Economic evaluation of eribulin as second-line treatment for metastatic breast cancer in South Korea [2016]
  • Journal of Breast Cancer
    • Differences in Clinical Outcomes between Luminal A and B Type Breast Cancers according to the St. Gallen Consensus 2013 [2015]
    • Meeting Highlights: The First Korean Breast Cancer Treatment Consensus Conference [2014]
  • Journal of Korean Medical Science
    • Nationwide Analysis of Treatment Patterns for Korean Breast Cancer Survivors Using National Health Insurance Service Data [2018]
  • Journal of the American Heart Association
    • Effects of Endocrine Therapy on Cardiovascular Diseases and Type 2 Diabetes Among Breast Cancer Survivors: The National Health Insurance Service Database of Korea [2022]
  • Nutrients
    • Adherence to Guidelines for Cancer Survivors and Health-Related Quality of Life among Korean Breast Cancer Survivors [2015]
• Serbia
  • JBUON
    • Serbian consensus of neoadjuvant therapy for breast cancer: NeoPULSE [2018]
• Singapore
  • Scientific Reports
    • Impact of deviation from guideline recommended treatment on breast cancer survival in Asia [2020]
• Spain
  • Breast Cancer Research and Treatment
    • Adherence of long-term breast cancer survivors to follow-up care guidelines: a study based on real-world data from the SURBCAN cohort [2022]
  • Clinical and Translational Oncology
    • Expert consensus to optimize the treatment of elderly patients with luminal metastatic breast cancer [2022]
    • Recommendations for the follow-up care of female breast cancer survivors: a guideline of the Spanish Society of Medical Oncology (SEOM), Spanish Society of General Medicine (SEMERGEN), Spanish Society for Family and Community Medicine (SEMFYC), Spanish Society for General and Family Physicians (SEMG), Spanish Society of Obstetrics and Gynecology (SEGO), Spanish Society of Radiation Oncology (SEOR), Spanish Society of Senology and Breast Pathology (SESPM), and Spanish Society of Cardiology (SEC) [2018]
    • Defining the optimal sequence for the systemic treatment of metastatic breast cancer [2016]
  • Health and Quality of Life Outcomes
    • Health-related quality of life in Spanish breast cancer patients: a systematic review [2011]
  • Journal of Drug Assessment
    • Broad consensus on the optimal sequence for the systemic treatment of metastatic breast cancer: results from a survey of Spanish medical oncologists [2019]
  • Oncologist
    • GEICAM Guidelines for the Management of Patients with Breast Cancer During Spain's COVID-19 Pandemic [2020]
  • Scientific Reports
    • Adequacy of early-stage breast cancer systemic adjuvant treatment to Saint Gallen-2013 statement: the MCC-Spain study [2021]
  • Sociedad Española de Oncología Médica
    • SEOM clinical guidelines in early stage breast cancer (2018) [2019]
    • SEOM clinical guidelines in advanced and recurrent breast cancer (2018) [2019]
    • SEOM clinical guidelines in metastatic breast cancer 2015 [2015]
• Sub-Saharan Africa
  • Breast Cancer Research
    • Inequities in breast cancer treatment in sub-Saharan Africa: findings from a prospective multi-country observational study [2019]
  • Lancet Oncology
    • Treatment guideline concordance, initiation, and abandonment in patients with non-metastatic breast cancer from the African Breast Cancer-Disparities in Outcomes (ABC-DO) cohort in sub-Saharan Africa: a prospective cohort study [2022]
• Switzerland
  • Cancers
    • Management and Outcome of Young Women (<=40 Years) with Breast Cancer in Switzerland [2022]
• Taiwan
  • Breast
    • Effectiveness and healthcare costs of eribulin versus capecitabine among metastatic breast cancer patients in Taiwan [2021]
  • Scientific Reports
    • Association of treatment delay and stage with mortality in breast cancer: a nationwide cohort study in Taiwan [2022]
    • Health Services Utilisation in Breast Cancer Survivors in Taiwan [2014]
• Turkey
  • Turkish Journal of Surgery
    • Turkish national consensus on breast cancer management during temporary state of emergency due to COVID-19 outbreak [2020]
• United Kingdom
  • Association of Breast Surgery
    • Endocrine Treatment for Breast Cancer [2021]
  • BMJ Open
    • Societal costs of chemotherapy in the UK: an incidence-based cost-of-illness model for early breast cancer [2021]
  • British Journal of Cancer
    • A real-world study of the first use of palbociclib for the treatment of advanced breast cancer within the UK National Health Service as part of the novel Ibrance® Patient Program [2023]
    • Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK ‘Alert Level 4’ phase of the B-MaP-C study [2021]
  • Cancer Biology & Medicine
    • The decision-making process for senior cancer patients: treatment allocation of older women with operable breast cancer in the UK [2015]
  • Healthcare Improvement Scotland
    • External assurance of performance against Breast Cancer QPIs - National review report: December 2016 [2016]
    • Breast Cancer Clinical Quality Performance Indicators [2016]
  • Indian Journal of Surgery
    • Breast Cancer Management Guidelines During COVID-19 Pandemic [2020]
  • National Institute for Health and Care Excellence
    • Talazoparib for treating HER2-negative advanced breast cancer with germline BRCA mutations [2024]
    • Olaparib for adjuvant treatment of BRCA mutation-positive HER2-negative high-risk early breast cancer after chemotherapy [2023]
    • Tucatinib with trastuzumab and capecitabine for treating HER2-positive advanced breast cancer after 2 or more anti-HER2 therapies [2022]
    • Palbociclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy [2022]
    • Alpelisib with fulvestrant for treating hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer [2022]
    • Abemaciclib with endocrine therapy for adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence [2022]
    • Ribociclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy [2021]
    • Abemaciclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy [2021]
    • Abemaciclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer [2019]
    • Eribulin for treating locally advanced or metastatic breast cancer after 1 chemotherapy regimen [2018]
    • Ribociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer [2017]
    • Palbociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer [2017]
    • Everolimus with exemestane for treating advanced breast cancer after endocrine therapy [2016]
    • Eribulin for treating locally advanced or metastatic breast cancer after 2 or more chemotherapy regimens [2016]
    • Lapatinib or trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone-receptor-positive breast cancer that overexpresses HER2 [2012]
    • Hormonal therapies for the adjuvant treatment of early oestrogen-receptor-positive breast cancer [2006]
• United States
  • American Cancer Society
    • American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline [2015]
  • American College of Radiology
    • Monitoring Response to Neoadjuvant Systemic Therapy for Breast Cancer
    • Locally Advanced Breast Cancer
  • American Society of Breast Surgeons
    • Analysis of the Impact of the COVID-19 Pandemic on the Multidisciplinary Management of Breast Cancer: Review from the American Society of Breast Surgeons COVID-19 and Mastery Registries [2021]
  • American Society of Clinical Oncology
    • Abemaciclib With Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Optimal Adjuvant Chemotherapy and Targeted Therapy Guideline Rapid Recommendation Update [2022]
    • Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline [2021]
    • Endocrine Treatment and Targeted Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: ASCO Guideline Update [2021]
    • Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor–Negative: ASCO Guideline Update [2021]
    • Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update [2020]
    • Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: Update of the ASCO Endorsement of the Cancer Care Ontario Guideline [2019]
    • Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: ASCO Clinical Practice Guideline Update [2018]
    • Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused Update [2018]
    • Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases: ASCO Clinical Practice Guideline Update [2018]
    • Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline [2018]
    • Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update [2018]
    • Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology–Cancer Care Ontario Focused Guideline Update [2017]
    • Selection of Optimal Adjuvant Chemotherapy Regimens for Human Epidermal Growth Factor Receptor 2 (HER2) –Negative and Adjuvant Targeted Therapy for HER2-Positive Breast Cancers: An American Society of Clinical Oncology Guideline [2016]
    • Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression [2016]
    • Breast Cancer Follow-Up and Management After Primary Treatment: American Society of Clinical Oncology Clinical Practice Guideline Update [2013]
    • Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer
    • Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision-Making for Early-Stage, Operable Breast Cancer
    • Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer
    • Endocrine Treatment and Targeted Therapy for HR-Positive, HER2-Negative Metastatic Breast Cancer
    • Chemo- and Targeted Therapy for Patients With HER2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative
  • ASCO Educational Book
    • Advances in the Management of Menopausal Symptoms, Fertility Preservation, and Bone Health for Women With Breast Cancer on Endocrine Therapy [2023]
    • What’s the Price? Toxicities of Targeted Therapies in Breast Cancer Care [2020]
  • Breast
    • Management of HR+/HER2+ lobular breast cancer and trends do not mirror better outcomes [2022]
  • Breast Cancer : Basic and Clinical Research
    • Endocrine Therapy Plus Anti-HER2 Therapy as Adjuvant Systemic Therapy for Luminal HER2-Positive Breast Cancer: An Analysis of the National Cancer Database [2020]
  • Breast Cancer : Targets and Therapy
    • Disparities in Guideline-Concordant Initial Systemic Treatment in Women with HER2-Negative Metastatic Breast Cancer: A SEER-Medicare Analysis [2021]
  • Breast Cancer Research and Treatment
    • Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium [2020]
    • Use of cyclin-dependent kinase (CDK) 4/6 inhibitors for hormone receptor-positive, human epidermal growth factor receptor 2-negative, metastatic breast cancer: a roundtable discussion by The Breast Cancer Therapy Expert Group (BCTEG) [2018]
    • Endocrine therapy and related issues in hormone receptor-positive early breast cancer: a roundtable discussion by the breast cancer therapy expert group (BCTEG) [2018]
    • Assessing racial/ethnic disparities in chemotherapy treatment among breast cancer patients in context of changing treatment guidelines [2013]
  • Cancer Medicine
    • Physician experiences and preferences in the treatment of HR+/HER2- metastatic breast cancer in the United States: a physician survey [2015]
  • Cancers
    • Racial/Ethnic Differences and Trends in Pathologic Complete Response Following Neoadjuvant Chemotherapy for Breast Cancer [2022]
  • Chinese Clinical Oncology
    • Chemotherapy principles of managing stage IV breast cancer in the United States [2016]
  • Current Breast Cancer Reports
    • Lessons Learned: Management of Breast Cancer Patients throughout the COVID-19 Pandemic [2021]
  • Expert Review of Anticancer Therapy
    • Treatment of small (T1mic, T1a, and T1b) node-negative HER2+ breast cancer - a review of current evidence for and against the use of anti-HER2 treatment regimens [2022]
  • Food and Drug Administration
    • U.S. FDA Drug Approvals for Breast Cancer: A Decade in Review [2022]
    • FDA Approval: Palbociclib for the Treatment of Postmenopausal Patients with Estrogen Receptor–Positive, HER2-Negative Metastatic Breast Cancer [2015]
  • JAMA Network Open
    • Cost-Effectiveness of Neoadjuvant-Adjuvant Treatment Strategies for Women With ERBB2 (HER2)–Positive Breast Cancer [2020]
  • JAMA Oncology
    • Evaluation of the Quality of Adjuvant Endocrine Therapy Delivery for Breast Cancer Care in the United States [2017]
  • JCO Oncology Practice
    • Management of Breast Cancer During the COVID-19 Pandemic: A Stage- and Subtype-Specific Approach [2020]
  • JNCCN
    • Potential Impact of Revised NCI Eligibility Criteria Guidance: Prior Malignancy Exclusion in Breast Cancer Clinical Trials [2022]
  • Journal of Cancer
    • Current Approaches and Challenges in Monitoring Treatment Responses in Breast Cancer [2014]
  • Journal of Cancer Survivorship
    • Current practice patterns and gaps in guideline-concordant breast cancer survivorship care [2023]
  • Journal of Clinical Oncology
    • Late Breast Cancer Survivorship: Side Effects and Care Recommendations [2022]
  • Journal of Oncology Practice
    • Improved Breast Cancer Care Quality Metrics After Implementation of a Standardized Tumor Board Documentation Template [2015]
  • National Cancer Institute
    • Childhood Breast Cancer Treatment (PDQ®)
    • Breast Cancer Treatment (PDQ®)
  • National Comprehensive Cancer Network
    • NCCN Guidelines® Insights: Breast Cancer, Version 4.2023 [2023]
    • Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology [2022]
    • NCCN resource-stratified and harmonized guidelines: A paradigm for optimizing global cancer care [2020]
  • Society for Immunotherapy of Cancer
    • Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer [2021]
  • Society for Integrative Oncology
    • Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment [2017]
• {Related topics}
  • Topic
    • Breast cancer treatment: vinca alkaloids
    • Breast cancer treatment: tyrosine kinase inhibitors
    • Breast cancer treatment: taxanes
    • Breast cancer treatment: surgery, radiotherapy
    • Breast cancer treatment: monoclonal antibodies
    • Breast cancer treatment: epothilones
    • Breast cancer treatment: bisphosphonates
    • Breast cancer treatment: aromatase inhibitors
    • Breast cancer treatment: antimetabolites
    • Breast cancer treatment: antiestrogens
    • Breast cancer treatment: anthracyclines
    • Breast cancer

Breast cancer treatment: anthracyclines

• China
  • Cancer Medicine
    • Profile, treatment patterns, and influencing factors of anthracycline use in breast cancer patients in China: A nation-wide multicenter study [2021]
• Lebanon
  • BMC Cancer
    • Role of baseline echocardiography prior to initiation of anthracycline-based chemotherapy in breast cancer patients [2015]
• Netherlands
  • British Journal of Cancer
    • Cardiovascular disease incidence after internal mammary chain irradiation and anthracycline-based chemotherapy for breast cancer [2018]
• Spain
  • Clinical and Translational Oncology
    • Galician consensus on management of cardiotoxicity in breast cancer: risk factors, prevention, and early intervention [2017]
• United States
  • Journal of Clinical Oncology
    • Decline in the Use of Anthracyclines for Breast Cancer [2012]
• {Related topics}
  • Topic
    • Breast cancer treatment

Breast cancer treatment: antiestrogens

• Australia, New Zealand
  • Royal Australian and New Zealand College of Obstetricians and Gynaecologists
    • Tamoxifen and the endometrium [2019]
• Europe
  • Breast
    • Patient database analysis of fulvestrant 500 mg in the treatment of metastatic breast cancer: A European perspective [2017]
• High-income countries
  • Cancer Reports
    • Tamoxifen use and risk of endometrial cancer in breast cancer patients: A systematic review and dose-response meta-analysis [2023]
• International
  • Clinical Pharmacology & Therapeutics
    • Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy [2018]
• Republic of Korea
  • Frontiers in Oncology
    • Effect of Tamoxifen on the Risk of Osteoporosis and Osteoporotic Fracture in Younger Breast Cancer Survivors: A Nationwide Study [2020]
• South Africa
  • Breast Cancer Research and Treatment
    • The impact of HIV on non-adherence for tamoxifen among women with breast cancer in South Africa [2023]
• Taiwan
  • Cancer Medicine
    • Gonadotropin-releasing hormone agonist treatment and ischemic heart disease among female patients with breast cancer: A cohort study [2023]
• United Kingdom
  • National Institute for Health and Care Excellence
    • Fulvestrant for untreated locally advanced or metastatic oestrogen-receptor positive breast cancer [2018]
    • Fulvestrant for the treatment of locally advanced or metastatic breast cancer [2011]
• United States
  • American College of Medical Genetics and Genomics
    • Laboratory testing of CYP2D6 alleles in relation to tamoxifen therapy [2012]
• {Related topics}
  • Topic
    • Breast cancer treatment

Breast cancer treatment: antimetabolites

• United Kingdom
  • National Institute for Health and Care Excellence
    • Gemcitabine for the treatment of metastatic breast cancer [2007]
• {Related topics}
  • Topic
    • Breast cancer treatment

Breast cancer treatment: aromatase inhibitors

• Australia
  • Medical Services Advisory Committee
    • Bone mineral density analyses using Dual Energy X-Ray Absorptiometry (DXA) in breast cancer patients receiving aromatase inhibitor treatment [2015]
• Canada
  • Current Oncology
    • Endocrine therapy for postmenopausal women with hormone receptor–positive her2–negative advanced breast cancer after progression or recurrence on nonsteroidal aromatase inhibitor therapy: a Canadian consensus statement [2013]
• China
  • OncoTargets and therapy
    • Clinical utility of letrozole in the treatment of breast cancer: a Chinese perspective [2016]
• International
  • Current Oncology
    • Risk of Cardiovascular Events and Lipid Profile Change in Patients with Breast Cancer Taking Aromatase Inhibitor: A Systematic Review and Meta-Analysis [2023]
  • Journal of Bone Oncology
    • Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG [2017]
• Lithuania
  • Medicina
    • Guidelines for diagnostics and treatment of aromatase inhibitor-induced bone loss in women with breast cancer: A consensus of Lithuanian medical oncologists, radiation oncologists, endocrinologists, and family medicine physicians [2014]
• United States
  • American College of Obstetricians and Gynecologists
    • Aromatase Inhibitors in Gynecologic Practice [2018]
  • Clinical Cardiology
    • Are Aromatase Inhibitors Associated with Higher Myocardial Infarction Risk in Breast Cancer Patients? A Medicare Population-Based Study [2018]
• {Related topics}
  • Topic
    • Breast cancer treatment

Breast cancer treatment: bisphosphonates

• Australia
  • Cancer Australia
    • Recommendations for use of bisphosphonates in early breast cancer [2011]
    • Recommendations for use of bisphosphonates for advanced breast cancer [2011]
    • Bisphosphonates in early breast cancer: a systematic literature review [2011]
• Canada
  • Breast Cancer Research and Treatment
    • Adjuvant bisphosphonate use in patients with early stage breast cancer: a physician survey [2021]
  • Journal of Bone Oncology
    • Are adjuvant bisphosphonates now standard of care of women with early stage breast cancer? A debate from the Canadian Bone and the Oncologist New Updates meeting [2015]
  • Ontario Health
    • Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer [2022]
• Canada, United States
  • American Society of Clinical Oncology
    • Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline [2017]
• Europe
  • Annals of Oncology
    • Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel [2016]
• High-income countries
  • Aging
    • Bisphosphonates and breast cancer survival: a meta-analysis and trial sequential analysis of 81508 participants from 23 prospective epidemiological studies [2021]
• International
  • PLoS ONE
    • The adverse effects of bisphosphonates in breast cancer: A systematic review and network meta-analysis [2021]
  • Therapeutic Advances in Medical Oncology
    • The incidence and relative risk of adverse events in patients treated with bisphosphonate therapy for breast cancer: a systematic review and meta-analysis [2019]
• Singapore
  • Annals Academy of Medicine Singapore
    • Singapore Cancer Network (SCAN) Guidelines for Bisphosphonate Use in the Adjuvant Breast Cancer Setting [2015]
• {Related topics}
  • Topic
    • Breast cancer treatment

Breast cancer treatment: epothilones

• Canada
  • BC Cancer Agency
    • Ixabepilone [2014]
• United States
  • Cancer Management and Research
    • Ixabepilone: a new treatment option for the management of taxane-resistant metastatic breast cancer [2009]
  • Drug Design, Development and Therapy
    • Management of advanced breast cancer with the epothilone B analog, ixabepilone [2009]
• {Related topics}
  • Topic
    • Breast cancer treatment

Breast cancer treatment: monoclonal antibodies

• Australia
  • Medical Services Advisory Committee
    • Testing for HER2 positivity in patients diagnosed with breast cancer to determine eligibility for treatment with trastuzumab [2017]
• Austria
  • Oncologist
    • Influence of the American ODAC Statement on Austrian Bevacizumab Prescribing Practice for Metastatic Breast Cancer [2012]
• Canada
  • Current Oncology
    • Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain [2022]
• Colombia
  • Revista de Salud Pública
    • ErbB2+ metastatic breast cancer treatment after progression on trastuzumab: a cost-effectiveness analysis for a developing country [2014]
• Europe
  • ESMO Open
    • Flexible care in breast cancer [2021]
• Germany
  • BMC Cancer
    • Trastuzumab in advanced breast cancer - a decade of experience in Germany [2014]
  • Breast Care
    • Adopting Guidelines into Clinical Practice: Implementation of Trastuzumab in the Adjuvant Treatment of Breast Cancer in Lower Saxony, Germany, in 2007 [2011]
• Hong Kong
  • Hong Kong Medical Journal
    • Cost-minimisation analysis of intravenous versus subcutaneous trastuzumab regimen for breast cancer management in Hong Kong [2023]
• India
  • JCO Global Oncology
    • Cost Effectiveness of Trastuzumab for Management of Breast Cancer in India [2020]
• International
  • Critical Reviews in Oncology/Hematology
    • Adjuvant treatment with trastuzumab of patients with HER2-positive, T1a-bN0M0 breast tumors: A systematic review and meta-analysis [2023]
  • Current Breast Cancer Reports
    • Incidence, Diagnosis, and Treatment of Cardiac Toxicity from Trastuzumab in Patients with Breast Cancer [2017]
  • PLoS ONE
    • The adverse effects of trastuzumab-containing regimes as a therapy in breast cancer: A piggy-back systematic review and meta-analysis [2022]
• Iran
  • PharmacoEconomics
    • Adjuvant Trastuzumab Therapy for Early HER2-Positive Breast Cancer in Iran: A Cost-Effectiveness and Scenario Analysis for an Optimal Treatment Strategy [2018]
• Italy
  • Oncologist
    • Cardiovascular risk after adjuvant trastuzumab in early breast cancer: an Italian population-based cohort study [2020]
• Japan
  • Breast Cancer Research and Treatment
    • A population-based recurrence risk management study of patients with pT1 node-negative HER2+ breast cancer: a National Clinical Database study [2019]
  • Molecular and Clinical Oncology
    • Pertuzumab for the treatment of patients with human epidermal growth factor receptor 2-positive breast cancer in Japan [2015]
• Netherlands
  • Breast
    • Efficacy of neoadjuvant treatment with or without pertuzumab in patients with stage II and III HER2-positive breast cancer: a nationwide cohort analysis of pathologic response and 5-year survival [2022]
  • Breast Cancer Research and Treatment
    • Survival before and after the introduction of pertuzumab and T-DM1 in HER2-positive advanced breast cancer, a study of the SONABRE Registry [2021]
  • Oncotarget
    • Cost and cost-effectiveness of adjuvant trastuzumab in the real world setting: A study of the Southeast Netherlands Breast Cancer Consortium [2017]
• New Zealand
  • PLoS Medicine
    • Adjuvant Trastuzumab in HER2-Positive Early Breast Cancer by Age and Hormone Receptor Status: A Cost-Utility Analysis [2016]
• Norway
  • Norwegian Institute of Public Health
    • Health Economic Analysis of Bevacizumab + Paclitaxel Versus Paclitaxel Alone as First-Line Treatment for Metastatic Breast Cancer [2009]
• Philippines
  • BMC Health Services Research
    • Cost-utility analysis of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer in the Philippines [2019]
• Singapore
  • Annals Academy of Medicine Singapore
    • Singapore Cancer Network (SCAN) Guidelines for Adjuvant Trastuzumab Use in Early Stage HER2 Positive Breast Cancer [2015]
• United Kingdom
  • Health Technology Assessment
    • Six versus 12 months' adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT [2020]
  • National Institute for Health and Care Excellence
    • Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 1 or more anti-HER2 treatments [2023]
    • Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 2 or more anti-HER2 therapies [2021]
    • Trastuzumab emtansine for adjuvant treatment of HER2-positive early breast cancer [2020]
    • Pertuzumab for adjuvant treatment of HER2-positive early stage breast cancer [2019]
    • Pertuzumab with trastuzumab and docetaxel for treating HER2-positive breast cancer [2018]
    • Trastuzumab emtansine for treating HER2-positive advanced breast cancer after trastuzumab and a taxane [2017]
    • Pertuzumab for the neoadjuvant treatment of HER2-positive breast cancer [2016]
    • Early and metastatic HER2-positive breast cancer: subcutaneous trastuzumab [2013]
    • Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer [2012]
    • Bevacizumab in combination with a taxane for the first-line treatment of metastatic breast cancer [2011]
• United States
  • American Journal of Managed Care
    • Integrating Trastuzumab Biosimilars and HER2-Directed Therapies into HER2-Positive Breast Cancer Management [2020]
  • JNCCN
    • Initiation of Trastuzumab by Women Younger Than 64 Years for Adjuvant Treatment of Stage I-III Breast Cancer [2018]
  • Journal of Clinical Oncology
    • Cardiac Surveillance Guidelines for Trastuzumab-Containing Therapy in Early-Stage Breast Cancer: Getting to the Heart of the Matter [2016]
• Uruguay
  • Medicine
    • Trastuzumab-induced cardiotoxicity in early breast cancer over a 10-year period in Uruguay [2022]
• {Related topics}
  • Topic
    • Breast cancer treatment

Breast cancer treatment: surgery, radiotherapy

• Africa
  • Journal of Global Oncology
    • Surgical Management of Breast Cancer in Africa: A Continent-Wide Review of Intervention Practices, Barriers to Care, and Adjuvant Therapy [2017]
• Australia
  • Australian Family Physician
    • Conservation surgery and radiation therapy in early breast cancer – An update [2017]
  • Better Safer Care
    • Double mastectomy for cancer in a single breast
  • Breast
    • Rates of reoperation after breast conserving cancer surgery in Western Australia before and after publication of the SSO-ASTRO margins guideline [2023]
  • Cancer Australia
    • Recommendations for use of hypofractionated radiotherapy for early (operable) breast cancer [2015]
    • Management of the axilla for early breast cancer: a systematic review [2011]
  • Medical Services Advisory Committee
    • Intraoperative Radiotherapy for Early Stage Breast Cancer [2017]
  • Radiotherapy and Oncology
    • Variation in the use of radiotherapy fractionation for breast cancer: Survival outcome and cost implications [2020]
• Austria, Germany, Switzerland
  • BMC Cancer
    • Are heart toxicities in breast cancer patients important for radiation oncologists? A practice pattern survey in German speaking countries [2017]
• Brazil
  • Revista da Associação Médica Brasileira
    • Recommendations for hypofractionated whole-breast irradiation [2018]
    • Treatment with intensity-modulated radiation therapy (IMRT) for breast cancer [2014]
• Canada
  • Breast Cancer Research and Treatment
    • COVID-19 vaccination and breast cancer surgery timing [2021]
  • Canadian Agency for Drugs and Technologies in Health
    • Intraoperative Mammography for Breast Cancer Surgery: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines [2019]
  • Canadian Family Physician
    • Breast reconstruction [2018]
  • CMAJ Open
    • Update to the Canadian clinical practice guideline for best-practice management of breast cancer-related lymphedema: study protocol [2022]
  • Current Oncology
    • National Variations in the Work-Up, Investigation, and Surgical Management of Ductal Carcinoma In Situ of the Breast across Canadian Surgeons [2021]
    • Consensus statement on tumour bed localization for radiation after oncoplastic breast surgery [2020]
    • Locoregional therapy of locally advanced breast cancer: a clinical practice guideline [2015]
• Central and Eastern Europe
  • Pathology & Oncology Research
    • Radiotherapy of Breast Cancer-Professional Guideline 1st Central-Eastern European Professional Consensus Statement on Breast Cancer [2022]
    • Modern Breast Cancer Surgery 1st Central-Eastern European Professional Consensus Statement on Breast Cancer [2022]
• China
  • Cancer Management and Research
    • Surgical Management Strategy for Breast Cancer Patients During the COVID-19 Outbreak [2020]
  • Chinese Medical Journal
    • Clinical practice guidelines for pre-operative evaluation of breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021 [2021]
    • Clinical practice guidelines for post-mastectomy breast reconstruction: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021 [2021]
    • Clinical practice guidelines for modified radical mastectomy of breast cancer: Chinese Society of Breast Surgery (CSBrs) practice guidelines 2021 [2021]
    • Clinical practice guidelines for endoscopic breast surgery in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021 [2021]
    • Clinical practice guideline for breast-conserving surgery in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021 [2021]
  • Journal of Cancer
    • Management of early-stage breast cancer patients during the coronavirus disease 2019 (COVID-19) pandemic: The experience in China from a surgical standpoint [2021]
  • Oncologist
    • Current Status and Factors Influencing Surgical Options for Breast Cancer in China: A Nationwide Cross-Sectional Survey of 110 Hospitals [2020]
• Denmark, Netherlands
  • Breast Cancer Research and Treatment
    • Breast-contour preserving procedures for early-stage breast cancer: a population-based study of the trends, variation in practice and predictive characteristics in Denmark and the Netherlands [2020]
• Estonia
  • International Journal for Equity in Health
    • The impact of sociodemographic factors on the utilization of radiation therapy in breast cancer patients in Estonia: a register-based study [2021]
• Europe
  • Breast
    • A multidisciplinary view of mastectomy and breast reconstruction: Understanding the challenges [2021]
  • Clinical Oncology
    • Postmastectomy Radiation Therapy Planning After Immediate Implant-based Reconstruction Using the European Society for Radiotherapy and Oncology-Advisory Committee in Radiation Oncology Practice Consensus Guidelines for Target Volume Delineation [2021]
  • European Organisation for Research and Treatment of Cancer
    • Patterns of practice of regional nodal irradiation in breast cancer: results of the European Organization for Research and Treatment of Cancer (EORTC) NOdal Radiotherapy (NORA) survey [2015]
  • European Society for Radiotherapy and Oncology
    • In regard to “The Italian Association of Radiotherapy and Oncology Recommendation for Breast Tumor Recurrence: Grades of Recommendation, Assessment, Development and Evaluation Criteria” [2021]
    • ESTRO-ACROP guideline: Interstitial multi-catheter breast brachytherapy as Accelerated Partial Breast Irradiation alone or as boost – GEC-ESTRO Breast Cancer Working Group practical recommendations [2018]
  • European Society of Regional Anaesthesia and Pain Therapy
    • PROSPECT guideline for oncological breast surgery: a systematic review and procedure-specific postoperative pain management recommendations [2020]
  • Radiotherapy and Oncology
    • The changing landscape in radiotherapy for breast cancer: Lessons from long term follow-up in some European breast cancer trials [2016]
• France
  • Cancer/Radiothérapie
    • Institut Curie guidelines on breast target volume delineation for patients treated in lateral position [2020]
  • Reports of Practical Oncology and Radiotherapy
    • Should the management of radiation therapy for breast cancer be standardized? Results of a survey on current French practices in breast radiotherapy [2021]
• Germany
  • Breast Care
    • Breast Cancer Surgery and Financial Reimbursement in Germany [2012]
  • Deutsche Gesellschaft für Radioonkologie
    • Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: Considerations regarding FAST and FAST-Forward [2021]
    • DEGRO practical guideline for partial-breast irradiation [2020]
    • Current controversies in radiotherapy for breast cancer [2017]
    • DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrences [2016]
    • DEGRO practical guidelines for radiotherapy of breast cancer V: Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastases [2015]
    • DEGRO practical guidelines: radiotherapy of breast cancer I [2013]
  • Deutsches Ärzteblatt International
    • Case Numbers and Process Quality in Breast Surgery in Germany [2015]
  • Institute for Quality and Efficiency in Health Care
    • Relationship between volume of services and quality of treatment outcome in the surgical treatment of breast cancer - rapid report [2020]
• India
  • Indian Journal of Medical Research
    • Breast conservation surgery & oncoplasty in India – Current scenario [2021]
    • Adjuvant radiation therapy in breast cancer: Recent advances & Indian data [2021]
• International
  • BMC Women's Health
    • Conservative interventions and clinical outcome measures used in the perioperative rehabilitation of breast cancer patients undergoing mastectomy: a scoping review [2022]
  • BMJ Open
    • Evaluation of guidelines regarding surgical treatment of breast cancer using the AGREE Instrument: a systematic review [2017]
  • Breast
    • Oncoplastic breast consortium recommendations for mastectomy and whole breast reconstruction in the setting of post-mastectomy radiation therapy [2022]
    • Should oncoplastic breast conserving surgery be used for the treatment of early stage breast cancer? Using the GRADE approach for development of clinical recommendations [2021]
  • Breast Cancer Research and Treatment
    • Current clinical practice in the management of phyllodes tumors of the breast: an international cross-sectional study among surgeons and oncologists [2023]
    • Oncoplastic Breast Consortium consensus conference on nipple-sparing mastectomy [2018]
  • Breast Journal
    • Preserving Nipple Sensitivity after Breast Cancer Surgery: A Systematic Review and Meta-Analysis [2022]
  • Cancer
    • Breast cancer recurrence after immediate and delayed postmastectomy breast reconstruction-A systematic review and meta-analysis [2022]
    • Locoregional treatment of primary breast cancer. Consensus recommendations from an International Expert Panel [2010]
  • Journal of Medical Radiation Sciences
    • Use of magnetic resonance image-guided radiotherapy for breast cancer: a scoping review [2022]
• Italy
  • Breast
    • Loco-regional adjuvant radiation therapy in breast cancer patients with positive axillary lymph-nodes at diagnosis (CN2) undergoing preoperative chemotherapy and with complete pathological lymph-nodes response. Development of GRADE (Grades of recommendation, assessment, Development and Evaluation) recommendation by the Italian Association of radiation therapy and Clinical Oncology (AIRO) [2021]
  • Journal of Breast Cancer
    • The Italian Association of Radiotherapy and Oncology Recommendation for Breast Tumor Recurrence: Grades of Recommendation, Assessment, Development and Evaluation Criteria [2021]
• Japan
  • Breast Cancer
    • The Japanese Breast Cancer Society clinical practice guidelines for surgical treatment of breast cancer, 2018 edition [2020]
    • The Japanese Breast Cancer Society Clinical Practice Guideline for radiation treatment of breast cancer, 2018 edition [2020]
  • Scientific Reports
    • Impact of coronavirus disease 2019 pandemic on breast cancer surgery using the National Database of Japan [2023]
• Netherlands
  • BJS
    • Nationwide population-based study of the impact of immediate breast reconstruction after mastectomy on the timing of adjuvant chemotherapy [2019]
  • Clinical Oncology
    • Model-Based Selection for Proton Therapy in Breast Cancer: Development of the National Indication Protocol for Proton Therapy and First Clinical Experiences [2022]
  • Radiation Oncology
    • Transparency in quality of radiotherapy for breast cancer in the Netherlands: a national registration of radiotherapy-parameters [2022]
  • Richtlijnendatabase
    • Breast reconstruction after mastectomy [2015]
• New Zealand
  • Ministry of Health New Zealand
    • Breast Reconstruction: National guidelines for best practice [2022]
    • Intraoperative radiotherapy for patients with early-stage breast cancer in New Zealand: An economic assessment [2017]
• Philippines
  • Annals of Surgical Oncology
    • Access to Surgical Treatment for Breast Cancer in the Philippines [2022]
• Republic of Korea
  • Journal of Breast Cancer
    • Patterns of Practice in Radiotherapy for Breast Cancer in Korea [2018]
    • The Practice Patterns and Perceptions of Korean Surgeons Regarding Margin Status after Breast-Conserving Surgery [2017]
  • Journal of Korean Medical Science
    • Changes in Korean National Healthcare Insurance Policy and Breast Cancer Surgery Trend in Korea [2021]
  • Medicine
    • Trends in the Application of Postmastectomy Radiotherapy for Breast Cancer With 1 to 3 Positive Axillary Nodes and Tumors <=5cm in the Modern Treatment Era [2016]
  • PLoS ONE
    • Incidence of hypothyroidism after treatment for breast cancer: A Korean population-based study [2022]
  • World Journal of Surgery
    • Psychological Impact of Type of Breast Cancer Surgery: A National Cohort Study [2022]
• Spain
  • Clinical and Translational Oncology
    • Evidence-based guidelines for hypofractionated radiation in breast cancer: conclusions of the Catalan expert working group [2022]
• Turkey
  • JCO Global Oncology
    • Surgical Trends in Breast Cancer in Turkey: An Increase in Breast-Conserving Surgery [2020]
• Uganda
  • PLoS ONE
    • Breast cancer care in Uganda: A multicenter study on the frequency of breast cancer surgery in relation to the incidence of breast cancer [2019]
• United Kingdom
  • Annals of The Royal College of Surgeons of England
    • Guidelines for oncoplastic breast reconstruction [2013]
  • Association of Breast Surgery
    • Oncoplastic breast surgery: A guide to good practice [2021]
    • Biological and synthetic mesh assisted breast reconstruction procedures: Joint guidelines from the Association of Breast Surgery and the British Association of Plastic, Reconstructive and Aesthetic Surgeons [2021]
    • Guidance for the Commissioning of Oncoplastic Breast Surgery [2018]
    • Contralateral Mastectomy for Unilateral Breast Cancer [2017]
    • Margin Width in Breast Conservation Surgery [2015]
    • National Mastectomy and Breast Reconstruction Audit [2011]
  • Breast Cancer Research and Treatment
    • Current practice and provision of oncoplastic breast-conserving surgery in the UK: results of the ANTHEM national practice questionnaire [2023]
    • Cost-effectiveness of 5 fraction and partial breast radiotherapy for early breast cancer in the UK: model-based multi-trial analysis [2023]
  • British Journal of Surgery
    • Ethnicity and the surgical management of early invasive breast cancer in over 164 000 women [2021]
  • European Journal of Surgical Oncology
    • The MARECA (national study of management of breast cancer locoregional recurrence and oncological outcomes) study: National practice questionnaire of United Kingdom multi-disciplinary decision making [2022]
    • A scoring system for 3D surface images of breast reconstruction developed using the Delphi consensus process [2020]
    • Adherence to best practice consensus guidelines for implant-based breast reconstruction: Results from the iBRA national practice questionnaire survey [2018]
  • Health Technology Assessment
    • One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT [2023]
    • Exercise to prevent shoulder problems after breast cancer surgery: the PROSPER RCT [2022]
  • National Institute for Health and Care Excellence
    • Intrabeam radiotherapy system for adjuvant treatment of early breast cancer [2018]
    • AlignRT in breast cancer radiotherapy [2018]
    • L-Dex U400 for lymphoedema after breast cancer treatment [2017]
    • Axxent electronic brachytherapy system for early stage breast cancer [2016]
    • Breast reconstruction using lipomodelling after breast cancer treatment [2012]
    • Endoscopic mastectomy and endoscopic wide local excision for breast cancer [2009]
  • NHS England
    • Radiotherapy after primary surgery for breast cancer [2016]
  • Royal College of Pathologists
    • Postoperative radiotherapy for breast cancer: UK consensus statements [2016]
  • Royal College of Radiologists
    • Development of Postoperative Radiotherapy for Breast Cancer: UK Consensus Statements - a Model of Patient, Clinical and Commissioner Engagement? [2018]
  • World Journal of Surgical Oncology
    • The Manchester guidelines for contralateral risk-reducing mastectomy [2015]
• United States
  • Advances in Radiation Oncology
    • The Association Between Cardiac Mortality and Adjuvant Radiation Therapy Among Older Patients With Stage I Estrogen Positive Breast Cancer: A Surveillance, Epidemiology, and End Results (SEER)–Based Study on Cardiac Mortality and Radiation Therapy [2020]
  • Aesthetic Surgery Journal
    • Influencers of Immediate Postmastectomy Reconstruction: A National Cancer Database Analysis [2022]
  • Agency for Healthcare Research and Quality
    • Partial Breast Irradiation for Breast Cancer [2023]
    • Breast Reconstruction After Mastectomy [2021]
  • American College of Radiology
    • Imaging of Deep Inferior Epigastric Arteries for Surgical Planning (Breast Reconstruction Surgery)
    • Conservative surgery and radiation - stage I and II breast cancer
  • American College of Surgeons
    • COVID-19 Pandemic Breast Cancer Consortium’s Considerations for Re-entry [2020]
    • COVID-19 Guidelines for Triage of Breast Cancer Patients [2020]
    • Risk of Synchronous Distant Recurrence at Time of Locoregional Recurrence in Patients With Stage II and III Breast Cancer (AFT-01) [2018]
  • American Physical Therapy Association
    • Interventions for Breast Cancer–Related Lymphedema: Clinical Practice Guideline From the Academy of Oncologic Physical Therapy of APTA [2020]
  • American Society for Radiation Oncology
    • Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline [2018]
    • Accelerated Partial Breast Irradiation: Executive summary for the update of an ASTRO Evidence-Based Consensus Statement [2017]
    • Society of Surgical Oncology–American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer [2014]
    • Fractionation for Whole Breast Irradiation: An American Society for Radiation Oncology (ASTRO) Evidence-Based Guideline [2011]
  • American Society of Breast Surgeons
    • Pain Control in Breast Surgery: Survey of Current Practice and Recommendations for Optimizing Management-American Society of Breast Surgeons Opioid/Pain Control Workgroup [2020]
    • Contralateral Prophylactic Mastectomy (CPM) Consensus Statement from the American Society of Breast Surgeons: Data on CPM Outcomes and Risks [2016]
    • Contralateral Prophylactic Mastectomy Consensus Statement from the American Society of Breast Surgeons: Additional Considerations and a Framework for Shared Decision Making [2016]
    • Toolbox to Reduce Lumpectomy Reoperations and Improve Cosmetic Outcome in Breast Cancer Patients: The American Society of Breast Surgeons Consensus Conference [2015]
    • Official Statements
  • American Society of Clinical Oncology
    • Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma In Situ [2016]
    • Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update [2016]
  • Annals of Surgical Oncology
    • Assessment of Practice Patterns Following Publication of the SSO–ASTRO Consensus Guideline on Margins for Breast-Conserving Therapy in Stage I and II Invasive Breast Cancer [2015]
  • Breast
    • Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability [2021]
  • Breast Cancer Research and Treatment
    • Bioimpedance spectroscopy for breast cancer-related lymphedema assessment: clinical practice guidelines [2023]
  • Cancer Medicine
    • Rural-urban differences in secular trends of locoregional treatment for ductal carcinoma in situ: A patterns of care analysis [2022]
  • Clinical Breast Cancer
    • Invasive Breast Cancer Treatment Patterns in Women Age 80 and Over: A Report from the National Cancer Database [2022]
  • International Journal of Surgery
    • Are the American Society for Radiation Oncology Guidelines Accurate Predictors of Recurrence in Early Stage Breast Cancer Patients Treated with Balloon-Based Brachytherapy? [2013]
  • JAMA
    • Uptake and Costs of Hypofractionated vs Conventional Whole Breast Irradiation After Breast Conserving Surgery in the United States, 2008–2013 [2014]
  • JAMA Oncology
    • Temporal Trends in Post-Mastectomy Radiation Therapy and Breast Reconstruction [2016]
  • JAMA Surgery
    • Analysis of a Trend Reversal in US Lumpectomy Rates From 2005 Through 2017 Using 3 Nationwide Data Sets [2022]
  • JCO Oncology Practice
    • Disparities at the Intersection of Race and Ethnicity: Examining Trends and Outcomes in Hispanic Women With Breast Cancer [2022]
    • Disaggregation of Asian American and Pacific Islander Women With Stage 0-II Breast Cancer Unmasks Disparities in Survival and Surgery-to-Radiation Intervals: A National Cancer Database Analysis From 2004 to 2017 [2022]
  • Journal of Surgical Oncology
    • Effects of COVID-19 on mastectomy and breast reconstruction rates: A national surgical sample [2022]
  • M.D. Anderson Cancer Center
    • Evolution in Surgical Management of Breast Cancer-related Lymphedema: The MD Anderson Cancer Center Experience [2020]
    • DCIS Margins and Breast Conservation: MD Anderson Cancer Center Multidisciplinary Practice Guidelines and Outcomes [2017]
    • Breast reconstruction at the MD Anderson Cancer Center [2016]
  • Medicine
    • Impact of lack of surgery on outcomes in elderly women with nonmetastatic breast cancer-A surveillance, epidemiology, and end results 18 population based study [2020]
  • National Comprehensive Cancer Network
    • Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in Oncology [2016]
  • NPJ Breast Cancer
    • Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint [2018]
  • Plastic and Reconstructive Surgery Global Open
    • Breast Reconstruction in Inflammatory Breast Cancer: An Analysis of Predictors, Trends, and Survival from the National Cancer Database [2021]
• {Related topics}
  • Topic
    • Breast cancer treatment

Breast cancer treatment: taxanes

• Australia
  • Cancer Australia
    • Recommendations for use of taxane-containing chemotherapy regimens for the treatment of early (operable) breast cancer [2008]
• China
  • Breast
    • Serum sodium ions and chloride ions associated with taxane-induced peripheral neuropathy in Chinese patients with early-stage breast cancer: A nation-wide multicenter study [2023]
• Germany
  • Geburtshilfe und Frauenheilkunde
    • Use of Taxanes in Metastatic HER2-negative Breast Cancer – a Status Report [2020]
• International
  • Clinical and Translational Science
    • Pharmacogenetics of taxane-induced neurotoxicity in breast cancer: Systematic review and meta-analysis [2022]
• {Related topics}
  • Topic
    • Breast cancer treatment

Breast cancer treatment: tyrosine kinase inhibitors

• Brazil
  • Breast Cancer : Targets and Therapy
    • Lapatinib in patients with metastatic breast cancer following initial treatment with trastuzumab: an economic analysis from the Brazilian public health care perspective [2012]
• China
  • Experimental and Therapeutic Medicine
    • Tyrosine kinase inhibitors in breast cancer (Review) [2022]
  • OncoTargets and therapy
    • Lapatinib for the treatment of breast cancer in the People’s Republic of China [2014]
  • PLoS ONE
    • Pyrotinib versus lapatinib therapy for HER2 positive metastatic breast cancer patients after first-line treatment failure: A meta-analysis and systematic review [2023]
• International
  • ESMO Open
    • Efficacy of tyrosine kinase inhibitors for the treatment of patients with HER2-positive breast cancer with brain metastases: a systematic review and meta-analysis [2022]
• United Kingdom
  • National Institute for Health and Care Excellence
    • Neratinib for extended adjuvant treatment of hormone receptor-positive, HER2-positive early stage breast cancer after adjuvant trastuzumab [2019]
• United States
  • Future Medicine
    • Neratinib: the emergence of a new player in the management of HER2+ breast cancer brain metastasis [2020]
• {Related topics}
  • Topic
    • Breast cancer treatment

Breast cancer treatment: vinca alkaloids

• China
  • Cancer Chemotherapy and Pharmacology
    • Oral vinorelbine versus intravenous vinorelbine, in combination with epirubicin as first-line chemotherapy in Chinese patients with metastatic breast cancer [2020]
• Poland
  • Contemporary Oncology
    • Evaluation of vinorelbine-based chemotherapy as the second or further-line treatment in patients with metastatic breast cancer [2013]
• Taiwan
  • Journal of Cancer
    • Metronomic vinorelbine is an excellent and safe treatment for advanced breast cancer: a retrospective, observational study [2021]
• {Related topics}
  • Topic
    • Breast cancer treatment

Breast imaging

• Asia
  • Diagnostics
    • Is Ultrasound an Accurate Alternative for Mammography in Breast Cancer Screening in an Asian Population? A Meta-Analysis [2020]
• Australia
  • Journal of Medical Radiation Sciences
    • MRI screening for breast cancer in women at high risk; is the Australian breast MRI screening access program addressing the needs of women at high risk of breast cancer? [2015]
  • Medical Services Advisory Committee
    • Breast Magnetic Resonance Imaging for improved definition of the breast cancer primary [2018]
    • Breast Magnetic Resonance Imaging (MRI) [2015]
    • Review of Interim Funded Service: Breast MRI [2014]
• Australia, New Zealand
  • Australasian Society for Ultrasound in Medicine
    • Guidelines on Breast Ultrasound Examination and Reporting [2018]
• Canada
  • Canadian Association of Radiologists
    • COVID-19: Safe Guidelines for Breast Imaging During the Pandemic [2020]
    • Breast Imaging and Intervention [2016]
  • Canadian Society of Breast Imaging
    • The Canadian Society of Breast Imaging Recommendations for the Management of Axillary Adenopathy in Patients with Recent COVID-19 Vaccination - Update [2021]
  • Ontario Health
    • Preoperative Breast Magnetic Resonance Imaging [2023]
    • Baseline Staging Imaging for Distant Metastasis in Women with Stage I, II, and III Breast Cancer [2019]
    • The Utility of PET/CT in Breast Cancer (Stages II-IV): An Evidence Summary [2014]
    • Effectiveness of Screening With Annual Magnetic Resonance Imaging and Mammography: Results of the Initial Screen From the Ontario High Risk Breast Screening Program [2014]
• Central and Eastern Europe
  • Pathology & Oncology Research
    • Use of Diagnostic Imaging Modalities in Modern Screening, Diagnostics and Management of Breast Tumours 1st Central-Eastern European Professional Consensus Statement on Breast Cancer [2022]
• China
  • Journal of Cancer Research and Therapeutics
    • Chinese association of ultrasound in medicine and engineering, superficial organs and peripheral vessels committee expert consensus on clinical frequently asked questions in breast ultrasonography, June 2018 [2018]
• Europe
  • European Commission
    • Preoperative breast magnetic resonance imaging in patients with ductal carcinoma in situ: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC) [2021]
  • European Society of Breast Imaging
    • Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI) [2022]
    • A survey by the European Society of Breast Imaging on the implementation of breast diffusion-weighted imaging in clinical practice [2022]
    • Axillary lymphadenopathy at the time of COVID-19 vaccination: ten recommendations from the European Society of Breast Imaging (EUSOBI) [2021]
    • Diffusion-weighted imaging of the breast-a consensus and mission statement from the EUSOBI International Breast Diffusion-Weighted Imaging working group [2020]
    • Breast ultrasound: recommendations for information to women and referring physicians by the European Society of Breast Imaging [2018]
    • A survey by the European Society of Breast Imaging on the utilisation of breast MRI in clinical practice [2017]
    • Breast MRI: EUSOBI recommendations for women’s information [2015]
    • Breast MRI: guidelines from the European Society of Breast Imaging [2008]
• Germany
  • Breast Care
    • Consensus Meeting of Breast Imaging: BI-RADS® and Beyond [2019]
  • RöFo
    • Updated Recommendations for MRI of the Breast [2014]
  • Ultraschall in der Medizin
    • Best Practice Guideline – DEGUM Recommendations on Breast Ultrasound – Part I – Examination technique, DEGUM ultrasound criteria, and documentation [2022]
• International
  • Clinical Breast Cancer
    • Performance of Supplemental Imaging Modalities for Breast Cancer in Women With Dense Breasts: Findings From an Umbrella Review and Primary Studies Analysis [2023]
  • World Federation for Ultrasound in Medicine and Biology
    • WFUMB Guidelines and Recommendations for Clinical Use of Ultrasound Elastography: Part 2: Breast [2015]
• Italy
  • La radiologia medica
    • Breast imaging and cancer diagnosis during the COVID-19 pandemic: recommendations from the Italian College of Breast Radiologists by SIRM [2020]
• Japan
  • Annals of Nuclear Medicine
    • Clinical practice guidelines for high-resolution breast PET, 2019 edition [2021]
    • Clinical practice guideline for dedicated breast PET [2014]
  • Journal of Medical Ultrasonics
    • The Japan Society of Ultrasonics in Medicine guidelines on non-mass abnormalities of the breast [2023]
• Netherlands
  • JAMA Oncology
    • Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk [2020]
• Republic of Korea
  • Ultrasonography
    • Practice guideline for the performance of breast ultrasound elastography [2014]
• South Africa
  • SA Journal of Radiology
    • Understanding indications and defining guidelines for breast magnetic resonance imaging [2018]
• United Kingdom
  • National Institute for Health and Care Excellence
    • Aixplorer ShearWave Elastography for ultrasound imaging and assessing suspicious breast lesions [2014]
  • NHS England
    • Breast screening: using MRI with higher risk women
  • Public Health England
    • Breast screening: reporting breast images from home
    • Breast screening: quality assurance for medical physics services
    • Breast screening: imaging equipment evaluation and protocol
  • Royal College of Radiologists
    • Guidance on screening and symptomatic breast imaging, Fourth edition [2019]
    • The breast imaging and diagnostic workforce in the United Kingdom [2016]
• United States
  • American College of Radiology
    • Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer [2010]
    • Supplemental Breast Cancer Screening Based on Breast Density
    • Palpable Breast Masses
    • Imaging of the Axilla
    • Imaging After Mastectomy and Breast Reconstruction
    • Imaging After Breast Surgery
    • Evaluation of Nipple Discharge
    • Breast Pain
    • Breast Imaging of Pregnant and Lactating Women
    • ACR Practice Parameter for the Performance of a Breast Ultrasound Examination
    • ACR Practice Parameter for the Performance of Whole-Breast Ultrasound for Screening and Staging
    • ACR Practice Parameter for the Performance of Preoperative Image-Guided Localization in the Breast
    • ACR Practice Parameter for the Performance of Molecular Breast Imaging (MBI) Using a Dedicated Gamma Camera
    • ACR Practice Parameter for the Performance of Contrast-Enhanced Magnetic Resonance Imaging (MRI) of the Breast
  • Breast Cancer Surveillance Consortium
    • Prioritizing breast imaging services during the COVID pandemic: A survey of breast imaging facilities within the Breast Cancer Surveillance Consortium [2021]
    • Performance of Screening Ultrasonography as an Adjunct to Screening Mammography in Women Across the Spectrum of Breast Cancer Risk [2019]
    • Is Breast MRI Better at Finding Second Breast Cancers than Mammograms Alone for Breast Cancer Survivors? [2019]
    • The Role of Preoperative Magnetic Resonance Imaging in the Assessment and Surgical Treatment of Interval and Screen-Detected Breast Cancer in Older Women [2016]
    • Patterns of breast magnetic resonance imaging use in community practice [2014]
  • Breast Journal
    • Screening Magnetic Resonance Imaging Recommendations and Outcomes in Patients at High Risk for Breast Cancer [2015]
  • Cancer
    • Disparities in the Use of Screening Breast MRI in Community Practice by Race, Ethnicity and Socioeconomic Status [2015]
• {Related topics}
  • Topic
    • Breast cancer screening, mammography
    • Breast cancer diagnosis
    • Breast cancer
    • Benign breast diseases

Breast plastic surgery

• Australia
  • Australian Institute of Health and Welfare
    • Breast implants: A guide for general practice [2021]
  • Medical Services Advisory Committee
    • Autologous fat grafting (AFG) by injection, for defects arising from breast surgery, cancer treatment/prevention or congenital deformity [2020]
    • Breast Magnetic Resonance Imaging for Breast Implant Associated Anaplastic Large Cell Lymphoma [2017]
  • Royal Australian College of General Practitioners
    • Recommended management of a patient with a breast implant [2020]
• Australia, New Zealand
  • Plastic and Reconstructive Surgery Global Open
    • Breast Implant Selection: Consensus Recommendations Using a Modified Delphi Method [2019]
• Canada
  • Canadian Agency for Drugs and Technologies in Health
    • Povidone-Iodine for Breast Implant Surgery: A Review of Clinical Effectiveness and Guidelines [2019]
• Denmark
  • Danish Medical Journal
    • Poor adherence to clinical guidelines for women undergoing breast reduction [2016]
• Europe, United States
  • Plastic and Reconstructive Surgery Global Open
    • Breast Implant Utilization Trends in USA versus Europe and the Impact of BIA-ALCL Publications [2021]
• Germany
  • Geburtshilfe und Frauenheilkunde
    • Biological Matrices and Synthetic Meshes Used in Implant-based Breast Reconstruction – a Review of Products Available in Germany [2013]
• International
  • Aesthetic Surgery Journal
    • 2022 Practice Recommendation Updates From the World Consensus Conference on BIA-ALCL [2022]
    • Expert Consensus on the Use of a New Bioengineered, Cell-Friendly, Smooth Surface Breast Implant [2019]
  • BMC Surgery
    • A systematic review and meta-analysis of risks and benefits with breast reduction in the public healthcare system: priorities for further research [2021]
  • European Journal of Breast Health
    • New Data on the Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma [2021]
• Ireland
  • Ireland's Health Services
    • Breast Implant Associated Anaplastic Large Cell Lymphoma - BIA-ALCL Report [2021]
• Israel
  • Israel Medical Association Journal
    • Breast Implantation Rates in Israel: Is There a Change in Trend? [2021]
• Italy
  • Breast
    • Clinical recommendations for diagnosis and treatment according to current updated knowledge on BIA-ALCL [2022]
• Netherlands
  • Aesthetic Surgery Journal
    • Breast Implant Prevalence in the Dutch Female Population Assessed by Chest Radiographs [2020]
• Sweden
  • Journal of Plastic Surgery and Hand Surgery
    • Prevalence of women with breast implants in Sweden: a study based on the population-based mammography screening programme [2023]
• United Kingdom
  • Association of Breast Surgery
    • UK Guidelines for Lipomodelling of the Breast on behalf of Plastic, Reconstructive and Aesthetic Surgery and Association of Breast Surgery Expert Advisory Group [2022]
    • Breast Implant Associated-Anaplastic Large Cell Lymphoma [2017]
  • Medicines and Healthcare products Regulatory Agency
    • UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) on behalf of the Medicines and Healthcare products Regulatory Agency (MHRA) Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group (PRASEAG) [2021]
  • NHS Digital
    • Breast and Cosmetic Implant Registry
  • NHS England
    • Breast screening: breast implant guidelines
  • Public Health England
    • Breast screening: imaging women with breast implants
• United States
  • American College of Radiology
    • Breast Implant Evaluation
  • Food and Drug Administration
    • Breast Implants
  • Journal of Clinical Oncology
    • Best Practices Guideline for the Pathologic Diagnosis of Breast Implant–Associated Anaplastic Large-Cell Lymphoma [2020]
  • Journal of General Internal Medicine
    • Breast Implant Safety: an Overview of Current Regulations and Screening Guidelines [2022]
  • National Comprehensive Cancer Network
    • 2019 NCCN Consensus Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) [2019]
    • NCCN Consensus Guidelines for the Diagnosis and Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma [2017]
  • Plastic and Reconstructive Surgery
    • Patient Registry and Outcomes for Breast Implants and Anaplastic Large Cell Lymphoma Etiology and Epidemiology (PROFILE): Initial Report of Findings 2012 – 2018 [2019]
  • Plastic Surgery
    • Breast Implant–Associated Anaplastic Large-Cell Lymphoma: Current Understanding and Recommendations for Management [2020]
  • Seminars in Plastic Surgery
    • Finding Consensus After Two Decades of Breast Implant-Associated Anaplastic Large Cell Lymphoma [2019]
• {Related topics}
  • Topic
    • Breast cancer treatment
    • Breast cancer
    • Benign breast diseases

Familial breast cancer

• Africa
  • International Journal of Breast Cancer
    • Breast Cancer in Africa: Limitations and Opportunities for Application of Genomic Medicine [2016]
  • SpringerPlus
    • Seventeen years after BRCA1: what is the BRCA mutation status of the breast cancer patients in Africa? – a systematic review [2012]
• Asia
  • Journal of Medical Genetics
    • Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countries [2015]
• Australia
  • Cancer Australia
    • Recommendations for the management of early breast cancer in women with an identified BRCA1 or BRCA2 gene mutation or at high risk of a gene mutation [2014]
• Canada
  • Canadian Family Physician
    • Identification and management of women with a family history of breast cancer: Practical guide for clinicians [2016]
• China
  • Chinese Medical Journal
    • Clinical practice guideline of BRCA1/2 testing for patients with breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021 [2021]
  • Journal of Epidemiology
    • Hereditary Breast Cancer in the Han Chinese Population [2013]
  • PLoS ONE
    • Identification of a Comprehensive Spectrum of Genetic Factors for Hereditary Breast Cancer in a Chinese Population by Next-Generation Sequencing [2015]
• Europe
  • European Journal of Cancer
    • Genetic counselling and testing of susceptibility genes for therapeutic decision-making in breast cancer—an European consensus statement and expert recommendations [2019]
  • European Society for Medical Oncology
    • BRCA in breast cancer: ESMO Clinical Practice Guidelines [2011]
  • Journal of Community Genetics
    • Genetic testing for familial/hereditary breast cancer—comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany [2011]
• Germany
  • Cancer Medicine
    • Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer [2018]
• International
  • Breast
    • Combined breast conservation therapy versus mastectomy for BRCA mutation carriers – A systematic review and meta-analysis [2021]
  • Breast Cancer Research
    • Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers [2020]
  • Cancer Management and Research
    • A systematic review of international guidelines and recommendations for the genetic screening, diagnosis, genetic counseling, and treatment of BRCA-mutated breast cancer [2019]
  • Cancer Medicine
    • A systematic review of recommendations on screening strategies for breast cancer due to hereditary predisposition: Who, When, and How? [2021]
  • Clinical Epidemiology
    • A systematic review of the international prevalence of BRCA mutation in breast cancer [2019]
  • New England Journal of Medicine
    • Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk [2015]
• Iran
  • Journal of Research in Medical Sciences
    • BRCA1 and BRCA2 mutations in Iranian breast cancer patients: A systematic review [2015]
• Ireland
  • Health Information and Quality Authority
    • HTA of High Risk Breast Cancer Surveillance [2013]
• Italy
  • Breast
    • PARP-inhibitors for BRCA1/2-related advanced HER2-negative breast cancer: A meta-analysis and GRADE recommendations by the Italian Association of Medical Oncology [2022]
• Japan
  • Journal of Human Genetics
    • The relationship between BRCA-associated breast cancer and age factors: an analysis of the Japanese HBOC consortium database [2021]
  • Scientific Reports
    • Impact of the coverage of risk-reducing salpingo-oophorectomy by the national insurance system for women with BRCA pathogenic variants in Japan [2023]
• Latin America
  • Revista de Investigación Clínica
    • Genetic Cancer Risk Assessment for Breast Cancer in Latin America [2017]
• Mexico
  • Salud Pública de México
    • Genetics of breast cancer: Applications to the Mexican population [2011]
• Netherlands
  • European Journal of Human Genetics
    • Evaluation of the Dutch BRCA1/2 clinical genetic center referral criteria in an unselected early breast cancer population [2014]
  • Journal of Medical Genetics
    • Clinical applicability of the Polygenic Risk Score for breast cancer risk prediction in familial cases [2023]
• Norway
  • BMC Cancer
    • Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriers [2017]
  • Norwegian Institute of Public Health
    • Diagnostic accuracy, clinical effectiveness and budget impact of screening BRCA1/2 mutation carriers by MRI. A health technology assessment [2018]
• Republic of Korea
  • Archives of Plastic Surgery
    • Perceptions of Prophylactic Mastectomy in Korea [2016]
  • International Journal of Environmental Research and Public Health
    • Association of Family History with the Development of Breast Cancer: A Cohort Study of 129,374 Women in KoGES Data [2021]
  • JAMA Network Open
    • Association of Breast Cancer Family History With Breast Density Over Time in Korean Women [2023]
  • Journal of Breast Cancer
    • The Korean Hereditary Breast Cancer Study: Review and Future Perspectives [2013]
• Singapore
  • Chinese Clinical Oncology
    • The management of BRCA1 and BRCA2 carriers in Singapore [2020]
• Slovenia
  • European Journal of Surgical Oncology
    • Trends and timing of risk-reducing mastectomy uptake in unaffected BRCA1 and BRCA2 carriers in Slovenia [2021]
• Spain
  • PLoS ONE
    • Frequency of breast cancer with hereditary risk features in Spain: Analysis from GEICAM “El Álamo III” retrospective study [2017]
• United Arab Emirates
  • Breast
    • Clinicopathological characteristics of gene-positive breast cancer in the United Arab Emirates [2020]
• United Kingdom
  • Association of Breast Surgery
    • Overview of the Implications and Implementation of NICE Guidelines on Familial Breast Cancer [2015]
  • Breast Cancer Research and Treatment
    • Family history and risk of breast cancer: an analysis accounting for family structure [2017]
  • British Journal of General Practice
    • Dealing with family history of breast cancer: something new, something old [2014]
  • Healthcare Improvement Scotland
    • Familial breast cancer report [2014]
  • Journal of Community Genetics
    • Specialist recommendation for chemoprevention medications in patients at familial risk of breast cancer: a cross-sectional survey in England [2021]
  • Journal of Medical Genetics
    • Update: variable implementation of the 2018 UKCGG/UKGTN guidelines for breast cancer gene panel tests offered by UK genetics services [2021]
  • National Institute for Health and Care Excellence
    • Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer [2023]
• United States
  • Agency for Healthcare Research and Quality
    • Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer [2013]
  • American Journal of Human Genetics
    • Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer [2016]
  • American Society for Radiation Oncology
    • ASTRO Radiation Therapy Summary of the ASCO-ASTRO-SSO Guideline on Management of Hereditary Breast Cancer [2020]
  • American Society of Breast Surgeons
    • Consensus Guidelines on Genetic Testing for Hereditary Breast Cancer from the American Society of Breast Surgeons [2019]
  • American Society of Clinical Oncology
    • Adjuvant PARP Inhibitors in Patients With High-Risk Early-Stage HER2-Negative Breast Cancer and Germline BRCA Mutations: ASCO Hereditary Breast Cancer Guideline Rapid Recommendation Update [2021]
    • Management of Hereditary Breast Cancer
  • Breast Cancer
    • Do current family history-based genetic testing guidelines contribute to breast cancer health inequities? [2022]
  • Breast Cancer Research and Treatment
    • Adherence to the 2020 American Cancer Society Guideline for Cancer Prevention and risk of breast cancer for women at increased familial and genetic risk in the Breast Cancer Family Registry: an evaluation of the weight, physical activity, and alcohol consumption recommendations [2022]
  • Breast Cancer Surveillance Consortium
    • Family History and Breast Cancer Risk Among Older Women in the Breast Cancer Surveillance Consortium Cohort [2018]
    • Family history of breast cancer, breast density, and breast cancer risk in a U.S. breast cancer screening population [2017]
    • Emerging Trends in Family History of Breast Cancer and Associated Risk [2017]
  • Journal of Community Genetics
    • Psychosocial approaches to participation in BRCA1/2 genetic risk assessment among African American women: a systematic review [2014]
• {Related topics}
  • Topic
    • Hereditary gynecologic cancer, genetic predisposition
    • Gynecologic oncology
    • Breast cancer risk
    • Breast cancer

Gynecomastia

• Canada
  • Plastic Surgery
    • Is routine pathological evaluation of tissue from gynecomastia necessary? A 15-year retrospective pathological and literature review [2014]
• Europe
  • European Academy of Andrology
    • EAA clinical practice guidelines—gynecomastia evaluation and management [2019]
• Germany
  • Deutsche Gesellschaft für Radioonkologie
    • Treatment strategies to prevent and reduce gynecomastia and/or breast pain caused by antiandrogen therapy for prostate cancer : Statement from the DEGRO working group prostate cancer [2020]
• United Kingdom
  • Association of Breast Surgery
    • Investigation and management of gynaecomastia in primary & secondary care [2021]
• United States
  • American College of Radiology
    • Evaluation of the Symptomatic Male Breast
• {Related topics}
  • Topic
    • Male hypogonadism, andropause
    • Benign breast diseases

Mastitis

• Australia
  • Australian Family Physician
    • Lactational mastitis and breast abscess - Diagnosis and management in general practice [2011]
• China
  • Chinese Medical Journal
    • Clinical practice guidelines for diagnosis and treatment of patients with non-puerperal mastitis: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021 [2021]
• Eastern and Southern Africa
  • International Breastfeeding Journal
    • Prevalence of and factors associated with lactational mastitis in eastern and southern Africa: an exploratory analysis of community-based household surveys [2022]
• Europe
  • Nutrients
    • Subclinical Mastitis in a European Multicenter Cohort: Prevalence, Impact on Human Milk (HM) Composition, and Association with Infant HM Intake and Growth [2019]
• Germany
  • Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften
    • S3-Guidelines for the Treatment of Inflammatory Breast Disease during the Lactation Period [2013]
• International
  • Journal of Human Lactation
    • Incidence of and Risk Factors for Lactational Mastitis: A Systematic Review [2020]
  • Military Medical Research
    • Management of granulomatous lobular mastitis: an international multidisciplinary consensus (2021 edition) [2022]
• United Kingdom
  • BJS
    • Best-practice care pathway for improving management of mastitis and breast abscess [2018]
• United States
  • Academy of Breastfeeding Medicine
    • Academy of Breastfeeding Medicine Clinical Protocol #36: The Mastitis Spectrum, Revised 2022 [2022]
• WHO
  • World Health Organization
    • Mastitis: causes and management [2000]
• {Related topics}
  • Topic
    • Breastfeeding complications
    • Benign breast diseases

Sentinel lymph node biopsy

• Australia
  • Cancer Australia
    • Recommendations for staging and managing the axilla in early (operable) breast cancer [2011]
• Austria
  • Wiener klinische Wochenschrift
    • Axillary lymph node status and invasive lobular breast cancer : Analysis of the Clinical Tumor Register of the AGO Austria [2023]
• Canada
  • Canadian Agency for Drugs and Technologies in Health
    • Magnetic Localization System for Sentinel Lymph Node Biopsy: A Review of the Diagnostic Accuracy, Cost-Effectiveness, and Guidelines [2020]
    • Sentinel Lymph Node Biopsy for the Management of Breast Cancer: A Review of Guidelines [2019]
• Canada, United States
  • American Society of Clinical Oncology
    • Management of the Axilla in Early-Stage Breast Cancer: Ontario Health (Cancer Care Ontario) and ASCO Guideline [2021]
• China
  • Chinese Medical Journal
    • Clinical practice guidelines for sentinel lymph node biopsy in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021 [2021]
  • Scientific Reports
    • The feasibility of the ACOSOG Z0011 Criteria to Chinese Breast Cancer Patients: A Multicenter Study [2015]
• Germany
  • Archives of Gynecology and Obstetrics
    • Current trends in diagnostic and therapeutic management of the axilla in breast cancer patients receiving neoadjuvant therapy: results of the German-wide NOGGO MONITOR 24 survey [2023]
    • Prognostic value and management of regional lymph nodes in locoregional breast cancer recurrence: a systematic review of the literature [2022]
  • Geburtshilfe und Frauenheilkunde
    • AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update [2021]
• High-income countries
  • BJS Open
    • Sentinel lymph node biopsy in patients with ductal carcinoma in situ: systematic review and meta-analysis [2022]
• International
  • Cancer Treatment Reviews
    • Uncertainties and controversies in axillary management of patients with breast cancer [2023]
  • Computational Intelligence and Neuroscience
    • Accuracy and Utility of Preoperative Ultrasound-Guided Axillary Lymph Node Biopsy for Invasive Breast Cancer: A Systematic Review and Meta-Analysis [2022]
  • International Collaboration on Cancer Reporting
    • Reporting of Surgically Removed Lymph Nodes for Breast Tumors: Recommendations From the International Collaboration on Cancer Reporting [2022]
    • Surgically Removed Lymph Nodes for Breast Tumours [2021]
• Italy
  • Current Oncology
    • Axillary Management in Breast Cancer Patients Undergoing Upfront Surgery: Results from a Nationwide Survey on Behalf of the Clinical Oncology Breast Cancer Group (COBCG) and the Breast Cancer Study Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) [2023]
• Netherlands
  • Annals of Surgical Oncology
    • What to Do with Non-visualized Sentinel Nodes? A Dutch Nationwide Survey Study [2017]
  • Breast Cancer Research and Treatment
    • Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy [2016]
• Republic of Korea
  • World Journal of Surgical Oncology
    • Impact of the ACOSOG Z0011 trial on surgical practice in Asian patients: trends in axillary surgery for breast cancer from a Korean Breast Cancer Registry analysis [2022]
• Sweden
  • Breast Cancer Research and Treatment
    • Swedish prospective multicenter trial on the accuracy and clinical relevance of sentinel lymph node biopsy before neoadjuvant systemic therapy in breast cancer [2017]
• United Kingdom
  • Association of Breast Surgery
    • Management of the Malignant Axilla in Early Breast Cancer [2015]
  • Clinical Oncology
    • Axillary Surgery Following Neoadjuvant Chemotherapy – Multidisciplinary Guidance From the Association of Breast Surgery, Faculty of Clinical Oncology of the Royal College of Radiologists, UK Breast Cancer Group, National Coordinating Committee for Breast Pathology and British Society of Breast Radiology [2019]
  • National Institute for Health and Care Excellence
    • Magtrace and Sentimag system for locating sentinel lymph nodes for breast cancer [2022]
    • Intraoperative tests (RD-100i OSNA system and Metasin test) for detecting sentinel lymph node metastases in breast cancer [2013]
    • Endoscopic axillary lymph node retrieval for breast cancer [2005]
• United States
  • American Society of Clinical Oncology
    • Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update [2017]
    • Management of the Axilla in Early-Stage Breast Cancer
  • Annals of Surgical Oncology
    • Do the ACOSOG Z0011 Criteria Affect the Number of Sentinel Lymph Nodes Removed? [2015]
  • BMC Surgery
    • DCIS and axillary nodal evaluation: compliance with national guidelines [2017]
  • Breast Cancer Research and Treatment
    • Axillary lymph node dissection in node-positive breast cancer: are ten nodes adequate and when is enough, enough? [2020]
  • Cancer
    • Cost-effectiveness of Choosing Wisely guidelines for axillary observation in women older than age 70 years with hormone receptor-positive, clinically node-negative, operable breast tumors [2022]
  • Current Oncology
    • Surgical Management of the Axilla in Invasive Lobular Carcinoma in the Z1071 Era: A Propensity-Score Matched Analysis of the National Cancer Database [2022]
  • JAMA Network Open
    • Trends in Sentinel Lymph Node Biopsies in Patients With Inflammatory Breast Cancer in the US [2022]
  • Journal of Surgical Research
    • Disparities of Management of the Axilla in Women With Clinically Node Negative Breast Cancer [2020]
• Venezuela
  • ecancermedicalscience
    • Treatment plan for breast cancer with sentinel node metastasis [2014]
• {Related topics}
  • Topic
    • Breast cancer
    • Breast biopsy, breast pathology

Triple negative breast cancer

• Africa
  • BMJ Open
    • Triple-negative breast cancer prevalence in Africa: a systematic review and meta-analysis [2022]
• Australia
  • Hereditary Cancer in Clinical Practice
    • Assessment of genetic referrals and outcomes for women with triple negative breast cancer in regional cancer centres in Australia [2021]
  • Medical Services Advisory Committee
    • PD-L1 (Programmed Death Ligand 1) immunohistochemistry (IHC) testing for access to atezolizumab as first line therapy for patients with locally advanced or metastatic triple-negative breast cancer (TNBC) [2021]
• Barbados
  • Cancer
    • High triple-negative breast cancer prevalence and aggressive prognostic factors in Barbadian women with breast cancer [2020]
• Brazil
  • BMC Cancer
    • Management of early-stage triple-negative breast cancer: recommendations of a panel of experts from the Brazilian Society of Mastology [2022]
• Developed countries
  • PharmacoEconomics
    • Economic and Humanistic Burden of Triple-Negative Breast Cancer: A Systematic Literature Review [2022]
• Europe
  • European Medicines Agency
    • The European Medicines Agency review of sacituzumab govitecan for the treatment of triple-negative breast cancer [2022]
• Finland
  • Breast Cancer Research and Treatment
    • FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population [2017]
• Germany
  • BMC Cancer
    • Adherence to treatment guidelines and survival in triple-negative breast cancer: a retrospective multi-center cohort study with 9156 patients [2013]
  • Geburtshilfe und Frauenheilkunde
    • Diagnosis and Therapy of Triple-Negative Breast Cancer (TNBC) – Recommendations for Daily Routine Practice [2019]
• India
  • JCO Global Oncology
    • Meta-Analysis of Prevalence of Triple-Negative Breast Cancer and Its Clinical Features at Incidence in Indian Patients With Breast Cancer [2020]
  • South Asian Journal of Cancer
    • Practical consensus recommendations on management of triple-negative metastatic breast cancer [2018]
• International
  • Asian Journal of Surgery
    • Efficacy of breast conservative surgery versus modified radical mastectomy for triple-negative breast cancer: A systematic review and meta-analysis [2022]
  • Breast
    • A systematic review and meta-analysis of BRCA1/2 mutation for predicting the effect of platinum-based chemotherapy in triple-negative breast cancer [2022]
  • Cancers
    • Breast-Gynaecological & Immuno-Oncology International Cancer Conference (BGICC) Consensus and Recommendations for the Management of Triple-Negative Breast Cancer [2021]
  • Technology in Cancer Research & Treatment
    • Molecular Classification, Treatment, and Genetic Biomarkers in Triple-Negative Breast Cancer: A Review [2023]
• Italy
  • Cancer Treatment Reviews
    • Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review [2023]
  • Cancers
    • Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medical Oncology (AIOM) [2019]
• Mexico
  • Breast Cancer Research and Treatment
    • The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer [2015]
• Republic of Korea
  • PLoS ONE
    • Prognostic Role of Adjuvant Chemotherapy in Node-Negative (N0), Triple-Negative (TN), Medullary Breast Cancer (MBC) in the Korean Population [2015]
• Thailand
  • PLoS ONE
    • Real-life clinical pattern, management, and survival in Thai patients with early-stage or metastatic triple-negative breast cancer [2018]
• United Kingdom
  • National Institute for Health and Care Excellence
    • Sacituzumab govitecan for treating unresectable triple-negative advanced breast cancer after 2 or more therapies [2022]
    • Pembrolizumab plus chemotherapy for untreated, triple-negative, locally recurrent unresectable or metastatic breast cancer [2022]
    • Pembrolizumab for neoadjuvant and adjuvant treatment of triple-negative early or locally advanced breast cancer [2022]
    • Atezolizumab with nab-paclitaxel for untreated PD-L1-positive, locally advanced or metastatic, triple-negative breast cancer [2020]
  • SpringerPlus
    • The treatment and survival of patients with triple negative breast cancer in a London population [2014]
• United States
  • Advances in Therapy
    • Cost-Effectiveness of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Single-Agent Pembrolizumab for High-Risk Early-Stage Triple-Negative Breast Cancer in the United States [2023]
  • Breast Cancer Research and Treatment
    • Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing [2014]
  • Frontiers in Public Health
    • Racial and regional disparities of triple negative breast cancer incidence rates in the United States: An analysis of 2011-2019 NPCR and SEER incidence data [2022]
  • JAMA Network Open
    • Clinical and Demographic Factors, Treatment Patterns, and Overall Survival Associated With Rare Triple-Negative Breast Carcinomas in the US [2021]
  • JNCCN
    • Integrating Immunotherapy in Early-Stage Triple-Negative Breast Cancer: Practical Evidence-Based Considerations [2022]
  • Oncologist
    • Sacituzumab Govitecan for Metastatic Triple-Negative Breast Cancer: Clinical Overview and Management of Potential Toxicities [2021]
• West Africa
  • JCO Global Oncology
    • Prevalence and Mortality of Triple-Negative Breast Cancer in West Africa: Biologic and Sociocultural Factors [2021]
• {Related topics}
  • Topic
    • Breast cancer